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Abstract 
In recent decades diabetes, most notably type 2, has become a considerable 
health problem in countries like Sri Lanka. Siddha Medicine is one of the four 
traditional medicines practised in Sri Lanka. α-Glucosidase inhibitors are one of 
the drugs types currently used to treat type 2 diabetes. However, they cause 
adverse side effects. The aims of this project are to identify, document, and 
make publicly available the plants historically and currently utilised to treat 
diabetes in Sri Lankan Siddha Medicine and identify one or more compounds 
capable of inhibiting α-glucosidase from the various plants studied. Historical 
documents used as Siddha Medicine degree textbooks in Sri Lankan 
universities were employed to obtain details on the plant species historically 
utilised. Apart from this, an ethnobotanical survey was carried out in the Eastern 
Province of Sri Lanka to identify the plant species currently used by Siddha 
empirical healers. Based on both the information from the historical documents 
and survey as well as the elimination of globally distributed and very well 
studied plant species, Achyranthes aspera, Coccinia grandis, Ipomoea 
aquatica, Mukia maderaspatana, and Artocarpus heterophyllus were selected 
for further study. The α-glucosidase inhibition assay was used to test inhibitory 
activity and Nuclear Magnetic Resonance spectroscopy was employed for 
metabolite profiling. In addition, Orthogonal Partial Least Square - Discriminant 
Analysis was employed to identify the compounds that showed α-glucosidase 
inhibition. Overall 171 species in 73 families were identified from the historical 
documents. Among them, Senna auriculata had been the most frequently cited 
species and the largest number of taxa was from the Fabaceae. Consultations 
with 27 Siddha empirical healers revealed 88 species from 46 families are 
currently used, while Syzygium cumini was the most frequently reported 
species. Remarkably, one-third of the currently used species was not listed in 
the historical documents. Again, Fabaceae yielded the largest number of 
species applied. The literature review of the documented plant species revealed 
that the majority of the species had in vivo antidiabetic evidence and the most 
number of studies were conducted in Type 1 diabetes models. The methanol 
extract of mature A. heterophyllus leaf exhibited the highest α-glucosidase 
inhibitory activity among the various extracts tested. Additionally, 38 samples of 
mature A. heterophyllus leaves had a range of IC50 values from 7.56 to 185.03 
µg/ml. There was a correlation observed between the α-glucosidase inhibitory 
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activity and the climatic conditions of the region from which the plant specimens 
used to prepare the extract was collected and the phytochemical composition. 
Metabolite profiling identified that Artoheterophyllin B might be the α-
glucosidase inhibitory compound found in the mature A. heterophyllus leaves. 
Hence, further phytochemical and pharmacological studies should be carried 
out to confirm this. This work created the foundation for more efficient studies of 
antidiabetic Sri Lankan SM preparations and the plants utilised in the future. 
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Research impact statement 
The population has diabetes is rising globally and diabetes causes life-
threatening complications with increased treatment costs. Traditional medicines 
have been used over centuries to treat numerous illenesses. Siddha Medicine 
(SM) is the traditional medicine which is mostly practised in the regions of Sri 
Lanka (SL) where the Tamils reside. Siddha empirical healers keep SM 
knowledge as secret and pass it to their next generation. Consequently, there is 
a need to identify, document, and make publicly available this knowledge to 
prevent from the future disappearance. Currently, Acarbose is one of the α-
glucosidase inhibitors utilised to treat type 2 diabetes (T2D) and it causes 
adverse side effects including diarrhoea, abdominal bloating, flatulence, and 
distention. Thus, an urgent need search for natural α-glucosidase inhibitors with 
no or less side effects.     
 
A huge number of plant species used to treat diabetes were identified from the 
Sri Lankan SM historical documents and the ethnobotanical survey carried out 
in the Eastern Province in SL in this study. A comparison study between these 
two sources revealed that there were changes and continuity in the SM 
diabetes treatment. Documentation of plants currently utilised to treat diabetes 
in the Eastern Province prevented the disappearance of this knowledge in the 
future. On top of that, the literature review conducted for several documented 
plant species showed that there was only a limited scientific evidence currently 
available. Therefore, this study suggests several potential plant species as the 
source for diabetes for future drug discovery studies.  
 
There was a massive variation of α-glucosidase inhibitory activity observed in 
38 samples of mature A. heterophyllus leaves. This suggests that a preliminary 
bioactivity screening should be performed to several plant samples to identify 
the most effective sample. This outcome can also be used to recognise mature 
Artocarpus heterophyllus leaves with more antidiabetic effects to make SM 
preparations.  
 
Finally, this work identified an α-glucosidase inhibiting plant extract (the 
methanol extract of mature Artocarpus heterophyllus leaves showed the 
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maximum α-glucosidase inhibitory activity) with 20 times more effect than the 
currently utilised one of the α-glucosidase inhibitors (Acarbose).  
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Chapter 1 
Aims and objectives 
 
1.1. Aims 
The aims of this study are: 
1. To identify, document, and make publicly available (the knowledge is kept as 
a secret) the plants used to treat diabetes in Sri Lankan Siddha Medicine (SM) 
to prevent this knowledge in future disappearance  
2. To identify natural α-glucosidase inhibitors (with from a documented plant 
species 
 
1.2. Objectives 
The objectives of this study are as follows: 
1. Identifying, documenting, and making publicly available the plants historically 
(Chapter 4) and contemporarily (which is kept as a secret) (Chapter 5) used to 
treat diabetes in Sri Lankan SM. 
• Knowledge of medicinal plant use in the Traditional Medicines (TMs) in 
Sri Lanka (SL) is at risk of disappearing due to the fast-socioeconomic 
changes and keeping the medicinal plant knowledge as a secret. Thus, 
there is a need to document this knowledge and make it available to the 
wider scientific community. More specifically, with the fast increase in 
diabetes globally and importantly in SL, it is essential to document and 
analyse both modern and historical uses of medicinal plants in the 
treatment of diabetes. Specifically, it is essential to describe the complex 
preparations used for the treatment of the condition and plant species 
included in these preparations.  
 
2. Assessing the level of antidiabetic scientific evidence for the documented 
plant species (Chapter 6) 
• Besides, with the majority of the rural population in SL still relies on TMs 
as their primary source of health care (Perera, P.K., 2012), such 
research can potentially provide alternative methods for primary care 
management of early stages of diabetes. This requires an assessment of 
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the current scientific knowledge of the pharmacological effects and 
possible clinical efficacy of the plants utilised.  
 
3. Identifying the natural α-glucosidase inhibitory compound/s from a selected 
plant species using metabolite profiling technique (Chapter 7) 
• Natural α-glucosidase inhibitors could be an economical, effective, and a 
safe way to control Type 2 Diabetes (T2D). Therefore, this project also 
aims to identify the natural α-glucosidase inhibitory compounds from a 
documented plant species used to treat diabetes in Sri Lankan SM using 
a rapid method (metabolite profiling). 
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Chapter 2 
Introduction 
2.1. Impact of diabetes globally 
Diabetes is causing increased strain on social and economic development in 
several developing countries. Undiagnosed diabetes cases increase the health 
cost of treatments and may also result in dangerous complications. In 2017, 
there were 425 million people living with diabetes globally. In other words, one 
in eleven people has diabetes. Unfortunately, half of the people (i.e. 212 million) 
have diabetes are undiagnosed (IDF, 2017). Furthermore, the most common 
type of diabetes is Type 2 diabetes (T2D), accounting for up to 90% of 
diagnosed diabetes cases (Bruno et al., 2005; Evans et al., 2000; Holman et al., 
2015). The majority of people diagnosed with diabetes live in the Western 
Pacific region (159 million) followed by South East Asia (82 million), Europe (58 
million), North America and the Caribbean (46 million), Middle East and North 
Africa (39 million), South and Central America (26 million), and finally Africa 
(except North Africa) (16 million) (IDF, 2017). The large proportion of diabetics 
(77%) live in low and middle-income countries due to limited access to 
biomedical health care (IDF, 2014). Additionally, the majority (two thirds) of the 
people with diabetes live in urban areas (279 million) with the rest living in rural 
areas (146 million). It has been found that those of working age (aged between 
20 and 64 years) account for 327 million of the people living with diabetes. In 
2045, the diabetic population is projected to increase to 629 million with a global 
increase of 48%. Moreover, in 2017 diabetes caused 4 million deaths worldwide 
in the age range between 20 to 79 years and global treatment costs for the 
disease amounted to US$ 727 billion (IDF, 2017). 
 
2.2. Impact of diabetes on Sri Lanka 
In 2017, there were 1.2 million people living with diabetes in Sri Lanka (SL) (20 
to 79 years) (IDF, 2017) and there were 625,000 undiagnosed cases in 2015 
(IDF, 2015). In 2016, it was found that diabetes was responsible for up to 7% of 
the deaths in SL (WHO, 2016), with the annual cost of treatment per person 
with diabetes is US$ 429.20 (IDF, 2015). 
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2.3. Diabetes in biomedicine 
Diabetes similarly referred to as hyperglycaemia, is defined by chronically 
elevated blood glucose concentrations (DeFronzo et al., 2015) in biomedicine 
(the definiation of biomedicine is stated in glossary). The insulin is secreted by 
the β-cells in the pancreas and released into the bloodstream. The blood 
glucose concentration will usually increase in cases where cells are unable to 
respond appropriately to the secretion of insulin. If untreated, diabetes can lead 
to various complications and may affect the nervous system, blood vessels, 
eyes, gums and teeth, heart, kidneys, or feet and skin (Zaccardi et al., 2015). 
The likelihood of suffering from diabetes can be lowered by both diet control 
and increased physical activity (WHO, 2017).    
 
Diabetes can be categorised into three types: 
1. Type 1 Diabetes or insulin-dependent diabetes: 
Type 1 Diabetes (T1D) is caused by the destruction of insulin-secreting β-cells 
in the pancreas by an autoimmune response. Hence, only very little or no 
insulin is secreted by the β-cells.  
2. Type 2 Diabetes or noninsulin dependent diabetes: 
T2D occurs when tissues develop insulin resistance and there is decreased 
secretion of insulin from the β-cells. 
3. Gestational diabetes: 
Gestational diabetes can occur during pregnancy. Pregnancy-related hormones 
such as human placental lactogen can interfere with insulin sensitivity (CDCP, 
2017).  
 
Diabetes is diagnosed using various blood tests in biomedicine, these include:  
1. Glycohaemoglobin (A1C) Test: 
This blood test measures the average blood glucose concentration over a two 
to three-month period. The result is expressed as a percentage and the normal 
level is below 5.7%, prediabetes is between 5.7 - 6.4%, and patients are 
diagnosed as being diabetic if their blood glucose concentration is over 6.5%.   
2. Fasting Plasma Glucose (FPG) Test: 
This diagnosis involves measuring the fasting blood glucose concentration. The 
standard fasting blood glucose level is between 70 and 100 mg/dl for 
nondiabetics and 126 mg/dl for diabetics.  
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3. Oral Glucose Tolerance Test (OGTT): 
This test measures the blood glucose concentration before and after two hours 
of drinking a sweet drink containing 75 g of sugar. The normal serum glucose 
level is lower than 140 mg/dl, between 140 – 100 mg/dl for pre-diabetes, and 
200 mg/dl and above for those with diabetes.  
4. Random Plasma Glucose Test: 
This blood test measures the blood glucose concentration of a non-fasting 
person. The normal blood glucose concentration is between 79 – 160 mg/dl, 
between 160 – 200 mg/dl is considered as pre-diabetes, and above 200 mg/dl 
is considered as diabetes (ADA, 2016). 
 
Currently, treatments are available for all types of diabetes. T1D is treated by 
injecting insulin and islet transplantation (Shahani and Shahani, 2015). T2D is 
commonly treated with oral drugs. Some of the different classes of drugs 
include:  
1. Insulin secretagogues: 
These drugs encourage the β-cells to secrete more insulin.  
E.g. Sulphonylureas, Meglitinides (glinides), and Incretins. 
2. Insulin sensitisers: 
These drugs decrease the production of glucose in the liver and assist the 
insulin to labour better in the fat and muscle. 
E.g. Thiazolidinediones (glitazones) and Metformin®. 
3. Direct plasma glucose reducers: 
These drugs reduce the amount of glucose produced by the liver and decrease 
the blood glucose levels.  
E.g. Sodium-Glucose Cotransporter-2 (SGLT2) inhibitors and Metformin® 
(Bailey et al., 2016). 
 
2.4.  α-Glucosidase inhibitory activity 
The enzyme α-glucosidase in the brush border of the small intestine is directly 
associated with glucose metabolism and soluble carbohydrate digestion. 
Oligosaccharides like disaccharides and polysaccharides and other 
carbohydrates (starch) are broken down into glucose (a monosaccharide) by 
the α-glucosidase enzyme (a carbohydrate-hydrolase). α-Glucose is released 
by hydrolysis of terminal non-reducing (1→4)-linked α-glucose residues by the 
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α-glucosidase enzyme. The released glucose is then absorbed into the intestine 
and then released into the bloodstream (Bischoff et al., 1985). Therefore, the α-
glucosidase inhibitory activity can decrease postprandial glucose concentrations 
in the bloodstream. By this, inhibiting α-glucosidase enzyme activity reduces the 
glucose absorption in the small intestine (Hanhineva et al., 2010). Currently, α-
glucosidase inhibitors as an illustration, Acarbose (Figure 2.1) are prescribed in 
biomedicine. Mechanism of action of α-glucosidase inhibitors (Acarbose) is 
shown in Figure 2.2. However, the currently available α-glucosidase inhibitors 
cause unwanted adverse side effects such as abdominal pain, diarrhoea, 
abdominal bloating, flatulence and distention (Bischoff et al., 1985). Notably, 
using natural α-glucosidase inhibitors could be an economical way to control 
postprandial hyperglycaemia and may cause fewer side effects compared to 
synthetic drugs (Matsui et al., 2006). Moreover, plants have a high α-
glucosidase inhibitory activity which could be used to manage T2D (Kwon et al., 
2006).   
 
 
Figure 2. 1 Chemical structure of Acarbose. Adapted from: 
https://www.sigmaaldrich.com/catalog/product/sigma/a8980?lang=en&region=G
B 
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Figure 2. 2 Mechanism of action of α-glucosidase inhibitors. (a) 
Oligosaccharides are broken down by α-glucoside to monosaccharides, which 
are simply absorbed in the small intestine brush border (the absence of an α 
glucosidase inhibitor (Acarbose)). (b) Oligosaccharides are not broken down by 
α-glucosidase to monosaccharides while the presence of an α-glucosidase 
inhibitor (Acarbose). Hence, production and absorption of monosaccharides are 
decreased in the small intestine brush border. AG: α-Glucosidase, AGI: α-
Glucosidase inhibitor (Acarbose). Adapted from: Arungarinathan et al. (2011). 
 
2.5. Plants and diabetes – the big picture 
Plants have been utilised for centuries in traditional medicines (TMs) to treat 
several illnesses, including diabetes (Nearing, 1985), whereby its treatments 
have to a great extent vanished in developed countries. In spite of the changes 
over the years, some patients still take food supplements based on traditional 
medicinal knowledge and some preparations are prescribed by the alternative 
medicinal practitioners (Bailey and Day, 1989). In the USA, 22% of people living 
with diabetes use herbal therapy while 31% use dietary supplements (Shane-
McWhorter, 2009). Conversely, it has been found that plants are still widely 
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used in developing countries to treat diabetes due to the limited access to 
biomedicine (Ajiboye A.T. et al., 2016a). Other factors that contribute to the use 
of plants in developing countries is that fact that plants are easily available and 
affordable (Nearing, 1985).  
 
Several plants utilised in TMs have shown positive antidiabetic effects linked to 
managing T2D (Jia et al., 2003; Yeh et al., 2003). Thus, plants are a more 
suitable natural source for antidiabetic drug discovery (Harvey, 2010). 
Metformin is a biguanide currently used as the primary drug for control of T2D in 
biomedicine and was developed from galegine (a guanidine) isolated from 
Galega officinalis L. (Fabaceae) (Witters, 2001).   
 
The most of the terpenoids and flavonoids isolated from natural sources 
showed antidiabetic activity (Yin et al., 2014). Approximately, 1200 plant 
species have been identified as being able to treat diabetes in TM. On top of 
that, 80% of TM preparations have shown antidiabetic activity in 
pharmacological studies (Marles and Farnsworth, 1995). TM preparations may, 
therefore, provide the foundation for developing new antidiabetic medications 
and dietary supplements (Bailey and Day, 1989).  
 
Examples of antidiabetic compounds isolated from plants and their mechanisms 
are discussed further. Cinnamaldehyde belongs to the lignan class of 
compounds and is isolated from Cinnamomum verum J.Presl (Lauraceae). Oral 
administration of 3 mg/kg body weight to Streptozotocin-induced diabetic rats 
for 45 days significantly decreased (63.29%) blood glucose concentration in a 
dose-dependent way compared to Glibenclamide (0.6 mg/kg). Besides, 
cinnamaldehyde (20 mg/kg body weight) notably reduced concentrations of 
glycosylated haemoglobin (A1C), triglyceride, and total cholesterol in the blood. 
It also elevated levels of hepatic glycogen, high-density lipoprotein cholesterol, 
and insulin in the blood, which returned the levels of enzymes such as alanine 
aminotransferase, alkaline phosphatase, acid phosphatase, aspartate 
aminotransferase, and lactate dehydrogenase to the usual level (Subash Babu 
et al., 2007).   
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In another study carried out by Noor Shahida et al. (2009), Bruceine D (a 
terpenoid) was isolated using the bio-assay guided isolation technique from the 
seeds of Brucea javanica (L.) Merr.. Oral administration of 1 mg/kg of Bruceine 
D to Streptozotocin-induced diabetic rats for 8 hours exhibited a notable plasma 
glucose reduction of (88%). Glibenclamide (3 mg/kg) was utilised as a positive 
control and was found to reduce blood glucose levels by up to 47%. 
 
2.6. Biodiversity of Sri Lanka 
SL is a South Asian island situated in the Indian Ocean. It has an area of 65 
610 km2 and a population of 21.2 million. The largest ethnic group is Sinhalese 
(75%), followed by Sri Lankan Tamil (11%), Sri Lankan Moor (9%), and Indian 
Tamil (4%). The official and national languages of SL are Sinhala and Tamil. 
The major and official religion is Buddhism (70%) followed by Saivism (13%), 
Islam (10%), and Christianity (7%) (DCSSL, 2017). 
 
SL has three climate zones, namely dry, intermediate, and wet zones. These 
zones have been classified based on the amount of annual rainfall experienced 
in the regions. Furthermore, the principle topographies determined by the 
elevations from the sea level and there are three types of topographies: coastal 
(0 to 30 m), plain (31 to 200 m), and highland (above 200 m) (DMSL, 2016). 
Added to that, the major soil groups include red-yellow podzol, reddish brown 
latosol, red and yellow latosol, and red-brown earths (Panabokke, 1996). 
 
SL is one of the 34 ‘biodiversity hotspots’ in the world and it possesses a great 
number of endemic plant species (IUCN, 2016). So far, 4,143 plant species 
from 214 families have been identified. In these plant species, 75% are 
indigenous to SL while 25% of them are either introduced or exotics. Besides, 
32% have become naturalised and 68% have been cultivated (Senaratna, 
2001). In 2010, nearly 29.7% of the Sri Lankan land area was covered by 
natural forests. The vegetation can be categorised as follows, according to the 
impact of soil and elevation: Montane, submontane, lowland rain, moist 
monsoon, dry monsoon, riverine dry, sparse and open, and mangrove forests 
(FDSL, 2017). The main export crops are Camellia sinensis (L.) Kuntze 
(Theaceae) (tea), Hevea brasiliensis (Willd. ex A.Juss.) Müll.Arg. 
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(Euphorbiaceae) (rubber), and Cocos nucifera L. (Arecaceae) (coconut) (MFSL, 
2017). 
 
2.7. Siddha Medicine 
Siddha Medicine (SM) is also called Tamil Medicine and it is originated in the 
main Tamil land in India from BCE 10,000 to 4,000. It is believed to be the 
premier medicinal system around the world (NIS, 2018). Yet, it is currently 
practised mostly in Tamil speaking regions in India and SL (AYUSH, 2018). SM 
has been recognised as a main Alternative East Indian Medicine within Tamils 
(Stephen, 2005). At present, SM is suitable for the treatment of all disorders 
apart from emergency cases (AYUSH, 2018). 
 
Siddha means “heavenly bliss” or “attaining perfection in life”. Siddhars are 
considered as superhumans who have supernatural powers, great scientists, 
and preservers of the globe. They had a huge intelligence. Siddhars are 
believed to have the ability to predict the future and they developed SM by 
including Yoga, rejuvenation therapy, astrology, philosophy, alchemy, and 
astronomy (NIS, 2018). There are 18 Siddhars who have contributed to SM: 
Agathiyar (அகத்தியர்), Thirumoolar (திருமூலர்), Bogar (ப ோகர்), Konganar 
(ககோங்கணர்), Therayar (பேரையர்)¸ Korakkar (பகோைக்கர்), Karuvooraar (கருவூைோர்)  , 
Idaikkaadar (இரைக்கோைர்), Sattamuni (சட்ரைமுனி), Suntharaananthar 
(சுந்ேைோனந்ேர்), Iraamathevar (இைோமபேவர்), Paampaatti ( ோம் ோட்டி), 
Machchamuni (மச்சமுனி), Kuthampai (குேம்ர ), Aluhannar (அழுகண்ணர்) , 
Ahappe (அகப்ப ), Nanthithevar (நந்திபேவர்), and Kahapusundar (கோகபுசுந்ேர்) 
(Uthamaroyan, 1992). There are a few notable Sri Lankan Siddhars who lived in 
the Eastern and Northern Provinces of SL. Especially, Yogarswami 
(பயோகர்சுவோமி) who lived half a century ago and his guru Sellappaswami 
(கசல்லப் ோசுவோமி); both lived in Jaffna and are reknown around the world 
(Anonymous, 2015). 
 
SM is based on Saiva philosophy. Saivism is one of the six branches of 
Hinduism and it reveres Sivaperuman as the main God. In SM, a human body is 
considered as a miniature of the universe (‘universe-body’ principle). In other 
words, the association between the universe and the human body 
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(Narayansami, 1975). The human body is composed of five principal elements: 
earth, water, fire, wind, and sky, whereas the human body functions are 
retained by three forces or faults, which are wind, bile, and phlegm. 
Nonequilibrium of these three forces are the cause of illnesses and Siddhar 
Yugimuni identified 4,448 disorders in SM (Ramanathan, 2008). 
 
SM places equal importance on body, mind, and spirit. It aims to make the body 
perfect and promote longevity by reinstating the essential balance between the 
mind and the human body. Lifestyle and diet are very important in treating 
illnesses as well as preserving health. There are some common philosophical 
concepts of Siddhars as “food is medicine, medicine is food” and “sound mind 
makes a sound body” (Sivasanmugarajah, 2001).  
 
SM treatments are considered as individual treatments. They are provided to 
patients based on their environment, age, gender, lifestyles, habitat, mental 
state, meteorological condition, appetite, physiological structure, and physical 
state (AYUSH, 2018). Moreover, SM has three types of treatments: divine, 
rational, and surgical treatments. In divine treatments, inorganic substances 
such as mercury and sulphur are used in the preparations. On the other hand, 
botanical ingredients are utilised in the preparations in rational treatments, 
whereas, surgical treatments, heat implementation, leech application, incision, 
bloodletting, and excision are employed. Ameliorative treatments in SM are 
further classified into fasting, purgative, steam, emetic, solar, oleation, Yoga, 
physical, and bloodletting therapies. In addition to these three tyes of 
treatments, the other type is called Varma, which is available for accidental 
injuries and traumatology. Such treatment is based on the concept of 100 
essential points (Varma points) which are the joints of ligaments, tendons, 
nerves, blood vessels, and bones. The principle behind this treatment is 
concentrating life energy (energy retains the body powerful and alive) on these 
joints during the manipulation to provide healing (Sivasanmugarajah, 2002). 
 
SM has eight different ways through which diagnosis is performed, these 
include the examination of the tongue, skin, pulse, speech, complexion, eye, 
urine, and stool. The pulse examination is the most significant diagnosis 
technique when determining the illness. A urine examination technique called 
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Neerkkuri (நீர்க்குறி) used in SM is unique and involves releasing a drop of 
sesame oil onto the collected urine (usually the patient’s first urine of the day) 
after which the shape and pattern of spreading are observed. The fundamental 
principle behind this diagnosis is linked to the surface tension of the urine 
(Narayansami, 1975). 
 
SM preparations are grouped into three classes: miracle, sophisticated, and 
common preparations. Miracle preparations are rare and they must be learned 
directly from a guru. A guru is a person who has achieved perfections in 
everything by experiencing all types of risks of the traineeship. Sophisticated 
preparations are produced precisely and prescribed by a trained Siddha 
practitioner without any hazard. Common preparations are the most economic 
and simple preparations widely utilised by the public, especially in the rural 
regions (Ramanathan, 2008).     
 
Ingredients used in the SM preparations are categorised into three herbal, 
inorganic (metals and minerals), and animal (incorporating marine organisms) 
materials. There are 32 types of internal and external treatment techniques 
employed in SM and they include cold and heat application, bloodletting, bath, 
ointments, suction, counter-irritation, decoctions, creams, dexterous procedures 
like Yoga and Varma (see above), diet and sanitation focus, emetics and 
purgatives use, precautionary techniques for grey hair, ageing and wrinkle 
formation, and illnesses, as well as deferring death for a desired length of time. 
In addition, pilgrimage, mountaineering, and peregrination are likewise utilised 
as practical treatment techniques (Sivasanmugarajah, 2001). 
 
2.8. Siddha Medicine in Sri Lanka 
The Sri Lankan Ministry of Health equally recognises both biomedicine and TMs 
(Sivashanmugarajah, 2000). In biomedicine, blood tests, x-rays, scanning, and 
surgeries are provided free of charge for all the citizens receiving treatment in 
state hospitals. Importantly, TM services are also provided free of charge in 
specialised hospitals. The Ministry of Indigenous Medicine is part of the Ministry 
of Health, Nutrition, and Indigenous Medicine and is responsible for TM services 
(Ministry of Health, Nutrition, and Indigenous Medicine, 2018). There are four 
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TMs (Ayurveda, Siddha, Unani, and Deshiya Chikitsa) currently practised with 
Desheeya Chikitsa known as the native TM of SL (Weragoda, 1980).  
 
SM is mostly practised in the Eastern and Northern Provinces of SL where the 
majority of Tamils reside. SM is recognised as the second-ranked TM by the Sri 
Lankan government (Sivashanmugarajah, 2001). Even so, SM preparations are 
manufactured and supplied to the state Siddha hospitals by the SL Ayurveda 
Drugs Corporation (SLADC, 2018). 
 
Both Siddha graduates and Siddha empirical healers (SEHs) currently provide 
SM treatments in SL (see below). Both services are accepted by the 
government, still, there is no association between them. The illnesses are 
diagnosed based on the SM clinical knowledge of both Siddha graduates and 
SEHs. Additionally, some of the preparations and ingredients used are not the 
same. Siddha graduates and SEHs must register with the Ayurvedic Medical 
Council functioning as a part of the Ministry of Health, Nutrition, and Indigenous 
Medicine before starting the medical practice. Siddha graduates can directly 
register. Anyhow, all the SEHs currently practising must pass a standard 
nationwide examination in SM conducted by the Ministry of Indigenous 
Medicine to register with the Ayurvedic Medical Council. As of 2008, there still 
were some, mostly older SEHs, who were not registered with the Ayurvedic 
Medical Council (Ramanathan, 2008). Although, specific latest data are not 
available. 
 
SEHs practise both in urban and rural regions. Despite that, the majority of 
them reside in the rural regions. They are self-employed and practise from their 
homes. Information about the ingredients in the preparations, preparation 
methods, and their properties, processing, purification, antidote, toxicity, 
dosage, and clinical administration are conserved in verse form and this 
information is only passed on within the family and to the future generations of 
the SEHs. As such, the details include the ingredients and preparations utilised 
by SEHs is not publicly known. The Ministry of Indigenous Medicine has been 
carrying out workshops and seminars about good practice for registered SEHs. 
The ministry also has been gathering information about the difficulties 
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experienced by the SEHs in obtaining and collecting ingredients to improve the 
service provided by the SEHs to the public (Ramanathan, 2008).   
 
There are two universities that offer a Bachelor of SM and Surgery (BSMS) 
degree - the Eastern University of SL in Eastern Province and the University of 
Jaffna in the Northern Province. This is a five-year degree course that 
comprises a year of internship at state Siddha hospitals. In both universities, 
separate Siddha faculties have been established similar to the faculties of 
biomedicine. In spite of that, the first two years for both SM and biomedicine 
students are taught together. For example, anatomy and biochemistry. Only SM 
graduates (i.e. not SEHs) can work as doctors at state Siddha hospitals 
(Ramanathan, 2008). 
 
2.9. Diabetes in Siddha Medicine 
The causes, signs, and symptoms of diabetes in terms of SM principles differ 
from biomedicine. For this reason, in this context terms in biomedicine like T1D 
and T2D are not meaningful. In SM diabetes is called Neerilivu (நீரிழிவு) or 
Salakkalichchal (சலக்கழிச்சல்) (losing water), Salaroham (சலபைோகம்) (water-
related disease), and Mathumeham (மதுபமகம்) (sweet urine). Based on these 
concepts it is characterised by frequently passing hot urine and passing foamy 
urine, like a pearl (drop) of fresh honey in the water. Diabetes is likewise seen 
as an incurable disease and it is classified as one of the 20 types of polyuria 
(பமகபைோகம் - Meharoham) related conditions. These 20 types are categorised 
into three groups: fire (six types), wind (four types), and water-related (ten 
types). Diabetes is considered one of the four types of wind-related polyuria 
related conditions (Anonymous, 2003). 
 
2.9.1. Causes of diabetes 
Diabetes (Neerilivu) is considered to be caused by excess consumption of 
foods which increase the coolness of the body, such as ghee, curd, and milk, 
sour foods, meat, and Irasam (இைசம்), irregular eating, eating disorder, not 
applying oil on the body, excessive walking in the sun, and excessive sexual 
intercourse (Anonymous, 2000).  
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Irasam is a decoction (commonly utilised as a gravy on diverse dishes) 
prepared using Cuminum cyminum L. dried fruit (Apiaceae), Coriandrum 
sativum L. dried fruit, Allium cepa L. (Amaryllidaceae) fresh bulb, A. sativum L. 
dried bulb, Tamarindus indica L. (Fabaceae) dried fruit juice, Piper nigrum L. 
(Piperaceae) dried fruit, Murraya koenigii (L.) Spreng. (Rutaceae) fresh leaf, 
Capsicum annuum L. (Solanaceae) dried fruit, and Curcuma longa L. 
(Zingiberaceae) dried rhizome powder (Anonymous, 2000). 
 
2.9.2. Signs of diabetes 
The signs of diabetes are believed to invlove feeling lazy, excessive sweating, 
body odour, tiredness, grease formation on tongue, sweet taste in mouth, 
desiring to consume cold drinks and foods, dry tongue, chest, and throat, rapid 
growth of hair and nails, ants and flies gather around the urine, burning 
sensation in the stomach, paleness of body skin, weight loss, loss of 
consciousness, feeling thirsty, nocturia, difficulty in walking, blurred vision on 
humid, foggy, and rainy days, excessive urination, feeling depressed, desire to 
quench thirst by drinking buttermilk and coconut water, loss of appetite, body 
ache, passing clear and foamless urine during day and night, extreme pain, ear 
congestion, insomnia, passing urine with properties of coconut water during the 
night, and body weakness and it may cause death (Anonymous, 2000; 
Anonymous, 2003). 
 
2.9.3. Types of diabetes  
In SM, 24 types of diabetes are distinguished and grouped into seven 
categories. The categories are based on the elements of the human body and 
the types are based on the taste and odour of the urine. The seven categories 
are: 
1. Wind associated diabetes, which includes three types and the urine is 
characterised by: 
• An odour of Mangifera indica L. (Anacardiaceae) flower and sour taste  
• An odour of Crocus sativus L. (Iridaceae) flower and sour-bitter taste 
 
2. Wind-fire associated diabetes which contains four types and the urine is 
characterised by: 
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• An odour of Curcuma longa L. rhizome (Zingiberaceae) and sour-bitter 
taste 
• An odour of Nerium oleander L. (Apocynaceae) flower and sweet-
pungent-bitter-sour-astringent taste  
• An odour of milk and buttery taste 
• An odour of the brain and bitter taste 
 
3. Fire associated diabetes which contains three types and the urine can be 
characterised by: 
• An odour of fruit juice and bitter taste  
• A salty odour and taste 
• An odour of Jasminum sambac (L.) Aiton (Oleaceae) flower and 
producing a burning sensation when urinating 
 
4. Fire-wind associated diabetes which includes two types and the urine is 
characterised by: 
• An odour of cow urine and astringent taste 
• An odour of Santalum album L. (Santalaceae) wood and peppery taste 
 
5. Water associated diabetes which contains four types and the urine is 
characterised by: 
• An odour of Pandanus odorifer (Forssk.) Kuntze (Pandanaceae) flower- 
cow manure-lemon-blood and sweet taste 
 
6. Water-fire associated diabetes which includes four types and the urine is 
characterised by:  
• An odour of Magnolia champaca (L.) Baill. ex Pierre (Magnoliaceae) 
flower 
• A taste like Syzygium cumini (L.) Skeels (Myrtaceae) fruit  
• A bad odour and a bitter-sour taste as well as ants gathering around the 
urine 
• An odour of slaked lime (calcium hydroxide) and producing a burning 
sensation (similar to the one caused by lime (calcium oxide) when 
urinating  
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7. Water-wind associated diabetes which contains four types and the urine is 
characterised by:  
• A strong odour and sour taste (Sithamparthanuppillai, 1982).   
 
2.9.4. Complications of diabetes 
Diabetes complications in SM incorporate lower abdominal pain, tiredness after 
urinating, flatulence, increased deficiency in sperm secretion, sperm in urine, 
general body weakness, loss of appetite, abscess formation, diarrhoea, 
unconsciousness, and death (Sithamparthanuppillai, 1982).   
 
2.10. Level of scientific evidence available for plant species 
TM is to a great extent not accepted by biomedical practitioners because 
traditional medicinal preparations have limited scientific evidence. For traditional 
medicinal preparations or medicinal plants to be accepted by biomedical 
practitioners, scientific evidence such as the safety and efficacy of the 
preparations are essential (Lemonnier et al., 2017; Wright et al., 2007). Equally, 
the existing data on preparation safety needs to be assessed. There are some 
benefits of grouping the levels of scientific evidence available for each plant 
species. Through this it will be possible to identify plant species that could be of 
interest for further study.  
 
As in previous studies, the plants used in TM were categorised based on the 
traditional and scientific evidence available. For example, in a study conducted 
by de Montellano (1975), the plant species were classified based on information 
as plant species recognised botanically and the phytochemicals isolated. The 
findings of this study suggested to use both the traditional and modern 
knowledge to assess the effectiveness of the plant species utilised in TM.  
 
Another study, by Heinrich et al. (1992) determined that the majority of the plant 
species reported to treat gastrointestinal illnesses in an ethnobotanical survey 
already had scientific evidence. Furthermore, Edwards et al. (2015) also 
classified common medicinal plants according to the maximum level of scientific 
evidence currently available in each. 
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In order to accept TM preparations within the modern health care practice, an 
assessment of potential toxic effects is essential. Toxicity can be split into 
intrinsic and extrinsic. Intrinsic toxicity can occur at either a normal dose or in 
the event of an overdose. The extrinsic toxicity can occur due to the 
contamination of preparations with microorganisms, heavy metals, pesticides, 
fertilizers, wrongly processed materials, and the addition of the wrong 
ingredients  (Zhang et al., 2012) or accidental or intentional adulterations.  
 
An example of intrinsic toxicity is seen with the aristolochic acids (aristolochic 
acid I and II) the principle toxic phytochemicals identified in plant species from 
the Aristolochiaceae. Aristolochic acid I and II cause direct damage to human 
epithelial kidney cells (HEK293) (Bakhiya et al., 2009). In a more recent study, 
aristolochic acids containing herbal preparations consumed by patients in South 
Korea had Fanconi syndrome (a kidney tubule function disorder) and severe 
kidney injuries (Ban et al., 2018). They are similarly toxic to other parts of the 
body (stomach and glomerular) (Kumar V. et al., 2003). Moreover, chronic 
administration of high dose of these compounds can lead to tubular epithelial 
cell death, urothelial cancer, damage to DNA, tubulointerstitial fibrosis, and 
renal failure (Debelle et al., 2008; Li et al., 2010).  
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Chapter 3 
Materials and methods 
3.1. Plants historically used to treat diabetes in Sri Lankan 
Siddha Medicine 
3.1.1. Sri Lankan Siddha Medicine historical documents 
There are several SM historical documents originally written and compiled in 
Tamil in SL. Still, they are all currently not accessible. On the other hand, some 
of the historical documents currently used as textbooks in Sri Lankan 
universities in the Bachelor of SM and Surgery (BSMS) degree are widely 
available and easily accessible. These textbooks are considered to be 
standardised Siddha historical documents and they form the basis of SM 
knowledge for SM graduates. This study, because of that, utilised these 
textbooks to obtain the information about historical antidiabetic Sri Lankan 
Siddha preparations. The three SM historical documents used were:  
1. Pararasaseharam (Fifth Part) ( ைைோசபசகைம் (ஐந்ேோம்  ோகம்) - 
Pararaasaseharam (Ainthaam Paaham)): This document was compiled under 
King Pararaasaseharan ( ைைோசபசகைன்) between 1478 and 1519. It was initially 
printed as a book in 1935 by Ponniapillai, I. in Mallaaham and reprinted in 2003 
by Sripathy Sarma, P. and published by Niyanthree Publication in Nallur, Jaffna, 
SL. (Anonymous, 2003).  
2. Seharaasasehara Treatment (கசகைோசபசகை ரவத்தியம் - Seharaasasehara 
Vaiththiyam): Contents of this document were compiled under King 
Seharaasaseharan (கசகைோசபசகைன்) between 1380 and 1414. It was first printed 
in 1927 by Ponniapillai, I. and reprinted in 2000 by the Provincial Department of 
Indigenous Medicine, Ministry of Health Eastern and Northern Provinces. 
(Anonymous, 2000). 
3. Siddha Medicinal Procedure (சித்ே ஔைே கசய்முரை - Siththa Audatha 
Seimurai): This book was compiled by Ponniah, S.M. and Sabapathipillai, I. in 
1980 and published by the Department of Ayurveda, Ministry of Health and 
Indigenous Medicine. (Ponniah and Sabapathipillai, 1980). 
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Only Anonymous (2003) and Anonymous (2000) contain both information about 
the symptoms and causes of diabetes as well as information on the 
preparations. On the other hand, Ponniah and Sabapathipillai (1980) only 
consists of information about the preparations. Only Sri Lankan origin 
preparations were considered in this study, consequently, a few preparations 
mentioned in Ponniah and Sabapathipillai (1980) were excluded because they 
were stated as Indian origin. 
 
3.1.2. Plant species stated in the Sri Lankan Siddha Medicine historical 
documents  
Causes, signs and symptoms, and antidiabetic preparations were written in the 
form of verses in ancient Tamil in the historical documents Anonymous (2000; 
2003). These verses were translated to modern Tamil and the names of the 
plant species were confirmed by Dr. Pholtan R Rajamanoharan (an SM 
graduate, community Siddha medical officer, planning officer at the Planning 
Unit, Provincial Department of Indigenous Medicine, and in charge of the 
Provincial Herbal Garden in Trincomalee). Ponniah and Sabapathipillai (1980) 
only comprises historical Sri Lankan and Indian SM antidiabetic preparations 
written in modern Tamil. It is important to note that there might be some 
inconsistencies in the plant species names mentioned in the historical 
documents and current botanical identification. The exact botanical identification 
was based on the information available in the historical documents only. All the 
plant species stated in the historical documents are presented in Appendix A.  
 
3.2. Plants contemporarily used to treat diabetes in Sri Lankan 
Siddha Medicine 
3.2.1. Ethnobotanical study region 
An ethnobotanical survey was conducted with SEHs residing in the Eastern 
Province of SL to obtain information about the plants they use to treat diabetes. 
The Eastern Province is one of the nine Provinces in SL and it consists of three 
districts (Batticaloa, Ampara, and Trincomalee) (Figure 3.1). The Eastern 
Province covers an area of 9,996 km2 and it falls in the dry climatic zone 
(DCSSL, 2011). The major language spoken is Tamil and the total population is 
1.6 million and is mainly made up of Sri Lankan Tamil (40%) followed by Sri 
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Lankan Moor (37%), Sinhalese (23%), and Indian Tamil (0.5%). The significant 
vegetation types identified in Eastern Province include dry mixed evergreen, 
grasslands, riverine, and mangrove forests (Dittus, 1985; Erdelen, 1988). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Map of the study region. Source: 
https://en.wikipedia.org/wiki/Eastern_Province,_Sri_Lanka 
 
3.2.2. Ethical approval for the research 
Research ethical approval was obtained from the UCL Research Ethics 
Committee (9141/001) on 13.06.2016 before conducting the interviews in SL. 
The purpose of this study and the informed consent sheet were read to each 
SEH before beginning the interview. The interviews were carried out only after 
receiving verbal consent from each SEH. SEHs participated voluntarily in this 
study. On top of that, they were free to withdraw at any point of the interview 
and no compensation was provided for participating in the interview. 
 
This study was conducted after recognising the relevant obligations under the 
Convention on Biological Diversity United Nations (2011). The protocol had not 
been signed or ratified yet by SL on 23.09.2018 (at the time of writing this 
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chapter). However, the UK ratified it on 22.02.2016 
(https://www.cbd.int/abs/nagoya-protocol/signatories/, accessed on 
23.09.2018). The right to authorship and use of the traditional knowledge of all 
informants was preserved. Still, using this information, except in scientific 
publications requires permission from the traditional owners of this knowledge. 
No permission is required by the government to collect and preserve plant 
material samples within SL. This ethnobotanical survey was started prior to the 
publication of the ConsEFS statement of best practice in ethnopharmacological 
research Heinrich et al. (2018). In spite of this, the ethnobotanical survey 
undertaken as part of this study has followed the guidelines outlined in Heinrich 
et al. (2018). 
 
3.2.3. Ethnobotanical data collection and interviews 
The ethnobotanical survey was conducted from 1st July to September 2016. I 
personally conducted the interviews with the SEHs and Dr. Pholtan R. 
Rajamanoharan was also present during all the interviews. The interviews were 
carried out in Tamil and the SEHs referred to the plant species using the Tamil 
names.  
 
So far, 92 SEHs have registered with the Ayurveda Medical Council in the 
Eastern Province (AMCSL, 2018). The participants were actively chosen by Dr. 
Pholtan R. Rajamanoharan from the database of the registered SEHs. 
Furthermore, permissions and appointments were obtained verbally from each 
SEH by Dr. Pholtan R. Rajamanoharan through telephone calls. All the 
interviews were conducted in SEHs’ homes. Anyhow, some of the SEHs who 
have provided permissions to participate in the survey were not able to 
participate in this study at the end due to unforeseen personal circumstances, 
while other SEHs directly refused to take part in this study. Accordingly, only 33 
SEHs participated in this study. Of those who participated, six of them 
mentioned that they do not carry out any treatment for diabetes. On that 
account, they were excluded from this study. Interviews were conducted using a 
questionnaire which includes semi-structured questions (Appendix D). The 
questions focused on the social and demographic data (the gender, age, years 
of practice, and plant species currently utilised to treat diabetes) and interviews 
with each SEH lasted for a minimum of 15 minutes. 
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3.2.4. Scientific plant species names  
Scientific names of the plant species stated in the historical documents and 
reported by the SEHs were obtained from Sugathadasa et al. (2008). They were 
then taxonomically validated using electronic databases like The Plant List 
(2013) and the Royal Botanic Gardens, Kew, Medicinal Plant Names Services 
(2016).  
 
3.2.5. Voucher specimens and plant identification 
Only plant species reported by the SEHs in the ethnobotanical survey were 
collected as voucher specimens. Priority was given to the plant species 
commonly available and cultivated in the Eastern Province. Fieldwork to collect 
plant part samples was conducted between September 2016 and June 2017. 
This is the ideal period for collecting flower and fruit specimens of most of the 
reported plant species. Collected plant samples were identified and confirmed 
by Dr. Pholtan R. Rajamanoharan. Herbarium specimens were prepared and 
deposited in the Herbarium of the Provincial Herbal Garden, Trincomalee for 
future reference. Voucher specimen numbers are indicated where applicable, in 
Table 5.2. 
 
Voucher specimens of the five plant species collected to identify the 
compound(s) which cause α-glucosidase inhibition were also deposited at the 
Provincial Herbal Garden, namely VSAA2014 (A. aspera), VSIA2014 (I. 
aquatica), VSCG2014 (C. grandis), VSMM2014 (M. maderaspatana), and 
VSAH2014 (A. heterophyllus).  
 
3.2.6. Ethnobotanical data analysis 
The plant species documented from both historical documents and the 
ethnobotanical survey were categorised as being either food or medicinal 
plants, based on the local use in the Eastern Province by myself and Dr. 
Pholtan R. Rajamanoharan as well as using published works such as 
Rajapaksha (1998), Sugathadasa et al. (2008), and Jayaweera (2006, 1982, 
1981, 1980).  
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3.2.7. Comparison of the historical and contemporary use of plants 
The plant species mentioned in the historical documents were compared with 
the species reported by the SEHs in the ethnobotanical survey. Further, plant 
species which were reported to treat diabetes in the other ethnobotanical 
surveys carried out in the other regions include Jaffna (Rajamanoharan, 2014) 
and Vavuniya (Rajamanoharan, 2016) where SM is practised in SL were 
compared.  
 
3.2.8. The assessment of the currently available scientific evidence  
Initially, electronic databases (Web of Science, Scopus, and PubMed) were 
used to identify the relevant published scientific evidence of the documented 
plant species. The majority of the results obtained using Scopus, and PubMed 
were similar to the results obtained using Web of Science. On the other hand, 
full texts of some of the results those appeared on Scopus and PubMed were 
not available and accessible online. Thus, the relevant published scientific 
evidence was identified using a Web of Science search which looked at from 
1900 to September 2017. The Web of Science database contains the following 
collections: Web of Science Core Collection (containing the world’s leading 
scholarly books, journals, and proceedings from 1900 - present), BIOSIS 
Citation Index (an extensive index comprising biomedical and life sciences 
research from 1926 – present), Current Contents Connect (containing a 
comprehensive table of contents of leading scholarly journals from 1998 - 
present), Data Citation Index (covers the data sets of international discovery 
research from 1994 - present), Derwent Innovations Index (containing world 
patent index from 1994 - present), KCI-Korean Journal Database (covering 
scholarly literature originally published in Korea from 1980 - present), 
MEDLINE® (The U.S. National Library of Medicine®  which is the primary 
database of life sciences, containing published literature from 1950 - present), 
Russian Science Citation Index (covering core Russian academic articles from 
2005 - present), and SciELO Citation Index (containing leading open access 
journals published in countries involing Spain, Portugal, South Africa, and Latin 
America from 1997 - present). Hence, the feature “All Databases” was chosen 
to obtain the most comprehensive results across all the above-mentioned 
databases.  
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The quality of an academic journal article was determined by giving priority to 
works published by leading scholarly publishers such as Elsevier, Springer, 
Taylor & Francis, and Wiley-Blackwell (Wischenbart, 2015). The other factors 
as the number of citations made, authors of the article (background, number of 
articles published, etc.), and the date of the publication were considered as the 
quality check for the articles, which are not published by the leading scholarly 
publishers. 
   
The plant species mentioned in American Herbal Pharmacopoeia (2011), 
Brendler (2010), European Medicines Agency (2009), Upton et al. (2016) and 
World Health Organization Monographs on Selected Medicinal Plants – 
Volumes 1 to 4 (1999; 2004; 2007; 2009) were excluded from the literature 
search. This was because the plant species stated in these works were globally 
distributed and scientifically very well studied. 
 
Taxonomically validated plant species names (both genus and species names) 
were typed inside a double quotation mark (" ") when performing the primary 
search. In addition, synonyms (where applicable) and the same spellings of the 
scientific names as shown in The Plant List (2013) and Royal Botanic Gardens, 
Kew, Medicinal Plant Names Services (2016) were utilised in the search. The 
results were then refined using the term diabet* for the secondary search. Only 
antidiabetic pharmacological and clinical studies associated with reducing blood 
glucose levels and the inhibitory activity of enzymes (α-amylase and α-
glucosidase) were considered for scientific evidence. Studies of diabetic 
complications were excluded from the searches. 
 
3.3. The α-glucosidase inhibitory activity and the identification of the 
α-glucosidase inhibitory compound from the selected plant species 
3.3.1. Fieldwork and sample collection  
More than one different sample is required to conduct the metabolite profiling 
technique to identify the active compounds from plant sources (Wen et al., 
2010). Hence, it was dicided to collect a plant species from different 
geographical sites in this work. A fieldwork was carried out to collect and 
preserve the selected plant samples between June and September 2014 from 
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various locations throughout SL. The plant species were identified and then the 
chosen part was carefully collected. The collected plant species were confirmed 
by Dr. Pholtan R.S. Rajamanoharan. After collection, the fresh plant material 
was placed in a water-soaked paper pile to provide water to the fresh material 
and stop drying without ventilation. The paper pile was then placed in a hard 
paper bag and this bag was placed inside a plastic bag. The plant material was 
removed from the plastic bag and it was placed on paper that had been laid on 
the floor. It was shade dried at room temperature in a ventilated room during the 
summer period in Batticaloa, Eastern Province, SL. A. aspera samples were 
shade dried for four weeks while the rest of the plant species materials were 
shade dried for two weeks. Further, only A. aspera and A. heterophyllus 
materials were cut into small pieces before packing. Each dried plant material 
was packed separately in a sealed plastic bag and stored at room temperature. 
Finally, approximately 40 samples each weighing between 3 to 5 g, of each 
plant species, was available for study.  
 
The official permit for transporting the collected plant materials to the UK from 
SL was obtained at the National Plant Quarantine Service (a part of the Ministry 
of Agriculture, SL) situated at the Colombo International Airport. The permit was 
issued after the samples were examined by experts in the lab of this 
department. Following from this, the plant samples were sent to the UK by fast 
courier service. On arrival to the UK, the samples were kept at room 
temperature, though, once they got to London, they were left in a freezer at – 20 
°C for 48 hours to prevent the spread of pests and the other microorganisms. 
After this, they were transferred to a normal refrigerator to stop production of 
microorganisms like fungi. 
 
3.3.2. Experimental 
3.3.2.1. Chemicals 
α-Glucosidase type I (Saccharomyces cerevisiae, lyophilised powder), 
Acarbose, and p-nitrophenyl α-D-glucopyranoside (PNPG) were purchased 
from Sigma-Aldrich Co. (St. Louis, MO). 
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3.3.2.2. Sample extraction 
The dried plant materials were ground using a laboratory blender (Model 
7009S, Waring® Laboratory Science, Torrington, CT) and sifted using a sieve of 
mesh (0.78 cm). Preliminary screening of the α-glucosidase inhibitory activity 
was conducted for the sample which had the greatest weight among the 
samples collected for each plant species. Solvents such as hexane, chloroform, 
ethyl acetate, acetone, methanol, and water were used to produce extracts 
which were then tested to determine which of them caused maximum inhibition 
of α-glucosidase. The extraction method utilised was based on that by Trinh et 
al. (2016). Briefly, 1 g of powdered dried plant material was mixed with 10 ml of 
solvent and vortexed for 1 minute. After which it was sonicated for 30 minutes. 
The mixture was then left at room temperature (25 °C) for 24 hours. The 
extracted solution was filtered using Whatman No. 1 filter paper and dried under 
pressure using a rotary evaporator (BUCHI Rotavapor®) at 40 °C until a 
concentrated mixture was obtained. The aqueous extracts were then obtained 
by freeze-drying the extracted water solutions.   
 
Only one extract (out of 30) exhibited maximum α-glucosidase inhibition at the 
highest concentration (200 µg/ml) in the preliminary screening and was chosen 
for further study. Based on this observation, the same solvent was used for the 
production of extracts for all the collected samples of that particular plant 
species. The α-glucosidase inhibitory activity of all the samples was then 
studied in detail. 
 
3.3.2.3. α-Glucosidase inhibition assay  
The α-glucosidase inhibition assay was carried out in a similar way to that 
carried out Fujita et al. (2015). Briefly, 100 µl of 1.0 U/ml of yeast α-glucosidase 
solution was prepared in 0.1 M phosphate buffer (pH 6.9) and added to 50 µl of 
the different concentrations of plant extract (for example, 200, 100, 50, 25, 12.5, 
6.25 µg/ml) in a 96-well plate to determine the IC50 value. The various plant 
extracts were completely dissolved in DMSO, apart from the aqueous extracts. 
The maximum amount of DMSO utilised was 1% for the highest concentration 
plant extract (200 µg/ml) and less than 1% for the other concentrations. The 
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mixtures were then incubated at 25 °C for 10 minutes. Following from this, 50 µl 
of 5 mM p-nitrophenyl-α-D-glucopyranoside solution prepared in 0.1 M 
phosphate buffer (pH 6.9) was added into each well at specified time intervals. 
The absorbance of each well was recorded at 405 nm using a microplate 
reader, then the 96-well plate was incubated again at 25 °C for a further 5 
minutes and the absorbance recorded at 405 nm. The phosphate buffer (50 µl 
of 0.1 M) was used as a negative control and Acarbose was utilised as a 
positive control. P-nitrophenyl-α-D-glucopyranoside is used as the substrate for 
α-glucosidase in this assay. P-nitrophenol is produced during the enzymatic 
hydrolysis of p-nitrophenyl-α-D-glucopyranoside. 
 
                                                          α-Glucosidase 
p-nitrophenyl-α-D-glucopyranoside       Product + p-nitrophenol 
 
The percentage inhibition of the extracts was calculated using the following 
formula: 
 
% Inhibition =
ΔAbsorption (Negative control) −  ΔAbsorption (Sample)
ΔAbsorption (Negative control)
 
 
Each concentration of the sample was added to three wells (triplicate) of the 96-
well plate and the experiment was repeated at least three times.  
 
3.3.2.4. Statistical analysis of α-glucosidase inhibition 
The mean, standard deviation, and standard errors were calculated using 
Microsoft Excel 2016 (Redmond, WA) and the IC50 values were calculated using 
GraphPad Prism 7 (La Jolla, CA). Further, the one-way Analysis of Variance 
(ANOVA) test followed by the Tukey Test Honest Significant Difference test was 
carried out using IBM SPSS Statistics 24 (Armonk, NY).  
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3.3.2.5. Sample preparation for 1H Nuclear Magnetic Resonance Spectra 
Deuterated methanol (CD3OD) (1 ml) was added to 200 mg of dried plant 
material in and vortexed for one minute after which it was sonicated for 30 
minutes and left for 24 hours. The sample was then centrifuged at 13,000 rpm 
for 15 minutes and 800 µl of the supernatant was transferred into an NMR 
sample tube for NMR spectroscopy analysis. A Bruker Avance 400 MHz NMR 
spectrometer was utilised to obtain 1H NMR spectra at 25 °C with 64 scans. 
 
3.3.2.6. Data reduction and statistical analysis of 1H Nuclear Magnetic 
Resonance Spectra 
The Mnova 9.0.1 – Mestrelab (Santiago de Compostela, Spain) was used for 
the data reduction of the NMR spectra. The solvent (CD3OD) peak at 3.31 ppm 
was utilised as a reference solvent peak and it was aligned to the NMR 
spectrum of each sample. Then the solvent peak regions (3.28 – 3.40 and 4.50 
– 5.00 ppm) were excluded in each spectrum. Then the 0.00 to 9.00 ppm region 
was binned with a 0.04 ppm bucket width, which provided 216 buckets. Then 
the binned data was normalised to a total area of 100. Finally, MetaboAnalyst 
(http://www.metaboanalyst.ca, Quebec, Canada) was used to perform OPLS-
DA.  
 
3.3.2.7. Compounds isolated from selected plant families 
The Web of Science (Philadelphia, PA), SciFinder® (Columbus, OH), and an 
online version of Dictionary of Natural Products (Boca Raton, FL) were utilised 
to identify the compounds isolated from Moraceae family. Even so, only the 
compounds that have had their 1H NMR spectra produced in deuterated 
methanol were considered.   
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Chapter 4 
Plants historically used to treat diabetes in Sri Lankan Siddha 
Medicine 
 
4.1. Materials and methods 
 
4.1.1. Documentation of traditional medicinal knowledge 
Traditional medicinal knowledge involves diagnosis methods and use of 
ingredients (e.g. medicinal plants) in the traditional medicinal preparations. As 
mentioned before, this knowledge is usually kept as a secret by the traditional 
healers and only passed on to the next generation. Nevertheless, this 
knowledge can also be documented and written to make it publicly available. 
Anyway, documenting traditional medicinal knowledge is a complicated 
procedure, which is necessary to document the knowledge in a suitable way 
(Abbott, 2014).  
 
There are some advantages and disadvantages of documenting traditional 
medicinal knowledge. The advantages like conservation of the knowledge for 
future generations to provide the access to develop TM use and encourage the 
commercialisation of traditional medicinal products. The disadvantages like the 
revelation of the knowledge to third parties and traditional healers will have 
restricted access and control to their knowledge (Abbott, 2014). 
 
Traditional medicinal historical documents are used to document historical 
ethnopharmacological information while ethnopharmacological surveys are 
employed to record modern information to make it publicly available. Both 
documentation methods have some benefits and drawbacks. One benefit of 
historical documentation is that they form the foundation for modern 
documentation. Another benefit is historical documents contain very detailed 
ethnopharmacological information. The drawback of using historical documents 
is plant species cannot be confirmed directly by a person. 
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The advantage of modern documentation is the plant species can be confirmed 
directly by the participants in the ethnopharmacological surveys. One 
disadvantage of modern documentation is only the plant species currently used 
are documented. Hence, the basis of the plant use and the time when the plants 
currently utilised were involved were unknown. Another disadvantage is the 
data collected in modern documentation is limited because the traditional 
healers are not willing to reveal all the information they have. 
 
Both historical and modern information is very useful in documenting 
ethnopharmacological information, because comparison studies can be carried 
out to investigate the changes and continuity of plant use in both methods, as 
well as fill the gaps created by the drawbacks of both methods. The recent 
surveys of antidiabetic plants have been published for several countries like 
India (Vidyasagar and Siddalinga, 2013), South Africa (Davids et al., 2016), 
Nigeria (Salihu Shinkafi et al., 2015), Mexico (Andrade-Cetto and Heinrich 
2005), Turkey (Durmuşkahya and Öztürk, 2013), and China (Guo et al., 2017). 
 
4.2. Results and discussion  
4.2.1. Comparison of diabetes concepts in biomedicine and Siddha 
Medicine  
There are some similarities and differences between the concepts (definition, 
causes, types, diagnosis, treatment, and complications) of diabetes. One of the 
similarities is that diabetes is considered as a polyuria associated condition. 
Biomedicine defines diabetes as being “excessive secretion of sweet urine”. On 
the other hand, SM defines diabetes as “passing foamy urine, like a pearl of 
fresh honey in the water”. Moreover, both medicines consider diabetes as an 
incurable disease. In addition, there are some common diabetes symptoms 
mentioned in both, including frequent urination, excessive thirst, blurred vision, 
weight loss, body odour, and insomnia. Another similarity between the two is 
that pills are orally administered during treatment. Diet management is also 
recommended in both biomedicine and SM in the diabetes treatment.   
 
The causes of diabetes in SM differ from those of biomedicine. Consumption of 
animal fat-rich diets and social behaviours are considered as being the causes 
of diabetes in SM (Chapter 2). Despite that, biomedicine considers diabetes as 
47 
 
being caused by the changes in the human body (Chapter 2). Besides, diabetes 
is grouped into three types in biomedicine whereas, it is classified into 24 types 
in SM. Another difference is diabetes diagnosed by various blood tests in 
biomedicine, while in SM the diagnosis is based on the diagnosis has based the 
odour and taste of the urine in SM. Apart from pills, other oral preparations (e.g. 
decoctions, powders, and diets) and topical preparations (e.g. oils and creams) 
are used in SM whereas insulin injections are the main route of drug 
administration in biomedicine (Anonymous, 2000). 
 
Biomedicine medications are known to cause several unwanted adverse side 
effects in which potential side effects of SM are undocumented. Additionally, as 
SM treatments are individual, it is assumed that they cause less or no side 
effects, in spite of that, there is no scientific evidence for this claim. 
 
4.2.2. Historical antidiabetic Sri Lankan Siddha Medicine 
preparations 
A total of 60 antidiabetic preparations were identified from the Sri Lankan SM 
historical documents. Information about the ingredients (either scientific or 
English name), the amount utilised (converted to metric units from Tamil units 
where applicable), preparation methods, and dosages are presented in 
Appendix B. These preparations are not only used to treat diabetes. They are 
also utilised to treat several other disorders which are not related to diabetes. 
Apart from the 60 antidiabetic preparations mentioned, there are many other 
preparations used to treat all 20 types of polyuria associated conditions. 
However, this project specifically focused on those preparations that were 
specifically utilised in the treatment of diabetes. 
 
Historical document, Anonymous (2003) contains the largest number of 
antidiabetic preparations followed by Anonymous (2000), and Ponniah and 
Sabapathipillai (1980). Both oral (pills, powders, decoctions, diets, and 
oils/creams) and topical (oils/creams) preparations were used to treat diabetes. 
The most common type of preparation was the pill (accounting for almost two-
thirds of the treatments), followed by powder, cream, decoction, diet, and oil. 
The Pittu (பிட்டு) is a common diet in SL consumed for breakfast and dinner and 
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rice flour is generally utilised to prepare it. While, other grain flours such as 
Vigna mungo (L.) Hepper and Eleusine coracana (L.) Gaertn. are used to 
prepare it. It is important to note that the preparations 4, 5, 6, and 7 are not 
commonly prepared for meals. Preparations 44 (Santhanaathiyennai - 
சந்ேனோதிகயண்கணய்), 46 (Piramehachchanthanaathiyennai - 
பிைபமகச்சந்ேனோதிகயண்கணய்), and 47 (Neerilivuchchanthanaathiyennai - 
நீரிழிவுச்சந்ேனோதிகயண்கணய்) are the only three topical preparations stated in the 
historical documents (Appendix B). 
 
The main components of the ingredients in the Sri Lankan antidiabetic 
preparations were plants, animal parts (comprising marine organisms), and 
inorganic substances (minerals and metals). The most common ingredient 
across the different preparations was plants, being found in approximately 97% 
of the preparations. This highlights the importance of plants in antidiabetic Sri 
Lankan Siddha preparations. Out of the 60 preparations, it was found that 
approximately two-thirds of them were made up entirely of plants. Preparation 
41 (Piramehakkulihai - பிைபமகக்குளிரக) comprises of only animal ingredients 
and preparation 42 (Piramehakkulihai - பிைபமகக்குளிரக) contains only animal 
and inorganic ingredients. Preparations 16 (Salakkalichchalpalavukkum 
kaimarunthu - சலக்கழிச்சல் லவுக்கும் ரகமருந்து) and 53 (தூள் – Thool) 
incorporate only a single (one botanical) ingredient. A combination of all types 
of ingredients utilised in 13 preparations. Preparation 46 
(Piramehachchanthanaathiyennai - பிைபமகச்சந்ேனோதிகயண்கணய்) consists the 
highest number of ingredients (64) including 54 plant species in 40 families. The 
majority of the decoctions only prepared using plant ingredients. Anyway, 
preparation 50 is made using both inorganic substances and plant materials. 
The same plant part (bark) of different plant species used in preparation 49 
(Kudineer - குடிநீர்). Besides, different parts of one plant species (Senna 
auriculata) utilised as the only ingredients in preparation 24 
(Salakkalichchalpalavukkum kaimarunthu - சலக்கழிச்சல் லவுக்கும் ரகமருந்து) 
(Appendix B). 
 
Adjuvants (honey, decoctions, and buttermilk, etc.) were usually consumed with 
antidiabetic Sri Lankan SM preparations. SM hospitals and SEHs only provide 
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the SM preparations, although, they do not provide the adjuvants that would 
usually accompany them when consumed. The adjuvants prepared by the 
patients where applicable. It is recommended to avoid certain diets while taking 
some preparations to achieve better treatment results. For example, bitter and 
sour foods and fish should be avoided while administering preparation 14 
(Suravappidippaanundai - சுவைப்பிடிப் ோணுண்ரை) (Appendix B).  
 
4.3. Plants used in the historical antidiabetic Sri Lankan Siddha 
Medicine preparations 
The scientific name, family, Tamil name, part used, preparation, and source of 
171 plant species in 73 families utilised in the antidiabetic Sri Lankan SM 
preparations are presented in Appendix A. The most commonly used plant 
species is Senna auriculata and the largest number of taxa are from the 
Fabaceae family. The plant parts including leaf, seed, bark, stem, root, fruit, 
flower, rhizome, and wood are utilised in the antidiabetic preparations and the 
seeds were the most commonly utilised part. The majority of the documented 
plant species used as food plants in SL. They are economically important, 
generally cultivated, and part of the wider Sri Lankan culture. Some examples of 
well-known and widely utilised food plants: Allium sativum, Curcuma longa, 
Piper cubeba, P. nigrum, Saccharum officinarum, Zingiber officinale and 
Tamarindus indica; fruits: Anacardium occidentale, Cocos nucifera, Phoenix 
dactylifera, Ph. pusilla, Punica granatum, Artocarpus heterophyllus, Musa × 
paradisiaca, and Syzygium cumini; green leaves: Alternanthera sessilis, 
Ipomoea aquatica, Rivea ornata, Coccinia grandis, Mukia maderaspatana, and 
Murraya koenigii; spices: Cinnamomum verum, Myristica fragrans, Elettaria 
cardamomum, and Syzygium aromaticum; grains: Oryza sativa, Sesamum 
indicum, Vigna mungo, Cajanus cajan, Eleusine coracana, Panicum 
sumatrense, and Paspalum scrobiculatum (Rajapaksha, 1998).  
 
Most of the plants historically used to treat diabetes in Sri Lankan SM also have 
various other uses such as in Saiva (religious) rituals (Elaeocarpus 
tuberculatus, Myroxylon balsamum, Cinnamomum cappara-coronde, Aegle 
marmelos, Santalum album, and Curcuma aromatica), in cosmetics (Crocus 
sativus, Chrysopogon zizanioides, and Santalum album), in hygiene (Ficus 
50 
 
benghalensis and Azadirachta indica), as an artefact (Acacia chundra), for 
manufacturing handicrafts (Bambusa bambos, Cocos nucifera, and Borassus 
flabellifer), textile production (Gossypium arboretum), incense (Myroxylon 
balsamum and Santalum album), and as medicine utilised for other conditions 
in SL (Justicia adhatoda, Acorus calamus, Terminalia chebula, Ricinus 
communis, Vitex negundo, Coscinium fenestratum, and Aloe vera) (Jayaweera, 
2006, 1982, 1981, 1980). On top of that, Cinnamomum cappara-coronde was 
the only plant species endemic to SL (Sugathadasa et al., 2008). 
 
There is only a mini review of plants utilised to treat diabetes in Indian SM 
currently available. This work was conducted by Parthiban et al. (2014) and 
identified 20 plant species from a historical Siddha Pharmacology document 
called Gunavagadam (குணவோைகம் ). Yet, 16 out of 20 plant species were 
identified in Sri Lankan SM historical documents. For instance, Terminalia 
arjuna, S. cumini, M. koenigii, C. grandis, Holarrhena pubescens, and 
Euphorbia hirta. On the other hand, plant species like Gymnema sylvestre, 
Helicteres isora, Hibiscus cannabinus, and Smilax china were not mentioned in 
the Sri Lankan SM antidiabetic preparations.  
 
Remarkably, almost all preparations contained either toxic plant species or plant 
species that belong to families containing many toxic plant species as 
ingredients in the antidiabetic preparations. According to Roth et al. (2012) and 
Harborne et al (1996), 49% of various parts of reviewed plant species (60 out of 
123) may cause acute or chronic toxicity, posing the risk of teratogenicity and 
cancerogenicity, as well as allergic reactions (e.g. Abrus precatorius, Strychnos 
potatorum, Aconitum heterophyllum, Hyoscyamus reticulatus, and Cycas 
circinalis). Though, toxicity is also depending on the plant parts used as well as 
the dose administrated. Additionally, a toxicity assessment of the plants 
employed in antidiabetic Sri Lankan SM preparations is beyond the scope of 
this work.  
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4.4. Animal ingredients used in antidiabetic Sri Lankan Siddha 
Medicine preparations 
Nearly, one-third of the antidiabetic preparations contain animal ingredients. 
Male deer musk (produced in a glandular sac in the lower abdomen), deer horn, 
civet musk (secreted in the anal scent glands), rhinoceros horn, cow gallstone 
and urine, human colostrum (foremilk), ant egg, Coccus lacca (Shellac – a resin 
excreted by the females of the lac insect) were utilised. Out of these different 
ingredients, cow gallstone was the most frequently utilised ingredient. In 
addition, marine organisms (pearl and red coral) were used in some of the 
preparations. Deer horn utilised in a calx form. Some of the ingredients as 
rhinoceros horn is rare and it will be unavailable in the future. It is also illegal to 
trade, possess, and use it.  
 
4.5. Inorganic substances used in antidiabetic Sri Lankan Siddha 
Medicine preparations 
Approximately, half of the antidiabetic preparations contain inorganic 
ingredients like metals (mercury, arsenic, iron, silver, gold, zinc, sulphur, and 
lead). Apart from metals, some of them contain minerals, including rock salt, 
borax, cinnabar, biotite (black mica), saltpetre (potassium nitrate), Roche alum, 
graphite, beryl, asbestos, gypsum, stibnite (contains antimony sulphide), mica 
(aluminium silicate), magnetite, and sulphur. Magnetite is the most frequently 
utilised inorganic substance. Noticeably, many of these inorganic substances 
are highly poisonous. For example, mercury, arsenic, etc. Silver and gold were 
used in a calx form and borax, cinnabar, and graphite were utilised in a purified 
form.  
 
Some studies have evaluated the toxicity of some inorganic substances utilised 
in TMs. For instance, biotite is used in several antidiabetic preparations. In a 
study performed by Srinivasa et al. (2010), biotite ash when utilised with 
different drug vehicle did not show any systemic toxicity. In another study 
carried out by Vardhini et al. (2010), there was no genotoxicity exhibited in both 
an in vivo micronucleus assay and comet assay in Wistar rats of both genders. 
‘Detoxification procedures’ are carried out for the inorganic substances while 
formulating the preparations. For example, the toxic properties of mica were 
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removed during the preparation steps (Wijenayake et al., 2014). Still, these 
practices are a major concern and toxicological risks need to be clearly 
addressed.  
 
4.6. Amounts and dosages used in Sri Lankan Siddha Medicine 
Tamil units are utilised to measure the weights and volumes of the ingredients 
and doses in Sri Lankan SM. However, some of the Tamil units have been 
standardised to the equivalent metric units. In Sri Lankan SM historical 
documents, the measurements were stated in both standardised and non-
standardised Tamil units. The standard Tamil units such as Palam (பலம், 1 
பலம் = 40 g), Panaavidai/Kaasidai (பணாவிடை/காசிடை, 1 பணாவிடை = 488 g), 
Kalanju (கழஞ்சு, 1 கழஞ்சு = 5 g), size of a louse (பபன்பிடிப்பிரமாணம் – 
Penpidippiramaanam = 1.25 mg), and size of an Areca catechu L. seed 
(பாக்களவு – Paakkalavu = 5 g) are used to measure the weights. Whereas, 
Marakkaal (மரக்கால், 1 மரக்கால் = 1200 ml), Naali (நாழி, 1 நாழி = 600 ml), Kalam 
(கலம், 1 கலம் = 57.6 l) and Koththu (ககாத்து, 1 ககாத்து = 150 ml) are utilised to 
measure the volumes of liquids. Likewise, non-standardised Tamil units like one 
handful (பிடி – Pidi), size of a small coconut (சிறு பேங்காயளவு – Siru 
Thengaaiyalavu), as required (பேடையானளவு – Thevaiyaanavalavu), and lemon 
size (எலுமிச்சங்காயளவு – Elumichchangkaayalavu) are used.  
 
There is a great disadvantage when using the non-standardised Tamil units 
because, it would lead to inconsistency in the preparation methods and doses 
due to anatomical variations (hand size: from one person to the next; one region 
to the other: lemon size, the size of a small coconut etc.). Therefore, it is 
recommended to standardise the non-standardised units into metric units. On 
top of that, encourage the SM preparation manufacturers like SEHs and 
patients to use the exact amounts of ingredients during the manufacturing 
procedures and recommended dosages.    
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Chapter 5 
Results and discussion  
Plants contemporarily used to treat diabetes in Sri Lankan 
Siddha Medicine 
5.1. Socio-demographic characteristics of the Siddha empirical 
healers who participated in the ethnopharmacological survey 
Initially, 33 SEHs residing in the Eastern Province of SL were approached, 
although, six of them stated that they do not practise or produce any treatment 
for diabetes. They were, therefore, excluded from this study. The remaining 27 
SEHs who are currently treating diabetes were interviewed for this study. The 
majority of participants were men and of the 27 who participated, it was found 
that most were aged between 61 and 70. Additionally, the majority of the SEHs 
had 41 – 50 years of experience practicing SM (Table 5.1). 
 
Table 5.1 Demographics of the Siddha empirical healers who participated in 
this study (n = 27) 
Category Number of Siddha empirical 
healers 
Percentage / 
% 
Gender 
  
Male 25 93 
Female 2 7 
   
Age group 
  
21 - 30 0 0 
31 - 40 6 22 
41 - 50 0 0 
51 - 60 0 0 
61 - 70 17 63 
71 - 80 3 11 
81 - 90 1 4 
90 - 100 0 0 
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Category Number of Siddha empirical 
healers 
Percentage / 
% 
   
Years practicing Siddha 
Medicine 
 
  
1 - 10 1 4 
11 - 20 5 19 
21 - 30 0 0 
31 - 40 0 0 
41 - 50 17 63 
51 - 60 3 11 
60 - 70 1 4 
Total 27 100 
 
5.2. Diagnosis methods currently employed by Siddha empirical 
healers to diagnose diabetes 
This study relies on the self-reporting information by the SEHs on their practice. 
In this investigation, the SEHs mentioned that they only use pulse reading (one 
of the eight diagnostic methods mentioned in Chapter 2) with a combination of 
symptoms recognised by SM as being linked to diabetes (stated in Chapter 2) 
to diagnose the illness.  
 
5.3. The number of diabetic patients seen by a Siddha empirical 
healer 
According to the information provided by the SEHs, on average, 12 diabetics 
are seen by an SEH per week. Nonetheless, they did not show any written 
evidence of the number of patients consulting them. Besides, they did not have 
any information on how many of the patients are returning for regular 
consultations and how many are visiting for the first time.  
 
5.4. Contemporary antidiabetic Sri Lankan Siddha Medicine 
preparations 
None of the SEHs wanted to reveal any information about the antidiabetic 
preparations such as the names, ingredients used, the dosage, and the units 
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utilised. Yet, SEHs have stated that they prepare the antidiabetic preparations 
by themselves in their homes by buying and collecting the majority of the 
ingredients. The rare ingredients are provided by the Ayurvedic Drug 
Corporation at a reduced cost. The SEHs usually provide a one-month 
preparation to each patient and the patients paid for their consultation and 
treatment costs, usually in cash to them.  
 
5.5. Types of ingredients currently used in the antidiabetic 
preparations 
Remarkably, the SEHs who participated in this study reported that they only use 
botanical ingredients (one of the three types of the ingredients mentioned in the 
Sri Lankan SM historical documents in Chapter 4) in the antidiabetic 
preparations. 
 
5.6. Plant species reported by the Siddha empirical healers 
Overall, 88 plant species from 46 families were documented in this study (Table 
5.2). Syzygium cumini was the most cited species (cited by 21 SEHs) followed 
by Gymnema sylvestre, Artocarpus heterophyllus, Salacia reticulata, and 
Achyranthes aspera. The largest number of reported taxa are from the 
Fabaceae family. The leaves were cited as the most frequently utilised plant 
part followed by fruits, whole plants, roots, and barks. Furthermore, the majority 
of the plants documented in this study were South Asian medicinal plants 
(Withania somnifera, Typhonium trilobatum, Tribulus terrestris, Toddalia 
asiatica, and Tinospora sinensis) followed by food plants (A. aspera, Borassus 
flabellifer, Cinnamomum verum, Eleusine coracana, and Limonia acidissima). 
Still, based on the study by Sugathadasa et al. (2008), none of the reported 
plant species is endemic to SL. 
 
As mentioned before, the SEHs participated in this study were aged between 31 
to 90 years, with a varying number of years of experience (1 to 70 years). In 
spite of this variation in both age and experience, all the participants reported 
using a combination of all types of plant species. In addition, there was no 
significant difference in the plant species reported by those aged under 40 and 
those aged over 70. 
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Remarkably, one-third of the plant species reported in this study had not been 
previously recorded either in the antidiabetic preparations of Sri Lankan SM 
historical documents or in the other ethnobotanical surveys carried out in the 
regions of SL where SM is practised. For instance, Sesbania grandiflora and 
Pedalium murex were reported for the first time in this study as ingredients in 
SM antidiabetic preparations in SL. At the same time, there was a strong 
overlap between the plant species reported by the SEHs and stated in the 
historical SM documents. For example, Ficus racemosa and Salacia reticulata 
were documented in both studies. Since these textbooks are employed in the 
university SM curriculum, this indicates that both written records (Leonti, 2011) 
and verbal communication form the basis of the plant species used. The most 
frequently utilised species in this study (S. cumini) was used in the antidiabetic 
preparations in the historical documents. Senna auriculata had been the most 
frequently stated plant species in the historical preparations (Sathasivampillai et 
al., 2017), although, only five SEHs in this work, consider it to be a useful plant 
in the antidiabetic preparations. 
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Table 5. 2 Reported plant species used to treat diabetes in Siddha Medicine in Eastern Province (n = 27) 
Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Abutilon indicum (L.) Sweet # Malvaceae துத்தி (Thuththi) Whole 
plant 
 
 
3 
Achyranthes aspera L. (VS001) Amaranthaceae நோயுருவி (Naayuruvi) 
 
Whole 
plant 
 
 
11 
Aegle marmelos (L.) Corrêa (VS002) #$ Rutaceae வில்ரவ (Vilvai) 
 
Bark, fruit 
 
 
7 
Aerva lanata (L.) Juss. (VS003) @ Amaranthaceae பேங்கோய்ப்பூக்கீரை 
(Thengaaippookkeerai) 
 
Whole 
plant 
 
 
2 
Allium sativum L. #$ Amaryllidaceae கவள்ரை கவங்கோயம் (Vellai 
vengaayam) 
 
 
Bulb 3 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Alternanthera sessilis (L.) R.Br. ex DC. (VS004)  Amaranthaceae க ோன்னோங்கோணி 
(Ponnaangkaani) 
 
 
Leaf 2 
Anacardium occidentale L. (VS005) #$ Anacardiaceae முந்திரிரக (Munthirihai) 
 
 
Fruit 1 
Andrographis paniculata (Burm.f.) Nees (VS006) #$@ Acanthaceae சிரியோள்நங்ரக 
(Siriyaalnangai) 
 
 
Whole 
plant 
3 
Anethum graveolens L. #$ Apiaceae சேகுப்ர  (Sathahuppai) 
 
 
Seed 1 
Aristolochia bracteolata Lam. #@ Aristolochiaceae ஆடுதின்னோப் ோரல 
(Aaduthinnaappaalai) 
 
 
Whole 
plant 
 
1 
Artocarpus heterophyllus Lam. (VS007) Moraceae  லோ (Palaa) Mature 
leaf 
 
 
13 
Averrhoa carambola L. #@ Oxalidaceae ேமைத்ரே (Thamaraththai) Fruit 1 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Azadirachta indica A.Juss. (VS008) #$ Meliaceae பவம்பு (Vembu) Bark, 
tender leaf 
 
 
4 
Bacopa monnieri (L.) Wettst. #$@ 
 
Plantaginaceae பிைோம்மி (Piraammi) 
 
Leaf 
 
1 
Basella alba L. (VS009) @ 
 
Basellaceae  சளி (Pasali) 
 
 
Leaf 
 
3 
Boerhavia diffusa L. Nyctaginaceae சோைரண (Saaranai) 
 
 
Leaf 
 
2 
Borassus flabellifer L. Arecaceae  ரன (Panai) 
 
 
Fruit 
 
2 
Calotropis procera (Aiton) Dryand. #@ Asclepiadaceae கவள்கைருக்கு (Vellerukku) 
 
 
Root 1 
Cardiospermum halicacabum L. (VS010) # Sapindaceae முைக்ககோத்ேோன் 
(Mudakkoththaan) 
 
 
Leaf 5 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Carica papaya L. (VS011) #$@ Caricaceae  ப் ோசி (Pappaasi) 
 
 
Leaf 3 
Cassia fistula L. (VS012) #$ Fabaceae ககோன்ரை (Kondrai) 
 
 
Bark 1 
Catharanthus roseus (L.) G.Don (VS013) #$@ 
 
 
Apocynaceae  ட்டி (Patti) 
 
Root 
 
1 
Cheilocostus speciosus (J.Koenig) C.D.Specht 
(VS014) 
 
 
Costaceae கவண்பகோட்ைம் (Venkottam) Rhizome 3 
Chrysopogon zizanioides (L.) Roberty Poaceae 
 
இலோமிச்ரச (Ilaamichchai) 
 
 
Root 1 
Cinnamomum verum J.Presl $ Lauraceae 
 
கறுவோ (Karuvaa) 
 
 
Bark, leaf 1 
Coccinia grandis (L.) Voigt (VS015) # Cucurbitaceae ககோவ்ரவ (Kovvai) 
 
 
Leaf 9 
Coriandrum sativum L. #$@ Apiaceae ககோத்ேமல்லி (Koththamalli) Seed 5 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Coscinium fenestratum (Goetgh.) Colebr. * Menispermaceae மைமஞ்சள் (Maramanjal) 
 
 
Stem 4 
Crateva adansonii DC. @ Capparaceae மோவிலங்கு (Maavilangu) 
 
 
Bark 1 
Cuminum cyminum L. #$ Apiaceae சிறுஞ்சீைகம் 
(Sirunjcheeraham) 
 
 
Fruit 5 
Curcuma longa L. #$ Zingiberaceae மஞ்சள் (Manjal) 
 
 
Rhizome 5 
Cyanthillium cinereum (L.) H.Rob. (VS016) Asteraceae சீபேவியோர் கசங்கழுநீர் 
(Seetheviyaar 
sengkaluneer) 
 
 
Whole 
plant 
2 
Cynodon dactylon (L.) Pers. (VS017) #$@ Poaceae அறுகு (Aruhu) Whole 
plant 
3 
62 
 
Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Dregea volubilis (L.f.) Benth. ex Hook.f. (VS018) @ Asclepiadaceae க ருகுறிஞ்சோ (Perukurinjaa) 
 
Leaf 
 
4 
Eclipta prostrata (L.) L. (VS019) Asteraceae கரிசலோங்கண்ணி 
(Karisalaangkanni) 
 
 
Whole 
plant 
 
3 
Elettaria cardamomum (L.) Maton #$ Zingiberaceae ஏலம் (Elam) 
 
 
Fruit 
 
5 
Eleusine coracana (L.) Gaertn. Poaceae குைக்கன் (Kurakkan) 
 
 
Seed 
 
1 
Evolvulus nummularius (L.) L. (VS020) @ Convolvulaceae கவள்ரை விட்டுணுகிைோந்தி 
(Vellai vittunukiraanthi) 
 
 
Whole 
plant 
 
1 
Ferula assa-foetida L. #$ Apiaceae க ருங்கோயம் 
(Perungkaayam) 
 
 
Resin 1 
Ficus benghalensis L. (VS021) Moraceae ஆல் (Aal) Bark 2 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Ficus racemosa L. (VS022) # Moraceae அத்தி (Aththi) 
 
 
Bark 2 
Ficus religiosa L. (VS033) Moraceae அைசு (Arasu) 
 
 
Bark 3 
Foeniculum vulgare Mill. #$ Apiaceae க ருஞ்சீைகம் 
(Perunjcheeraham) 
 
 
Fruit 2 
Gymnema sylvestre (Retz.) R.Br. ex Sm. (VS024) $@ Apocynaceae சிறுகுறிஞ்சோ (Sirukurinjaa) 
 
 
Leaf, root 18 
Hygrophila auriculata (Schumach.) Heine * Acanthaceae நீர்முள்ளி (Neermulli) 
 
 
Leaf 4 
Illicium verum Hook.f. $@ Schisandraceae அன்னோசிப்பூ (Annaasippoo) 
 
 
Fruit 1 
Indigofera aspalathoides DC. @ Fabaceae சிவோனோர்பவம்பு 
(Sivanaarvembu) 
 
 
Whole 
plant 
2 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Indigofera tinctoria L. Fabaceae அவுரி (Avuri) 
 
 
Root 2 
Ipomoea aquatica Forssk. (VS025) Convolvulaceae வள்ைல் (Vallal) 
 
 
Leaf 4 
Kaempferia galanga L. # Zingiberaceae கச்பசோலம் (Kachcholam) 
 
 
Rhizome 2 
Limonia acidissima Groff (VS026) # Rutaceae விைோத்தி (Vilaaththi) 
 
 
Fruit 2 
Merremia emarginata (Burm. f.) Hallier f. @ Convolvulaceae பூமிசக்கரை (Poomisakkarai) 
 
 
Rhizome 3 
Mesua ferrea L. Calophyllaceae சிறுநோகம் (Sirunaaham) 
 
 
Flower 2 
Momordica charantia L. (VS027) #$@ Cucurbitaceae  ோகல் (Paahal) 
 
 
Fruit, leaf 3 
Mukia maderaspatana (L.) M.Roem. (VS028) # Cucurbitaceae கமோசுகமோசுக்ரக 
(Mosumosukkai) 
Leaf 6 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Murraya koenigii (L.) Spreng. (VS029) #$ Rutaceae கறிபவம்பு (Karivembu) 
 
 
Leaf 10 
Myristica fragrans Houtt. # Myristicaceae சோதிக்கோய் (Saathikkaai) 
 
 
Leaf, mace 3 
Nigella sativa L. #$ Ranunculaceae கருஞ்சீைகம் 
(Karunjcheeraham) 
 
 
Seed 2 
Ocimum tenuiflorum L. (VS030) $@ Lamiaceae கருந்துைசி (Karunthulasi) 
 
Whole 
plant 
 
3 
Oryza sativa L. (VS031) $ Poaceae கநல் (Nel) 
 
 
Seed 4 
Passiflora edulis Sims (VS032) $@ Passifloraceae ககோடித்பேோரை 
(Kodiththodai) 
 
 
Leaf 2 
Pavetta indica L. #@ Rubiaceae  ோவட்ரை (Paavattai) Leaf 2 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Pedalium murex L. @ Pedaliaceae ஆரனகநருஞ்சில் 
(Aanainerunjil) 
 
 
Whole 
plant 
2 
Phyllanthus emblica L. (VS033) $ Phyllanthaceae கநல்லி (Nelli) 
 
 
Fruit, root 8 
Piper longum L. (VS034) $ Piperaceae திப்பிலி (Thippili) 
 
 
Fruit 2 
Piper nigrum L. $ Piperaceae மிைகு (Milahu) 
 
 
Fruit 2 
Pongamia pinnata (L.) Pierre (VS035) *#@ Fabaceae புங்கு (Pungu) 
 
 
Root 3 
Salacia reticulata Wight (VS036) Celastraceae கைலிைோஞ்சி (Kadaliraanji) 
 
 
Bark 12 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Scoparia dulcis L. Plantaginaceae கோட்டுக்ககோத்ேமல்லி 
(Kaattukkoththamalli) 
 
Leaf 1 
Senna auriculata (L.) Roxb. (VS037) Fabaceae ஆவோரை (Aavaarai) Bark, 
flower, 
leaf, root, 
seed 
 
 
5 
Senna sophera (L.) Roxb. (VS038) Fabaceae க ோன்னோவரை 
(Ponnaavarai) 
 
 
Flower 2 
Sesbania grandiflora (L.) Pers. (VS039) @ Fabaceae அகத்தி (Ahaththi) 
 
 
Leaf 
 
3 
Setaria italica (L.) P.Beauv. @ Poaceae திரன (Thinai) 
 
 
Seed 
 
2 
Stereospermum chelonoides (L.f.) DC. Bignoniaceae  ோதிரி (Paathiri) Root 
 
2 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
 
 
Syzygium aromaticum (L.) Merr. & L.M.Perry $ Myrtaceae கைோம்பு (Karaambu) 
 
 
Flower bud 4 
Syzygium cumini (L.) Skeels (VS040) Myrtaceae நோவல் (Naaval) Bark, root, 
seed 
 
 
21 
Terminalia arjuna (Roxb. ex DC.) Wight & Arn. (VS041) 
$ 
 
Combretaceae மருது (Maruthu) 
 
 
Bark 
 
1 
Terminalia bellirica (Gaertn.) Roxb. (VS042) $ Combretaceae ேோன்றி (Thaandri) 
 
 
Fruit 
 
2 
Terminalia chebula Retz. $ Combretaceae கடுக்கோய் (Kadukkaai) 
 
 
Fruit 5 
Thespesia populnea (L.) Sol. ex Corrêa (VS043) *# Malvaceae பூவைசு (Poovarasu) 
 
 
Bark 
 
1 
Tinospora sinensis (Lour.) Merr. $ Menispermaceae சீந்தில் (Seenthil) 
 
 
Stem 
 
1 
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Scientific name, voucher specimen identification Family Tamil name Part used Number 
of times 
cited 
Toddalia asiatica (L.) Lam. $@ Rutaceae மிைகைரண (Milaharanai) 
 
 
Root 
 
1 
Trachyspermum roxburghianum (DC.) H. Wolff # Apiaceae ஓமம் (Omam) 
 
 
Fruit 
 
3 
Tribulus terrestris L. (VS044) #$ Zygophyllaceae கநருஞ்சில் (Nerunjchil) 
 
Whole 
plant 
 
 
1 
Trigonella foenum-graecum L. #$ 
 
Fabaceae கவந்ேயம் (Venthayam) 
 
Seed 
 
6 
Typhonium trilobatum (L.) Schott @ Araceae கோட்டுக்கருரண 
(Kaattukkarunai) 
 
 
Rhizome 1 
Withania somnifera (L.) Dunal #$ Solanaceae அமுக்கிைோய் (Amukkiraai) 
 
 
Rhizome 4 
Zingiber officinale Roscoe $ Zingiberaceae இஞ்சி (Inji) Rhizome 4 
 
* Rare (threatened) plant species based on IUCN (2018) - Red List of Threatened Species 
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$ Very well studied and globally distributed plant species based on American Herbal Pharmacopoeia (2011), Brendler (2010), European 
Medicines Agency (2009), Upton et al. (2016) and World Health Organization Monographs on Selected Medicinal Plants – Volumes 1 to 
4 (1999; 2004; 2007; 2009) which were excluded from antidiabetic scientific evidence analysis 
@ Plant species had not been reported in either antidiabetic preparations in Sri Lankan SM historical documents or ethnobotanical 
surveys carried out in SM practicing regions in SL 
# Toxic plant species based on Roth et al. (2012) and Harborne et al (1996) 
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Eight plant species were recorded previously to treat diabetes in the Northern 
Province. Seven species were reported in Vavuniya and only Scoparia dulcis 
was recorded in Jaffna (Rajamanoharan, 2014; 2016). The species like 
Momordica charantia and G. sylvestre were reported in both Eastern and 
Northern Provinces. Likewise, species such as Andrographis paniculata and 
Toddalia asiatica had only been reported in the Eastern Province. Interestingly, 
the most frequently mentioned species in this study (S. cumini) and cited in 
historical documents (S. auriculata) had not been recorded in the Northern 
Province (Rajamanoharan, 2014, 2016; Sathasivampillai et al., 2017). 
Additionally, as mentioned in the previous chapter, species including S. 
auriculata, C. grandis, Trigonella foenum-graecum, and S. cumini were 
mentioned in an Indian SM historical document. Though, species like Smilax 
china, Terminalia arjuna, Acacia chundra, and Hibiscus cannabinus utilised in 
Indian SM had not been mentioned by the SEHs in this study (Parthiban et al., 
2014).  
 
The toxicity studies of the plant extracts and herbal preparations play a very 
important role in assessing the safety and efficacy of drug purposes. Some 
species (e.g. Aristolochia bracteolate) are clearly toxic (Michl et al. 2016) and 
their use cannot be endorsed.  
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Chapter 6 
Results and discussion  
The antidiabetic scientific evidence available for plants used to 
treat diabetes in Sri Lankan Siddha Medicine 
No antidiabetic scientific evidence is available for the antidiabetic preparations 
mentioned in the historical documents (Appendix B). As stated in the previous 
chapter, the SEHs did not reveal any information on the antidiabetic 
preparations they use. Due to this lack of background information, the 
pharmacological and clinical studies which are related to the antidiabetic activity 
of the individual plant species utilised in these preparations, as well as plant 
species reported by the SEHs, were reviewed to identify the relevant literature. 
Information like scientific name, family, level of scientific evidence, plant part 
used, active compound / extract, bioassay / model used, concentration / dose, 
duration, and references presented in Appendix C. 
 
A total of 48 plant species (28%) mentioned in the historical documents 
(Appendix A) and 39 plant species (44%) reported by the SEHs (Chapter 5) 
were globally distributed and very well studied (as mentioned in 3.10. The 
assessment of the currently available scientific evidence and these plant 
species marked as $ in Appendix A and Table 5.2). Consequently, these plant 
species were excluded from further analysis. The remaining 123 out of the initial 
171 plant species (72%) mentioned in the historical documents and 49 out of 88 
plant species (56%) reported in the ethnobotanical survey were further 
assessed to identify the scientific evidence. Four levels of scientific evidence 
were established based on either the bioassay or model used to study the 
antidiabetic activity of the plant species:  
1. Plants with no scientific evidence available  
2. In vitro evidence and active compounds identified  
3. In vivo evidence and active compounds identified 
4. Clinical evidence and active compounds identified 
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6.1. Plants with no scientific evidence available  
Approximately 41% (51 out of 123) of plant species historically utilised and 27% 
(13 out of 49) of plant species currently reported to have no scientific evidence 
of antidiabetic activity like Lannea coromandelica, Piper cubeba, 
Trachyspermum roxburghianum, Phoenix pusilla, and Saccharum officinarum. 
Some plant species were stated in several antidiabetic historical preparations 
and reported by many of the SEHs while, no scientific evidence was found to 
corroborate their antidiabetic activities. These plant species are suited for future 
studies to determine both their antidiabetic activity as well as potential toxicity. 
For example, Pavetta indica, Crateva adansonii, Evolvulus nummularius, 
Pedalium murex, and Kaempferia galangal, Limonia acidissima, Nymphaea 
pubescens, Hyoscyamus reticulatus, Aconitum heterophyllum, Cinnamomum 
cappara-coronde, Cissampelos pareira, Mesua ferrea, and Acacia chundra.   
 
6.2. In vitro evidence and active compounds identified 
α- Glucosidase, β-glucosidase, and α-amylase inhibitory, and glycogen 
synthesis bioassays were employed to investigate the antidiabetic activity in in 
vitro studies (Appendix C). It was found that the α-glucosidase inhibitory 
bioassay was the most frequently used among the reviewed in vitro studies.  
 
Only 7 out of 123 plant species (6%) stated in the historical documents and 2 
out of 49 plant species (4%) reported by the SEHs were found to have in vitro 
evidence. For instance, Anacyclus pyrethrum, Setaria italica, Bambusa bambos, 
Mukia maderaspatana, and Gossypium arboretum. Among them, Abrus 
precatorius has the has the most in vitro evidence to support its antidiabetic 
properties. 
 
Active compounds had been only identified from A. precatorius and 
Dichrostachys cinerea. Three compounds were isolated from 50% methanol 
extract of A. precatorius leaves namely, lupenone, 24- methylenecycloartenone, 
and luteolin. These compounds exhibited α-amylase inhibitory activity with IC50 
31 µM, 0.6 mM, and 3.1 mM respectively (Yonemoto et al., 2014). It is of interest 
that the active compounds in the other plant species that have been shown to 
have in vitro activity are also identified. This can then be taken further and in 
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vivo tests performed in animal models to provide more evidence regarding their 
antidiabetic properties.  
 
6.3. In vivo evidence and active compounds identified 
T1D (Alloxan- and Streptozotocin-induced diabetic) and T2D (diabetic 
dyslipidaemia [db/db], Kyoji Kondo Ay/a [KKAy], and high fat fed) (see Glossary 
for descriptions of these models) animal models were employed to study the 
antidiabetic activity (King and Bowe, 2016; King, 2012) (Appendix C). The 
majority of the studies were carried out in T1D (Streptozotocin-induced diabetic) 
models rather than T2D models. Still, as mentioned before in Chapter 2, the 
majority of the people have T2D. Hence, it is recommended to use more T2D 
models to study the antidiabetic activity of the plant extracts and active 
compounds in the future.  
 
The most of the plant species both historically and currently used have in vivo 
evidence. A total of 59 out of 123 of the plant species (48%) historically utilised 
and 29 out of 49 of the plant species (59%) currently reported in the 
ethnobotanical survey have been studied up to this level, like Tamarindus 
indica, Thespesia populnea, Ficus religiosa, Phyllanthus amarus, Alpinia 
galanga, Coccinia grandis, Sesbania grandiflora, Cardiospermum halicacabum, 
and Coscinium fenestratum. Syzygium cumini has been studied the most 
frequently in in vivo models. 
 
The antidiabetic compounds isolated from the species, including Acorus 
calamus, Areca catechu, Cheilocostus speciosus, Plumbago zeylanica, Eclipta 
prostrata, Senna auriculata, Ficus benghalensis, Myristica fragrans, Syzygium 
cumini, Averrhoa carambola, and Scoparia dulcis. The majority of the 
antidiabetic compounds (5) identified in Oroxylum indicum. In T1D models, β-
amyrin palmitate (50 µg/kg) isolated from Hemidesmus indicus root when orally 
administered to Streptozotocin- and Alloxan-induced diabetic rats for 15 days, 
was able to reduce the blood glucose level to normal level. It was noted that β-
amyrin palmitate was blocking glucose entering the intestine as one of its 
mechanisms of action (Nair et al., 2014). Costunolide (5 mg/kg) isolated from C. 
speciosus roots was orally administered to Streptozotocin-induced diabetic rats 
daily for 30 days. This treatment significantly reduced the blood glucose, total 
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cholesterol, and triglyceride concentrations. Further, it was observed that the 
levels of plasma insulin, serum protein, and tissue glycogen were elevated. It is 
believed that costunolide may have induced insulin secretion in the pancreas 
(Eliza et al., 2009b). In another study carried out by Venkatachalam et al. 
(2013), 2-(3-acetoxy-4,4,14-trimethylandrost- 8-en-17-yl) (5 mg/kg) identified in 
S. auriculata flowers was orally administered to Alloxan-induced diabetic rats for 
15 days. After 15 days, it was observed to decrease the blood glucose levels.  
 
In T2D models, macelingan (10 mg/kg) isolated from Myristica fragrans seed 
kernel orally administrated to db/db mouse for 14 days reduced the elevated 
serum glucose, free fatty acid levels, and triglycerides concentrations. It was 
noticed that macelingan improved the insulin and glucose tolerance in the mice 
(Han et al., 2008). 
 
Toxicity of the active extracts and compounds investigated further in some 
studies. For instance, 8000 mg/kg of both aqueous and methanol extracts 
obtained from Achyranthes aspera whole plant orally administered to Alloxan-
induced diabetic rabbits for 7 days. This study revealed that this dose was 
nontoxic with no adverse side effects (Akhtar M. and Iqbal, 1991). In another 
study carried out by Kumar A. et al. (2008), mycaminose (2000 mg/kg) identified 
from Syzygium cumini mature seeds was administered to Streptozotocin-
induced diabetic rats for 14 days and was found to be nontoxic.  
 
The antidiabetic compounds should be identified in the rest of the plant species 
have in vivo evidence and they should be further studied in clinical trials. Plant 
species such as Borassus flabellifer, Alternanthera sessilis, Ipomoea aquatica, 
and Senna sophera were found to be the potential candidates for clinical 
studies because they are commonly available and widely consumed food plants 
in SL 
 
6.4. Clinical evidence and active compounds identified 
T1D and T2D patients were employed to investigate the antidiabetic activity at 
this level. However, most of the studies involved T2D patients (Appendix C). A 
sum of 6 out of 123 plant species (5%) mentioned in the historical documents 
and 5 out of 49 plant species (10%) reported by the SEHs were found to have 
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clinical scientific evidence for treating diabetes (e.g. Cyanthillium cinereum, 
Salacia reticulata, Ficus racemosa, Artocarpus heterophyllus, and Eleusine 
coracana).  
 
F. racemosa bark aqueous extract (1200 g/d) orally administered to T2D 
patients (18 men and 12 women) for one month showed a 15% reduction of 
fasting and 22% reduction of postprandial blood glucose levels (Ahmed et al., 
2011). However, the authors did not state whether or not this clinical trial was a 
controlled trial. In another study, F. racemosa bark extract (100 mg twice a day) 
was administered orally to diabetics (25 male and 25 female) for 15 days and 
was found to reduce fasting and after breakfast serum glucose concentrations 
in both male and female participants. Moreover, renal and liver toxicity 
examinations revealed normal functions, thereby, this extract seems to be safe 
(Gul-E-Rana et al., 2013). A study carried out by Radha and Amrithaveni 
(2009), 2 g of S. reticulata bark powder was orally administered to 30 T2D 
subjects for 90 days. On the 90th day, the blood tests revealed that there was a 
significant reduction in the blood glucose and lipid concentrations. Anyway, this 
study did not mention the toxicity outcomes.  
 
Diabetes is a chronic disorder, thus, chronic clinical studies would provide more 
accurate results. There was a chronic study conducted by Bin Sayeed et al. 
(2013) for a preparation (6 g/day) containing C. cinereum root (as well as other 
unspecified ingredients) orally administrated for 6 months to 24 T2D sufferers 
(who had had the disease for more than 6 months). The results showed that 
there was a significant reduction in the blood glucose, triglyceride, haemoglobin 
A1C, and cholesterol concentrations. Yet, the dose used was very high. 
Besides, it was not reported how much C. cinereum root was present in the 
preparation. That being so, it seems appropriate to validate the data in 
additional clinical studies. A chronic toxicity study did not show any toxic effect 
of this dose for renal and liver functions.  
 
Antidiabetic compounds (β-sitosterol, stigmasterol, and lanosterol) were only 
identified in the F. racemosa (Kushwaha et al., 2015). Anyhow, these 
compounds have not been studied in the clinical trials. On that account, the 
active compounds of the other plant species have clinical evidence should be 
77 
 
identified and studied in further in vitro bioassays, in vivo models, and clinical 
trials.    
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Chapter 7 
The α-glucosidase inhibitory activity and the identification of 
the α-glucosidase inhibitory compound from the selected plant 
species 
As metabolite profiling using the Nuclear Magnetic Resonance (NMR) spectra 
and Orthogonal Partial Least Square - Discriminant Analysis (OPLS-DA) model 
has several advantages over the other techniques and also shown successful 
outcomes in identifying the active compounds in the plant extracts (see below), 
this approach was used as a part of a strategy to potentially identify  α-
glucosidase inhibitors from the extracts of a particular plant species grown in 
different geographical regions and under different ecological conditions by 
studying the correlation between the α-glucosidase inhibitory activity and the 
compounds present. The metabolite profiling technique is based on a statistical 
analysis of spectra data. Moreover, the variation of the phytochemical 
composition in the extracts causes the variation of a pharmacological activity. 
Hence, rather than using a single sample extract, a number of different sample 
extracts were used in metabolite profiling to study the variation of phytochemical 
composition (Liland, 2011). The sample size (number of samples) is an 
important factor which affects the quality of study involving statistical analysis. 
On that account, using a large number of samples in an investigation give more 
accurate outcomes, identify the outliers, and provide small margin error. On the 
other hand, a small sample size leads to inconclusive outcomes (Lenth, 2012). 
Therefore, a single sample cannot be utilised to conduct metabolite profiling 
technique to identify the α-glucosidase inhibitory compounds. Also, OPLS-DA is 
a supervised Multivariate Data Analysis (MVDA) method which requires a few 
groups of samples to conduct and identify the major contributors (NMR spectra 
signals) which are causing the separations between these groups. In other 
words, a particular extract of a single plant sample (one sample) cannot be 
used to group into a few groups. In this study, the samples were categorised as 
higher, moderate, and lower α-glucosidase inhibitory groups, consequently, at 
least three different samples were required to carry out this approach. 
Henceforward, several samples of a particular plant species were collected from 
the different geographical sites to conduct metabolite profiling to obtain more 
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accurate results (statistically) by comparing the NMR spectra signals and 
identify the α-glucosidase inhibitory compound/s in this study.  
 
7.1. Materials and methods 
7.1.1. The identification of α-glucosidase inhibitory compounds from 
plants 
7.1.1.1. Metabolite profiling 
The bioactivities of a plant extract are caused by the compounds present within 
it. Bioassay-guided isolation is the most common technique used to identify 
bioactive compounds from plant extracts. There are some advantages and 
disadvantages of using this technique. The main advantage is that it can be 
utilised to identify novel bioactive compounds (Weller, 2012). On the other 
hand, when using this technique, the bioactive compounds can be destroyed 
during the isolation process. Thus, the bioactivity of the compounds can be lost 
before isolation. In addition, the concentration of an active compound can be 
reduced when using column chromatographic techniques, because the active 
compound is spread over several fractions (Strömstedt et al., 2014). 
 
Metabolite profiling is used to study the comprehensive chemicals present in 
biological samples and their association between either a specific 
pharmacological activity or compound class (Yuliana et al., 2011). This reveals 
the major differences between the compounds and pharmacological activity, 
which could be related to chemical profiles (Wolfender et al., 2009). It is widely 
utilised in the following disciplines: Phytochemistry (Mandrone et al., 2017), 
chemotaxonomy (Sarrou et al., 2017), quality control (Agapouda et al., 2017), 
and clinical chemistry (Qian et al., 2017). Biological functional modification is 
caused by pathophysiological alterations, genetic changes, or challenges with 
external environment can be also assessed using metabolite profiling (Dunn et 
al., 2008). There are some benefits of this technique compared to bioassay-
guided isolation technique. Metabolite profiling method is a quantitative, 
reproducible, and straightforward technique. It is a rapid way to identify the 
active compounds in a crude plant extract (Wang et al., 2004). Even so, the 
major drawback of this technique is that it is unable to predict unknown 
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compounds present in the plant extract (Wen et al., 2010). Contemporarily, 
metabolite profiling combined with pharmacological activity approach is 
preferred over the traditional bioassay-guided isolation technique in drug 
discovery projects (Wolfender et al., 2015).  
 
NMR spectroscopy is widely used to study the plant extracts in the metabolite 
profile (Kim et al., 2010). Non-interfering chemical structure investigations of 
compounds in cell suspensions, crude natural extracts, in vivo analysis of entire 
organisms, and undamaged tissues are studied by employing NMR 
spectroscopy. NMR spectroscopy provides distinct and individual spectra for 
every compound (Verpoorte et al., 2007). There are some advantages of NMR 
spectroscopy over the other analytical spectroscopy techniques. One of the 
advantages of NMR spectroscopy is the outstanding reproducibility (Colquhoun, 
2007). Additionally, NMR spectroscopy can be utilised to identify novel 
compounds from extracts. The sample preparation procedure is straightforward 
(Verpoorte et al., 2007). The limitations of NMR spectroscopy include lower 
sensitivity, compounds with lower concentration often not being detectable, and 
signal overlapping (Holmes et al., 2006; Safer et al., 2011). 
 
MVDA is a statistical based method employed to analyse the data obtained 
from more than one sample (CAMO, 2015) and this technique used to interpret 
the NMR spectroscopy measurements in metabolite profiling (Bylesjö et al., 
2006; Wiklund et al., 2008). A regression, association between two data sets 
can be studied using MVDA, where the X component is the chemical profile and 
the Y component is the bioactivity (Sussulini, 2017). The OPLS-DA is a 
supervised method widely utilised to observe the association between the 
metabolite profile and bioactivity (Eriksson et al., 2013). The bioactive 
compounds are identified by recognising the NMR signals responsible for the 
separation between the high and low bioactive sample groups. OPLS-DA 
method is more appropriate than other the MVDA techniques such as Principle 
Component Analysis (PCA) when it comes to metabolite profiling, because 
OPLS-DA is a supervised method, the data can be categorised into groups 
before carrying out the MVDA. On the other hand, PCA is an unsupervised 
MVDA technique (Kang et al., 2008).  
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The combination of 1H NMR spectroscopy with bioactivity and OPLS-DA has 
provided successful outcomes in previous studies. The bioactive compounds 
suvanine, halisulfate 1, and halisulfate 3 - 5 (sesterterpenes) which exhibited 
adenosine A1 receptor binding activity were identified from crude extracts of 
marine sponges (PsammociniaII) using NMR spectroscopy and OPLS-DA (Ali 
et al., 2013). Another example, Yuliana et al. (2013) correspondingly identified 
two flavonoid derivatives (hydroxy-panduratin and pinocembrine) responsible 
for adenosine A1 receptor binding activity from crude rhizome extract of 
Boesenbergia rotunda (L.) Mansf. (Zingiberaceae).  
  
7.1.2. Selected plant species used for the α-glucosidase inhibitory activity 
and the identification α-glucosidase inhibitory compounds in this study 
When selecting the plant species to study for α-glucosidase inhibitory activity, 
initially the plant species which are very well scientifically studied and commonly 
distributed around the world which marked in Appendix A and Table 5.2 were 
excluded. For example, garlic and ginger. After that, rare (threatened) and toxic 
plant species (see Appendix A and Table 5.2) were also omitted. Then from the 
remaining plant species (based on a systematic search of the scientific 
literature), antidiabetic active compounds had been identified were excluded. 
Then, species had no reports on α-glucosidase inhibitory activity were included. 
Plant species which are widely distributed throughout SL and easily accessible 
were prioritised. Plant parts of the species (used in the antidiabetic 
preparations) which are available throughout the year, easier to collect, and 
easier to preserve were considered. For instance, plant parts such as root, bark, 
flower, seed, and fruit of plant species which are used in the antidiabetic 
preparations were excluded and specifically leaves (including trees) and whole 
plants of herbaceous plants were included. Finally, the following five plant 
species were chosen for this study: Achyranthes aspera L. (whole plant), 
Ipomoea aquatica Forssk. (leaf), Coccinia grandis (L.) Voigt (leaf), Mukia 
maderaspatana (L.) M.Roem. (leaf), and Artocarpus heterophyllus Lam. (mature 
leaf). Yet, these selected plant species showed antidiabetic activities in various 
models (mostly in in vivo models) and there might be the other pharmacological 
mechanisms of action accountable for the antidiabetic activity of these selected 
plant species. For instance, Senna auriculata (Appendix C) flowers showed 
antidiabetic activities in various bioassays and in vivo models. Consequently, 
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this study was aimed to study the α-glucosidase inhibitory activity and identify 
the α-glucosidase inhibitory compounds from one of these selected plants.  
 
7.1.2.1. Achyranthes aspera L.     
Achyranthes aspera (Figure 7.1) is a weed that belongs to the Amaranthaceae 
family. It is called Naayuruvi (நோயுருவி) in Tamil (SM) and is found in the tropical 
regions of the world (e.g. Africa, America, Asia, Australia, and Europe) (de 
Lange et al., 2004; Prain, 1963; Hooker, 1885). It is a food plant in Eastern SL. 
The common food dish for lunch is prepared using the stems and leaves (before 
flowering). A. aspera is likewise commonly used in TMs around the world (Fikru 
et al., 2012; Pai et al., 2010; Shibeshi et al., 2006). In Sri Lankan SM, the whole 
plant is utilised in antidiabetic preparations Kaareeya sinthooram (preparation 
32) and Neerilivukku vanga senthooram (preparation 56) (Appendix B). 
 
There are some pharmacological studies carried out in various experimental 
models using A. aspera. It exhibited anti-inflammatory (Khuda et al., 2014; 
Vetrichelvan and Jegadeesan, 2003), antiarthritic (Gokhale et al., 2002), 
abortifacient (Pakrashi and Bhattacharya, 1977), antifertility (Prakash, 1986; 
Varshney et al., 1986; Wadhwa et al., 1986), cancer chemopreventive 
(Chakraborty et al., 2002), antioxidant (Upadhya et al., 2015), antifungal, 
antibacterial (Khuda et al., 2015), and wound-healing effects (Barua et al, 2012) 
in several studies.  
 
A. apsera has in vivo antidiabetic scientific evidence. The extract of dried stem 
and leaf (80% ethanol) at a dose of 200 mg/kg per day when orally 
administrated to Alloxan-induced diabetic rats for 2 weeks caused a significant 
decrease in the fasting blood glucose levels. The results observed were better 
than the positive control (Metformin®) utilised in this study (Talukder et al., 
2012). Another study carried out by Akhtar and Iqbal (1991), using both 
aqueous and methanol extracts of the shade-dried whole plant (4000 mg/kg) 
involved oral administration to normal and Alloxan-induced diabetic rats. After 4 
hours, it was noticed that blood glucose concentration was lowered to normal 
levels. Furthermore, toxicity study carried out during this study showed that an 
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orally administered dose of 8000 mg/kg showed no toxic effects even after 7 
days of treatment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 1 Achyranthes aspera sample collected at Anaipanthy Pillaiyar 
Temple, Puliyantheevu, Batticaloa 
 
Several compounds have been isolated from A. aspera including the betulinic 
acid (Pai et al., 2014), ecdysterone, linolenic acid, oleic acid, palmitic acid, 
stearic acid (Chakrabarti et al., 2012), betaine (Mehta et al., 2011), oleanolic 
acid (Mehta et al., 2010), strigmasta-5, 22-dien-3-beta-ol, trans-13-docasenoic 
acid, n-hexacosanyl n-decaniate, n-hexacos-17-enoic acid and n-hexacos-11-
enoic acid, and n-hexacos-14-noic acid (Sharma S.K.R et al., 2009).  
 
7.1.2.2. Ipomoea aquatica Forssk.  
Ipomoea aquatica (Figure 7.2) is a perennial creeper and belongs to the 
Convolvulaceae family. It is called Vallal (வள்ைல்) in Tamil (SM). This species is 
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generally found in Africa, Australia, and Asia (Edie and Ho, 1969). I. aquatica is 
a common food plant in SL and its leaves and stems are used to cook. I. 
aquatica leaves are utilised as an ingredient in Neerilivuchchanthanaathiyennai 
(preparation 47) (Appendix B) in Sri Lankan SM to treat diabetes.    
 
Pharmacological studies show that I. aquatica possesses antioxidant (Bhalodi 
et al., 2008), anti-inflammatory and antibacterial (Dhanasekaran et al., 2010), 
antiulcer (Sivaraman and Muralidaran, 2008), hypolipidemic (Sivaraman, 2010), 
and diuretic (Mamun et al., 2003) activities. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 2 Ipomoea aquatica sample collected in Vavunatheevu, Batticaloa 
 
Past literature shows that there is currently in vivo evidence regarding the 
antidiabetic properties of I. aquatica. An aqueous extract of the leaves was 
prepared using a dose of 3300 mg starting material /kg. This extract was orally 
administered to glucose challenged Wistar rats. After 2 hours, it was observed 
that the elevated blood glucose was lowered to a normal concentration. This 
effect was equivalent to the effect caused by the positive control used (15 
mg/kg of Tolbutamide) (Malalavidhane et al. 2001). In another study carried out 
by Malalavidhane et al. (2000) in SL, an extract was prepared by boiling 3400 
mg/kg of leaves of I. aquatica. This extract was orally administered to glucose 
challenged healthy rats. The results revealed that there was a 33% reduction in 
the blood glucose concentrations after 2 hours. In a further experiment, fresh 
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leaves and stems (3400 mg/kg) were orally administered to Streptozotocin-
induced diabetic rats for 1 week and blood tests showed that there was a 
significant reduction in fasting blood glucose concentration (Malalavidhane et al. 
2003). 
 
Compounds including aquaterin I – XI (Fan et al., 2014), violaxanthin, lutein, β-
carotene (Fu et al., 2011), 7-O-beta-D-glucopyranosyl-dihydroquercetin-3-O-α-
D-glucopyranoside (Prasad et al., 2005), 1-hexadecanoylpyrrolidine, 1-(14-
methylhexadecanoyl)pyrrolidine, 1-octadecanoylpyrrolidine (Tofern et al., 1999), 
α-carotene, β-carotene, lutein, zeaxanthin, antheraxanthin, flavoxanthin, 
auroxanthin, luteoxanthin, neoxanthin (Wills and Rangga, 1996), pheophytin a, 
chlorophyll a, chlorophyll b, and lutein epoxide (Chen and Chen, 1992) have 
been isolated from I. aquatica. 
 
7.1.2.3. Coccinia grandis (L.) Voigt 
Coccinia grandis (Figure 7.3) is a climber and belongs to the Cucurbitaceae 
family. It is called Kovvai (ககோவ்ரவ) in Tamil (SM) and found throughout Asia, 
Africa, Australia and Oceania, Caribbean and Southern USA (Muniappan et al., 
2009). C. grandis leaves are used for both food and medicinal purposes in SL. 
The leaves are utilised to prepare dishes as Sothy (கசோதி) (a traditional soup 
made with coconut milk, turmeric powder, green chilies, onions, and fenugreek) 
and Sambal (சம் ல்) (a salad prepared with fresh green leaves mixed with 
green chilies, onions, salt, and pepper) in the Eastern, Northern, and Central 
SL. These dishes are also used as medicine to treat diabetes in the Eastern 
and Northern SL (Rajapaksha, 1998). Sri Lankan SM historical documents 
mention that C. grandis leaves are utilised in Neerilivuchchanthanaathiyennai 
(preparation 47) (Appendix B) to treat diabetes. C. grandis has been shown to 
have bioactivities such as anticancer (Bhattacharya et al., 2011), antioxidant 
(Umamaheswari and Chatterjee, 2008), and anti-inflammatory (Deshpande et 
al., 2011) properties.  
 
There is currently in vivo scientific evidence showing that C. grandis has 
antidiabetic activity. In one study, an aqueous extract (750 mg/kg) prepared 
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from leaves, dried at 40 °C was orally administered to Streptozotocin-induced 
diabetic rats for 30 days. Blood tests revealed a decrease in the blood glucose 
levels. It was additonally observed that insulin secretion in the β-cells was 
increased (Attanayake et al., 2015). In another study, again 750 mg/kg aqueous 
extract of leaves was orally administered to Alloxan-induced diabetic rats. Blood 
tests carried out after 4 hours showed reduced blood sugar levels compared to 
the positive control Glibenclamide (0.50 mg/kg). In the acute toxicity study, it 
was revealed that there were no adverse effects when an aqueous extract of C. 
grandis leaves (2000 mg/kg) was administered orally for 2 days (Attanayake et 
al., 2013). Some compounds, includ ing taraxerol (Gantait et al., 2010), palmitic 
acid, stearic acid, oleic acid, linoleic acid, α-tocopherol, γ-tocopherol, and β-
carotene (Sadou et al., 2007) have been isolated from this species.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 3 Coccinia grandis sample collected at Thirukonecharam Temple, 
Trincomalee 
 
7.1.2.4. Mukia maderaspatana (L.) M. Roem.     
Mukia maderaspatana (Figure 7.4) is also a climber and belongs to the 
Cucurbitaceae family. It is called Mosumosukkai (கமோசுகமோசுக்ரக) in Tamil 
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(SM) and it is distributed throughout most of the tropical zones in the world, 
incorporating Australia and Oceania (FZ, 2016). M. maderaspatana leaves are 
used for both food and medicinal purposes in SL. Leaves are utilised to prepare 
dishes like Sothy and Sambal (see section 1.12.3. Coccinia grandis (L.) Voigt) 
in SL. These food preparations are used to treat coughs (Rajapaksha, 1998). 
They are utilised in Neerilivuchchanthanaathiyennai (preparation 47) to treat 
diabetes in Sri Lankan SM (Appendix B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 4 Mukia maderaspatana sample collected in Batharamulla, Colombo 
 
Antimicrobial (Dhanaraj et al., 2012), gastroprotective (Gomathy et al., 2015), 
and antioxidant (Petrus and Bhuvaneshwari, 2012), activities of M. 
maderaspatana have been observed in past pharmacological studies. There is 
currently only one in vitro antidiabetic study for M. maderaspatana. The 
methanol extract of a shade-dried whole plant (0.25 mg/ml) was able to inhibit 
gluconeogenesis in a rat liver slice assay (Srilatha and Ananda, 2014). 
Compounds like 7-O-β-D-glucopyranosyl-6-C-β-D-glucopyranosylluteolin, 8-C-
β-D-glucopyranosylapigenin, 6-C-β-D-glucopyranosylapigenin, 7-O-β-D-
glucopyranosyl-6-C-β-D-glucopyranosylapigenin, 8-C-β-D-
glucopyranosylluteolin, and 6-C-β-D-glucopyranosylluteolin (Petrus and 
88 
 
Bhuvaneshwari, 2012) have been identified and isolated from various parts of 
M. maderaspatana. 
 
7.1.2.5. Artocarpus heterophyllus Lam.  
Artocarpus heterophyllus (Figure 7.5) belongs to the Moraceae family and is 
referred to as Palaa ( லோ) in Tamil (SM). It is commonly distributed in Asia, 
Australia, Africa, North and South America (Morton and Dowling,1987). The 
mature leaves of A. heterophyllus are utilised as both cattle food and medicine 
in SL. The decoction made by boiling mature leaves in water is consumed to 
treat diabetes (Jayaweera, 1982). Mature leaves are used as an ingredient in 
Neerilivuchchanthanaathiyennai (preparation 47) (Appendix B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. 5 Artocarpus heterophyllus sample collected in Peradeniya Royal 
Botanical Gardens, Lake Drive, Peradeniya, Kandy 
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Pharmacological studies show that A. heterophyllus has antiproliferative (Zheng 
et al., 2014) and anti-inflammatory (Wei et al., 2005) activities. In addition, 
clinical studies have shown that this species has antidiabetic properties. One 
such study utilised fresh mature leaves clinical evidence for treating diabetes. 
Fresh mature leaves (20 000mg/kg of starting plant material) which were then 
boiled in water and a 110 ml decoction orally administered to 10 normal and 10 
T2D people. After 2 hours blood glucose levels had returned to the normal level 
(Fernando et al., 1991).  
 
An ethanol extract of shade-dried leaves (100 mg/kg body weight) was orally 
administered to Alloxan-induced diabetic rats for 7 days. The results showed a 
decrease in the fasting blood sugar level. Glibenclamide (2.5 mg/kg) was 
utilised as a positive control in this study. Also, toxicity studies showed that 
when a dose of up to 5000 mg/kg was administered orally over a 7-day period 
there was no mortality (Okonkwo et al., 2015). In another study, 70% ethanol 
extract and n-butanol extract of the air-dried leaves (200 mg/kg) was orally 
administrated to Streptozotocin-induced diabetic rats for 10 days. The results 
show that there was a significant reduction in fasting blood glucose from 200 to 
56 mg% and increased the insulin level in the blood from 10.8 to 19.5 µU/ml. 
These observed results were more effective than the positive control 
(Glibenclamide, 600 µg/kg) (Omar et al., 2011). In a study carried out by 
Chackrewarthy et al. (2010), the ethyl acetate fraction of dichloromethane 
extract of the fresh mature leaves (20 mg/kg) was orally administered to 
Streptozotocin-induced diabetic rats for 5 weeks. It was observed that plasma 
glucose levels were lowered by 39%. 
 
An in vitro study conducted by Kotowaroo et al. (2006), the aqueous extract of 
the dried leaves (1000 μl/ml) exhibited inhibition of α-amylase while using starch 
as a substrate. In another study, the aqueous seed extract showed 87.52% 
antiglycation activity (Shakthi Deve et al., 2014). A. heterophyllus has 
pytochemicals including artoheterone A, artoheterone B, artocarpanone, β-
carotene, lutein, lycopene, β-cryptoxanthin, flavokawain A, gemichalcone A, 
cyanomaclurin, dihydromorin, sakuranetin, naringenin, artocarpanone, 
isosinensetin, norartocarpetin, artonin Y, artoindonesianin S, artopeden A, 
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artonin A, artonin F, morusin, artocarpin, cycloheterophyllin, isocyclomulberrin, 
and cyclocommunol (Ren et al., 2015; Ruiz-Montanez et al., 2015) all of which 
have been isolated. 
 
7.2. Results and discussion  
7.2.1. The α-glucosidase inhibitory activity of selected plant species 
The mean percentage (n = 3) of the preliminary α-glucosidase inhibitory activity 
of the 30 extracts from the five selected plant species presented in Table 7.1. 
The methanol extract from mature Artocarpus heterophyllus leaves exhibited 
the highest α-glucosidase inhibitory activity (99.93 ± 0.01 %) at the highest 
concentration tested (200 μg/ml). Hence, all the collected methanol extract of 
mature A. heterophyllus leaf samples were studied further in this work. 
Additionally, there was no previous α-glucosidase inhibitory activity data 
available for all the selected plant species to compare to the results obtained in 
this study. 
 
Table 7.1 α-Glucosidase inhibitory activity of the extracts of selected plant 
species and the positive control (Acarbose) 
Plant species, extract, and Acarbose α-Glucosidase inhibition / % 
Achyranthes aspera   
Hexane 35.98 ± 0.79 
Chloroform 23.82 ± 0.84 
Ethyl acetate 19.29 ± 0.83 
Acetone 17.34 ± 0.61 
Methanol 8.76 ± 0.07 
Aqueous 0.00 
    
Artocarpus heterophyllus   
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Plant species, extract, and Acarbose α-Glucosidase inhibition / % 
Hexane 0.00 
Chloroform 6.51 ± 0.15 
Ethyl acetate 25.13 ± 1.24 
Acetone 39.36 ± 1.72 
Methanol 99.93 ± 0.01 
Aqueous 52.09 ± 2.58 
    
Coccinia grandis   
Hexane 0.00 
Chloroform 0.00 
Ethyl acetate 7.72 ± 0.36 
Acetone 12.16 ± 0.49 
Methanol 12.66 ± 0.52 
Aqueous 39.40 ± 1.48 
    
Ipomoea aquatica   
Hexane 12.36 ± 0.34 
Chloroform 15.93 ± 0.86 
Ethyl acetate 17.41 ± 0.94 
Acetone 32.55 ± 1.72 
Methanol 41.02 ± 1.58 
Aqueous 0.00 
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Plant species, extract, and Acarbose α-Glucosidase inhibition / % 
    
Mukia maderaspatana   
Hexane 18.47 ± 0.21 
Chloroform 9.04 ± 0.23 
Ethyl acetate 5.14 ± 0.20 
Acetone 0.00 
Methanol 0.00 
Aqueous 0.00 
    
Acarbose / µg/ml   
200 98.48 ± 0.28 
175 88.74 ± 0.51 
150 53.96 ± 0.54 
125 10.48 ± 0.75 
100 8.07 ± 0.30 
75 5.54 ± 0.12 
 
% α-Glucosidase inhibition values are presented as mean ± SD (n = 3) 
 
7.2.2. The α-glucosidase inhibitory activity of collected samples of mature 
Artocarpus heterophyllus leaves 
It was observed that the inhibitory activity of A. heterophyllus extracts on α-
glucosidase was dose-dependent. The IC50 is the concentration of an inhibitor 
needed to provide 50% inhibition. On top of that, it is a scale used to determine 
the effectiveness of an inhibitor (Sittampalam et al., 2004). The IC50 values of 
93 
 
38 samples were found to compare the α-glucosidase inhibitory activity (Table 
7.2). Samples with higher IC50 values had lower α-glucosidase inhibitory activity 
and vice versa. 
 
It was found that the IC50 values varied significantly and were between 7.56 to 
185.03 µg/ml depending on the extract utilised. The different metabolite 
composition and concentration can cause a variation of the bioactivities of 
biological samples (Oliver et al., 1998). It seems that the metabolite 
concentration is causing the variation of the α-glucosidase inhibitory activity 
observed in this study. This is discussed further below (7.3. Identifying the α-
glucosidase inhibitory compounds). 
 
Sample 32 collected from Nuwara Eliya (wet zone, 1416 m elevation, and red-
yellow podzol soil) exhibited the greatest α-glucosidase inhibitory activity with 
IC50 of 7.56 µg/ml while, sample 15 collected from Kandy (also wet zone, at 586 
m elevation, and reddish-brown latosol soil) had the lowest α-glucosidase 
inhibitory activity with IC50 of 185.03 µg/ml. This clearly shows that the α-
glucosidase inhibitory activity varies with the geographical sites. Still, the mean 
IC50 value was 21.65 µg/ml for 38 samples. Acarbose was used as a positive 
control in this study had IC50 of 149.81 ± 0.95 µg/ml (~ 150 µg/ml). This value 
was previously reported by Lordan et al. (2013) (150 µg/ml) and Fujita et al. 
(2015) (152 µg/ml). The graph of α-glucosidase inhibition versus concentration 
is presented in Figure 7.6. The outcomes of the α-glucosidase inhibitory activity 
exhibit that the mature A. heterophyllus leaves are more effective in inhibiting α-
glucosidase enzyme compared to Acarbose. For instance, samples had the 
higher α-glucosidase inhibitory activity.  
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Figure 7. 6 Graph of α-glucosidase inhibition versus concentrations used of 
Acarbose 
 
All the samples were grouped into three groups based on their IC50 values: 
lower (greater than IC50 of 31.65 µg/ml), moderate (mean ± 10 µg/ml, in the 
range of IC50 from 11.65 to 31.65 µg/ml), and higher (less than IC50 of 11.65 
µg/ml) α-glucosidase inhibitory activity. The majority of the samples (23) had 
moderate, 12 samples showed higher, and three samples showed lower α-
glucosidase inhibitory activities.  
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Table 7.2 The geographical information and the IC50 values of α-glucosidase inhibitory activity of 38 samples and Acarbose 
Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
1 Anaipanthy Pillaiyar Temple, 
Batticaloa 
7.70846 81.69324 Dry 18 Regosol and alluvium 14.55 ± 0.38 
                
2 88 Lake Road No. 2, Batticaloa 7.70549 81.69353 Dry 9 Regosol and alluvium 14.51 ± 0.43 
  
 
            
3 Thiruchendur Muruhan Temple, 
Batticaloa 
7.72152 81.7149 Dry 10 Regosol and alluvium 11.37 ± 0.41 
  
 
            
4 Old Rest House Road, Batticaloa 7.71820 81.70016 Dry 10 Regosol and alluvium 16.91 ± 1.22 
                
5 Mullamunai, Batticaloa 7.67844 81.60082 Dry 10 Regosol and alluvium 9.67 ± 0.47 
                
6 Pandiruppu, Ampara 7.42597 81.81467 Dry 3 Regosol and alluvium 9.57 ± 0.51 
                
7 Kalmunai, Ampara 7.42131 81.82225 Dry 10 Regosol and alluvium 9.73 ± 0.63 
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Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
8 Muthiyagana Raja Buddhist 
Temple, Badulla 
6.98431 81.06157 Intermediate 667 Red yellow podzol 46.25 ± 2.76 
                
9 Muthiyagana Raja Buddhist 
Temple, Badulla 
6.98412 81.06089 Intermediate 667 Red yellow podzol 56.69 ± 2.83 
                
10 Battaramulla, Colombo 6.89979 79.91831 Wet 8 Red yellow podzol 11.37 ± 0.91 
                
11 Jawatte Road, Colombo 6.89975 79.86647 Wet 13 Red yellow podzol 26.16 ± 1.56 
                
12 Kacheri Road, Hambantota 6.12289 81.12663 Dry 17 Regosol and alluvium 11.94 ± 0.49 
                
13 Yogarswamihal Ninaivalayam, 
Jaffna 
9.65302 80.03865 Dry 10 Regosol and alluvium 14.37 ± 0.48 
                
14 Chavakachcheri, Jaffna 9.66012 80.16342 Dry 11 Regosol and alluvium 25.08 ± 1.19 
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Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
15 Kurinji Kumaran Temple, Kandy 7.25746 80.60336 Wet 586 Reddish brown latosol 185.03 ± 9.25 
                
16 Pallekele, Kandy 7.27924 80.70378 Intermediate 468 Reddish brown latosol 13.26 ± 0.93 
                
17 Peradeniya, Kandy 7.28078 80.62067 Wet 490 Reddish brown latosol 12.79 ± 0.92 
                
18 Peradeniya, Kandy 7.28067 80.61979 Wet 491 Reddish brown latosol 15.20 ± 0.60 
                
19 Church of Ceylon, Kilinochchi 9.38829 80.40776 Dry 28 Reddish brown 15.17 ± 1.25 
                
20 Wathhimi Road, Kurunegala 7.48973 80.36666 Intermediate 135 Red yellow podzol 18.28 ± 0.97 
                
21 Maliga Pitiya Stadium, Kurunegala 7.49089 80.36657 Intermediate 127 Red yellow podzol 10.48 ± 0.09 
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Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
22 Kachcheri Road, Kurunegala 7.49132 80.3667 Intermediate 126 Red yellow podzol 22.40 ± 1.24 
                
23 Dambulla, Matale 7.87089 80.64993 Dry 162 Reddish brown 8.83 ± 0.72 
                
24 Matale Muthumariamman Temple, 
Matale 
7.47205 80.62441 Wet 358 Reddish brown latosol 24.62 ± 1.07 
                
25 Bandarapola, Matale 7.45020 80.67085 Wet 659 Reddish brown latosol 18.21 ± 0.94 
                
26 Bandarapola, Matale 7.44975 80.68097 Wet 768 Reddish brown latosol 23.28 ± 1.16 
                
27 Thiruketheecharam, Mannar 8.95114 79.96023 Dry 5 Solodised solonetz and 
solonchaks 
26.59 ± 1.56 
                
28 Dondra, Matara 5.92090 80.59259 Wet 14 Red yellow podzol 29.13 ± 0.64 
                
29 Dondra, Matara 5.92248 80.58974 Wet 17 Red yellow podzol 15.14 ± 1.12 
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Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
30 Kathirhamam Muruhan Temple, 
Monaragala 
6.41846 81.33376 Dry 48 Reddish brown 16.30 ± 1.23 
                
31 Kataragama, Monaragala 6.41418 81.32979 Dry 48 Reddish brown 11.91 ± 0.97 
                
32 Nallathanniya, Nuwara Eliya 6.82145 80.50596 Wet 1416 Red yellow podzol 7.56 ± 0.67 
                
33 Nallathanniya, Nuwara Eliya 6.82548 80.52180 Wet 1257 Red yellow podzol 7.62 ± 0.19 
                
34 Mulgama, Nuwara Eliya 6.82601 80.52692 Wet 1235 Red yellow podzol 11.30 ± 0.57 
                
35 Thirukonecharam Temple, 
Trincomalee 
8.58096 81.24425 Dry 34 Reddish brown 19.98 ± 0.34 
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Sample Location Latitude / 
°N 
Longitude / 
°E 
Climate zone Elevation / m Soil type IC50 / µg/ml 
36 St. Antony's Church, Trincomalee 8.57215 81.23327 Dry 10 Reddish brown 13.20 ± 0.70 
                
37 Rambaikulam, Vavuniya 8.73390 80.50737 Dry 100 Reddish brown 10.14 ± 0.57 
                
38 Kovilkulam, Vavuniya 8.74211 80.50886 Dry 102 Reddish brown 8.17 ± 0.14 
NA Acarbose NA NA NA NA NA 149.81 ± 0.95  
 
IC50 values are presented as mean ± SD (n = 3) 
NA: Not applicable 
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Table 7.3 Mean of the IC50 values for Artocarpus heterophyllus based on the climate zones, topography, and soil types 
Category Minimum / µg/ml Maximum / µg/ml Mean / µg/ml Number of samples 
IC50 value 
    
Low (Higher inhibition) 7.56 11.37 9.65* 3 
Moderate (Moderate inhibition) 11.91 29.13 18.22* 23 
High (Lower inhibition) 46.25 185.03 95.99* 12 
     
Climate zone 
    
Dry 8.17 26.59 14.10 19 
Intermediate 10.48 56.69 27.89 6 
Wet 7.56 185.03 29.80 13 
     
Topography region / elevation 
    
Coastal (0 - 30 m) 9.57 29.13 16.43 17 
Plain (31 - 200 m) 8.17 22.40 13.52 9 
Highland (above 200 m)  7.56 185.03 35.15 12 
     
Soil type 
    
Red-yellow podzol 7.56 56.69 21.87 12 
Reddish-brown 8.17 19.98 12.96 8 
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Category Minimum / µg/ml Maximum / µg/ml Mean / µg/ml Number of samples 
Reddish-brown latosol 12.79 185.03 41.77 7 
Regosol and alluvium 9.57 25.08 13.77 10 
* Significant at p < 0.01 
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The correlation between the α-glucosidase inhibitory activity and the physical 
environmental factors such as climatic condition, topography (elevation), and 
soil types observed are discussed further. The samples were collected in all 
three climate zones (dry, intermediate, and wet) in SL. Remarkably, samples 
collected from the wet zone had both the highest (sample 32) and the lowest 
(sample 15) α-glucosidase inhibitory activities. The majority of the samples were 
collected from the dry (19 samples) followed by the wet (13 samples), and 
finally the intermediate (6 samples) zones (Table 7.3). The samples collected 
from the dry zone had the lowest mean IC50 value (14.10 µg/ml) followed by, the 
intermediate (27.89 µg/ml), and the wet zone samples (29.80 µg/ml). These 
results suggest that samples collected from the dry zone had the highest α-
glucosidase inhibitory activity while those from the wet zone had the least 
inhibitory activity. As a result, it seems that there was a direct relationship 
between the α-glucosidase inhibitory activity and the climatic conditions.  
 
The samples collected from three types of main topographies of SL (coastal, 
plain, and highland regions). The greatest number of samples (17 samples) was 
collected from the coastal region followed by the highland (12 samples), and 
plain (9 samples) regions. Again, remarkably samples collected from the 
highland region had both the highest (sample 32) and the lowest (sample 15) α-
glucosidase inhibitory activities in this study. The plain region samples had the 
lowest mean IC50 value (13.52 µg/ml) followed by, the coastal (16.43 µg/ml), 
and highland (35.15 µg/ml) regions samples. Which probably seems that there 
was no direct correlation between the elevation (topography) and the α-
glucosidase inhibitory activity of methanol extracts of mature A. heterophyllus 
leaves.  
 
The majority of mature A. heterophyllus leaf samples were collected from the 
red-yellow podzol soil (12 samples) followed by the regosol and alluvium (10 
samples), reddish-brown (8 samples), reddish-brown latosol (7 samples), and 
solodised-solonetz and solonchaks (1 sample) soils. The sample 32 which had 
the highest α-glucosidase inhibitory activity in this study and was collected from 
the red-yellow podzol soil whereas sample 15 had the lowest α-glucosidase 
inhibitory activity was collected from the reddish-brown latosol soil. The reddish-
brown soil samples had the mean greatest α-glucosidase inhibitory activity (IC50 
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of 12.96 µg/ml) followed by the regosol and alluvium (IC50 of 13.77 µg/ml), red-
yellow podzol (IC50 of 21.87 µg/ml), and reddish-brown latosol (IC50 of 41.77 
µg/ml). Only one sample was collected from the solodised solonetz and 
solonchaks soil (sample 27 from Mannar) and was found to have an IC50 of 
26.59 µg/ml.  
 
Even though, the α-glucosidase inhibitory activity of mature A. heterophyllus 
leaves has not been studied before. Mature A. heterophyllus leaves were 
previously studied in in vivo models and a clinical study conducted to evaluate 
its antidiabetic effects (see 7.1.2.5. Artocarpus heterophyllus Lam.). There 
might be the other pharmacological mechanisms responsible for the antidiabetic 
activity of mature A. heterophyllus leaves. Consequently, additional 
pharmacological and clinical investigations should be carried out. This study 
reveals that the antidiabetic activity of methanol extracts of mature A. 
heterophyllus leaves is linked to the α-glucosidase inhibitory activity. 
 
7.2.3. Identifying the α-glucosidase inhibitory compounds  
Three sample groups were established (higher, moderate, and lower α-
glucosidase inhibitory activities) and used to identify the α-glucosidase inhibitory 
compound by using multivariate statistical analysis (OPLS-DA statistical model) 
of 1H NMR spectra. The score plot of the OPLS-DA model is illustrated in Figure 
7.7. The T score [1] and Orthogonal T score [1] showed 17.7% and 36.4% 
variability respectively. Further, a significant separation was observed between 
the higher, moderate, and lower α-glucosidase inhibitory active sample groups. 
Sample 32 had the highest α-glucosidase inhibitory activity followed by samples 
33 and 38. These three samples were clearly grouped in the higher inhibition 
group (red). In addition, the rest of the samples had the higher α-glucosidase 
inhibitory activity (samples 3, 5, 6, 21, 23, 34, and 37) were clustered with the 
higher inhibition group while overlapping with the moderate inhibition group 
(blue). Sample 15 had the lowest α-glucosidase inhibitory activity followed by, 
the samples 9 and 8. All these three samples were clustered in the lower 
inhibition group while samples 9 and 8 were overlapped with the moderate 
inhibition group (green). Likewise, it was observed that sample 15 was located 
further away from all the other samples. On top of that, there was one outlier 
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identified in this model, sample 22 had moderate α-glucosidase inhibitory 
activity and was located closer to sample 15. This seems to be a strong 
correlation between the α-glucosidase inhibitory activity and the chemical 
composition variation in this study.   
 
 
Figure 7.7 Orthogonal Partial Least Square - Discriminant Analysis score plot of 
the lower, moderate, and higher α-glucosidase inhibitory activity groups of 
mature A. heterophyllus leaf samples 
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The s-plot for the OPLS-DA model was used to identify the most relevant 
buckets contributing to the variation between the lower, moderate, and higher α-
glucosidase inhibition sample groups (Figure 7.8). The s-plot revealed that 1.72, 
1.92, 1.96, 1.28, and 1.44 ppm and 4.44, 4.32, 9.00, 6.84, and 8.40 ppm 
buckets were the major contributors to the chemical compostion variation 
between the higher and lower α-glucosidase inhibition groups.
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Figure 7.8 The s-plot analysis representing the major contributors of 1H NMR 
spectra signals for the separations between the higher, moderate, and lower α-
glucosidase inhibition groups 
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Figure 7.9 The 1H NMR spectra of the samples had the highest (sample 32, 
above) and the lowest (sample 15, below) α-glucosidase inhibitory activities 
 
The intensities of the NMR spectrum signals are directly proportional to the 
concentrations of the compounds present in the samples. Therefore, the 
compounds with higher concentrations will provide stronger signals with higher 
intensities, while, the compounds with less concentration will provide weaker 
signals with lower intensities (Mo and Raftery, 2008). As mentioned before, 
external factors affect the metabolite concentration in the biological samples 
(Oliver et al., 1998). Accordingly, environmental (external) factors such as 
climates, elevations, and soil types could be responsible for the variation in the 
metabolite concentrations in this study.  
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Figure 7.10 Chemical structure of Artoheterophyllin B 
 
 
 
 
 
 
 
 
Figure 7.11 Chemical structure of Moracin M 
 
1H NMR spectra, performed in the methanol-d4 solvent, of the compounds 
isolated from Moraceae family plant species were compared to the major 
buckets contributing to the separations in the OPLS-DA model. The major 
contributing buckets (6.84 and 1.72) matched with the corresponding 1H NMR 
spectrum signals of Artoheterophyllin B (a flavonoid) (Figure 7.10) which was 
isolated from the methanol extract of A. heterophyllus twigs (Zheng et al., 2009) 
and Moracin M (also a flavonoid) (Figure 7.11) which had been isolated from 
the ethanol extract of A. heterophyllus leaves (Wang X. et al., 2017). Both 
compounds give NMR spectrum signals at 6.84 ppm, while the signals below 2 
ppm (1.72 ppm) are very likely due to the aliphatic protons present in 
Artoheterophyllin B. Therefore, it is likely that Artoheterophyllin B is responsible 
for the higher α-glucosidase inhibitory activity of mature A. heterophyllus leaves. 
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Even so, no studies have been performed so far to determine the antidiabetic 
activity of Artoheterophyllin B. Thus, another chemical analytical technique such 
as Liquid Chromatography-Mass Spectrometry (LC-MS) should be utilised to 
confirm this. In addition, further phytochemical and pharmacological analysis 
should be carried out to identify the other α-glucosidase inhibitory compounds 
present in mature A. heterophyllus leaves.   
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Chapter 8 
Conclusion 
8.1. Findings and limitations 
The findings of this Ph.D. research incorporate four parts. The first part is to 
identify and document the plant species mentioned in the Sri Lankan SM 
historical documents to treat diabetes (Chapter 4). The second part 
encompasses an ethnobotanical survey carried out in the Eastern Province of 
SL with SEHs to identify and document the plant species currently used to treat 
diabetes with a key aim being to prevent this knowledge from disappearing in 
the future. Additionally, the plant species recorded in the ethnobotanical survey 
were compared with the plant species documented in the historical documents 
in order to understand continuity and the change in the treatment of diabetes 
(Chapter 5). The third part assessed the current scientific evidence available 
using relevant published studies on antidiabetic activity for the majority of the 
plant species documented from both the historical documents and the 
ethnobotanical survey to provide a basis for future pharmacological and 
phytochemical studies (Chapter 6). In the final part, a metabolomics approach 
was utilised to assess the activity of a species on α-glucosidase as a target. An 
α-glucosidase inhibitor from a selected plant species was identified tentatively 
using a metabolomic profiling approach employing NMR spectroscopy and 
OPLS-DA (Chapter 7).   
 
In the nutshell, the aims and objectives of this Ph.D. project have been 
achieved, despite the fact that there were some limitations identified in this 
work. The findings of this work contribute the new knowledge to 
ethnopharmacology, pharmacognosy, and medicinal plant research more 
broadly.   
 
As stated in Chapter 2, SM is one of the TMs practised in SL and it is the main 
TM for Tamils. Ayurveda is the TM mostly practised in SL, followed by SM 
(Sivasanmugarajah, 2001). Comparatively, the majority of the published works 
regarding plants and preparations utilised in TM in SL were based on Ayurveda, 
for example, Kankanamalage et al. (2015) and Thabrew et al. (2001). In 
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addition, a couple of ethnobotanical surveys had been carried out in the SM 
practising areas (Rajamanoharan 2014, 2016). There was only one study which 
assessed the plants used to treat diabetes in an Indian SM historical document 
(Parthiban et al., 2014). Therefore, this Ph.D. project systematically assessed 
and documented the importance of the historical and current Sri Lankan SM 
diabetes treatments and the plant species utilised in the preparations. This 
information was made publicly available also to prevent its disappearance in the 
future. Furthermore, since this information is now available in the public domain, 
it will be possible to be established this knowledge based on SM (Chapters 4 
and 5).  
 
Three Sri Lankan SM historical documents (used as university textbooks) were 
utilised to obtain information about the historical diabetes treatments in this 
investigation. In this respect, these documents revealed that there were 
considerable overlap between the symptoms utilised in biomedicine and SM to 
describe diabetes (Chapter 4). Since other historical documents could not be 
involved, more Sri Lankan SM historical documents currently available and 
accessible could have been identified and included in this study to obtain more 
details of diabetes and its treatments. 
 
The ethnobotanical survey with the SEHs showed that they have great 
knowledge about diagnosing and treating diabetes. Moreover, they have 
expertise in plant species identifications, collections, preservations, and SM 
pharmacological skills (Chapter 5).    
 
Only a minority of SEHs (one-third of currently registered) participated in this 
ethnobotanical survey (Chapter 5). Generally, some of the SEHs interviewed 
were not willing to reveal the most of the plant species they use to prepare the 
antidiabetic preparations. Much effort was put into this study to obtain the 
information presented in this work. Thus, more SEHs could have been covered 
in this investigation to obtain more information about current diabetes 
treatments. However, it was not possible to compare the preparations 
historically and currently utilised, as none of the SEHs revealed the names of 
the preparations they use. 
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The duration of the ethnobotanical survey was relatively short (three months) 
(Chapter 5), due to visa restriction in SL and only a limited time and funding 
were available to conduct this research. Because of that, this might have limited 
the number of species and other information obtained. 
 
SM has been used for hundreds of years, which has numerous beneficial 
impacts including affordability and being easily accessible. Apart from these 
advantages, certainly there are other disadvantages as well in which ingredients 
(rhinoceros horn and rare plant species) are difficult to obtain and in some 
cases illegal to handle (Chapter 4 and Appendix B). 
 
SM is less well-known to the Western world than the other TMs such as 
Ayurveda and Unani practised in SL. Most of the SM literature in Tamil has not 
been translated (Thas, 2008). Inversely, historical diabetes treatments in Sri 
Lankan SM have been translated and made publicly available in this project 
(Chapter 2 and Appendix B) considerably contributed towards SM. Anyhow, this 
study had only covered a part of the many facets of SM. For instance, a wide 
range of ingredients utilised in the preparations and the unique SM urine 
examination (Chapter 2) show that there is a great wealth of empirical 
knowledge in SM.  
 
The historical documents contained almost exclusively preparations with a large 
number of diverse ingredients (Appendix B), hence, the principal active 
ingredient is unknown in such complex preparations. Untangling these complex 
preparations will remain an enormous challenge for the future. 
 
Plants were the most important and commonly used ingredients in the 
antidiabetic preparations (Chapter 4 and Appendix B). Currently, SEHs are 
using only botanical ingredients in antidiabetic preparations. Further, more plant 
species were recorded in the historical documents than the ethnobotanical 
survey, which simply linked to the detailed analysis of the two parts of this 
research, with less information available for the current uses. There were 
114 
 
continuity and some changes observed between the historical plant species and 
currently utilised. For example, the plant species currently utilised are mostly 
based on historical knowledge while presently no animal ingredients and 
inorganic substances are utilised.    
 
Several pure metals and minerals were used in the historical preparations 
(Appendix B). This shows the wealth of chemistry knowledge in SM. 
Nevertheless, the procedures utilised to purify and convert metals and minerals 
were not mentioned for the antidiabetic preparations analysed in this work.  
 
One of the main reasons for avoiding animal ingredients and inorganic 
substances at present by the SEHs may be due to the three-decade civil war in 
SL which ended in 2009. This war severely affected the Eastern and Northern 
Provinces, due to the limited supply of inorganic substances and animal 
ingredients during this period, they might have stopped using them. Still, during 
the interviews, the SEHs did not state the reasons for currently avoiding these 
ingredients. One can speculate why such information was not provided, and it is 
not possible to decide whether this is in fact linked to the inorganic substances 
no longer being utilised or an unwillingness to report their use. In general, it 
appeared that the information about these ingredients used as medicines are 
much more limited and may well deserve further research regarding their 
current potential benefits (if they exist) and risks. This should comprise 
epidemiological studies on the use of such preparations. 
 
The literature search using electronic database revealed that the majority of the 
plant species had some in vivo scientific evidence and several plant species 
had no scientific evidence (Chapter 6). Overall, as one would expect, the 
information is very limited, most of the pharmacological studies carried out in 
T1D models. Yet, as stated above, approximately 90% of diabetics suffer from 
T2D (Holman et al., 2015). Therefore, further investigations of plant extracts 
and phytochemicals should be conducted in T2D related in vivo models in the 
future. The plants for which have no scientific evidence available may be 
potential candidates for further studies on antidiabetic activities.  
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None of the 60 preparations documented in this study have scientific evidence 
that could be used to assess potential therapeutic benefits. Even so, 
considerable pharmacological and clinical information of the individual plant 
species extracts are currently available, hence, it was not possible to assess the 
scientific evidence of the historical complex preparations.  
 
Several full texts of the scientific evidence identified using Scopus and PubMed 
electronic databases were not available (Chapter 3), whereas only the abstracts 
of these works were available. The reason for this might be the journals 
discontinued by the publisher. Reviewed the scientific evidence required full 
texts to obtain more information about the studies. More broadly, this part of the 
study relies only on the published evidence and the quality of the studies 
utilised. Apparently, concerns have been raised about the reproducibility of 
clinical studies and this is not possible in such a review (Mullane et al., 2015; 
Mullane and Williams, 2015). Also, there were some problems identified. The 
pharmacological and clinical studies reviewed were often methodologically 
problematic for other reasons (e.g. unrealistic high doses, poor general design, 
etc.). Diabetes is a chronic illness thus the studies could have been conducted 
for a longer period to study the pharmacological effects. In the future, more 
rigorous experimental approaches will be needed to study the antidiabetic 
activity of the plant extracts and compounds. In many cases, the chemistry of 
the plant species was known relatively well.  In further steps, observational and 
ideally intervention studies are essential.  
 
Plant extracts contain mixtures of active, partly active, and inactive compounds. 
The bioactivity of a plant extract is not dependent on a single compound, as a 
result, due to this complexity, results from bioactivity assessments are often not 
reproducible (Heinrich, 2010). For instance, metabolomics techniques linked 
with in vitro or in vivo screening for bioactivity and toxicity can be used for a 
better phytochemical characterisation of plant extracts. Besides, several 
different samples of one plant species are required to conduct the metabolite 
profiling technique. Apart from this, as stated in Chapter 7, there are more 
advantages employing bioassay-guided isolation technique than metabolite 
profiling technique to identify the active compounds from plant extracts, like less 
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time consumption to carry out this technique and identification of the synergetic 
effects of compounds (Wang et al., 2004). On that account, it was decided to 
employ the metabolite profiling approach to identify the α-glucosidase inhibitory 
compounds from mature A. heterophyllus leaf samples (Chapter 7).  
 
In this study, 38 mature A. heterophyllus leaf samples had been collected from 
different geographical sites to conduct metabolite profiling. Again, a larger 
number of mature A. heterophyllus leaf samples could have been collected to 
study the α-glucosidase inhibitory activity to obtain more details of the α-
glucosidase inhibitory compounds (Chapter 7).  
 
α-Glucosidase inhibitory activities of selected plant species were conducted to 
create new scientific evidence in terms of evidence-based TM (Chapter 7). 
However, among the five selected plant species, only mature A. heterophyllus 
leaves showed a strong α-glucosidase inhibitory activity. Accordingly, all the 
collected samples of this species were studied in detail. Due to the time 
constraint in this Ph.D. research, all the other samples of the selected plant 
species had not been studied.  
 
There was a huge variation of the α-glucosidase inhibitory activity of the mature 
A. heterophyllus leaf samples collected from different locations in SL (Chapter 
7). Due to time and funding constraints, the initial idea of using the metabolomic 
analysis as a starting point to identify which compounds could be responsible 
for the activity could not be followed up in more detail. Although, a geographical 
comparison could still be completed. As stated before, the variation of the 
metabolite composition in the biological samples is caused by the physiological 
condition, interaction with other creatures, and genetic modification. In addition, 
the variation of metabolite concentrations is likewise caused by external factors 
such as physical environmental conditions (climate, elevations, and soil types) 
(Oliver et al., 1998). Based on the details of the environmental conditions of the 
geographical sites of each sample, there was an association between the α-
glucosidase inhibitory activity and climatic conditions and phytochemical 
composition variability of crude methanol extracts of mature A. heterophyllus 
leaves. On the other hand, there was no association observed between the α-
glucosidase inhibitory activity and elevation (Chapter 7). This study similarly 
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suggests that several different samples of the same species should be collected 
and used for preliminarily screening to study a bioactivity. Afterward, further 
pharmacological and phytochemical studies should be conducted on the sample 
that showed the best bioactivity. Further, this finding suggests the geographical 
site to collect more potential mature A. heterophyllus leaves which can be 
utilised to prepare SM preparations. 
 
The sample had the best α-glucosidase inhibitory activity (sample 32, IC50 of 
7.56 µg/ml) was nearly 20 times more effective than the positive control 
(Acarbose, IC50 of 149.81 µg/ml) used in this study. It is a potential source for 
the natural α-glucosidase inhibitor (Chapter 7). A. heterophyllus is one of the 
most common plant species found in SL and which is easily obtainable with less 
or no cost, thus, after further research, this extract could be utilised as an 
inexpensive α-glucosidase inhibitor and affordable by the most people with 
diabetes in SL. Further studies required to be carried out to make use of this.  
 
There were some drawbacks of using NMR spectroscopy like lower sensitivity 
(Safer et al., 2011) (Chapter 7). Despite that, a combination of NMR spectra 
and OPLS-DA technique revealed that Artoheterophyllin B might be responsible 
for the α-glucosidase inhibitory activity (Chapter 7). Anyhow, another analytical 
technique which is more sensitive than NMR spectroscopy, to give an example, 
Liquid Chromatography-Mass Spectrometry (LC-MS) could have been 
employed to confirm this outcome.  
 
At present, the number of people relying on the biomedicine is increasing than 
TMs. Consequently, there is a potential risk to SM in the future because there 
are more biomedical hospitals than SM hospitals in the areas where SM mostly 
practised in SL. For example, there are 58 biomedical and 12 SM state-owned 
hospitals in the Eastern Province (MFSL, 2016). This clearly shows that the 
majority of the Tamil population are currently relying on biomedicine than SM in 
the Eastern Province. In addition, SM is currently more suitable for non-
emergency treatments (AYUSH, 2018). At present, some of the patients are not 
benefiting from the treatments provided by the SEHs, on that account, the 
patients are losing the trust in the SEHs, treatments provided by them, and SM. 
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This is due to the inconsistent in the preparations provided by the SEHs 
(Sivasanmugarajah, 2001). These potential risks can be overcome by creating 
more scientific evidence for the SM preparations and implementing the 
recommendations provided below.  
 
8.2. Future works 
In the future, this work should be expanded to cover all currently available and 
accessible published SM books are written in SL to gain more information about 
diabetes treatments including the plants used in the preparations. On top of 
that, the same information can be obtained from the Indian SM historical 
documents and published books. A comparative study can be carried out 
between the diabetes treatments in Sri Lankan and Indian SM. 
 
Ethnobotanical surveys should be carried out with SEHs residing in the 
Northern Province to record the useful plant species utilised by them before this 
knowledge disappears in the future. This information will provide the whole list 
of plants currently utilised to treat diabetes in Sri Lankan SM and more 
traditional SM information which is not available in the printed documents. 
Again, a comparative study would be highly desirable to identify the continuity 
and change between the treatments.  
 
Additional pharmacological, phytochemical, and toxicity studies should be 
carried out to the mature A. heterophyllus leaf sample which showed the best α-
glucosidase inhibitory activity. If this extract showed less or no side effects than 
currently available biomedical drugs, then it can be developed further and 
marketed for an affordable price in SL. On the other hand, α-glucosidase 
inhibitory compounds from this extract should be identified and the potential 
active compounds should be studied in T2D in vivo models and clinical trials.  
 
Last but not least, this work will build the foundation for a more rigorous study in 
the future of antidiabetic Sri Lankan SM preparations and the plants utilised. It is 
also providing new opportunities to discover the best α-glucosidase inhibitory 
active extract and novel active compounds in drug discovery programs.  
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8.3. Recommendations beyond the immediate scope of this study 
Based on the most of the aims and objectives (Chapter 1) achieved in this 
Ph.D. study, the following recommendations for the policy and practice and 
research needs were also identified. All these policies cannot be implemented 
immediately, nevertheless, they can be included in the practice in the future. 
The identified recommendations are discussed below: 
 
8.3.1. For research and development 
The following recommendations focusing on scientific aspects such as research 
methods, sample selections for future pharmacological, phytochemical, and 
toxicity studies are recommended: 
1. Scientific investigations should be conducted to study the interactions, side 
effects, and complications caused by taking both biomedical drugs and SM 
preparations to treat diabetes. 
 
2. Freeze-dried, fresh juices of the same plant part materials used in the SM 
preparations are recommended to use in the future pharmacological studies 
where fresh materials are available and easily obtainable.   
 
8.3.2. For policy and practice 
From the policy and practice perspective recommendations focus on how to 
further develop policies and for implementing best practice:  
1. The Sri Lankan government needs to develop a strategy for advising the 
SEHs, biomedical doctors, and the population about the potential uses and 
safety of the plants. Additionally, awareness should be raised regarding 
potential interactions, side effects, and complications caused by taking both 
biomedical drugs and SM preparations to treat diabetes.  
 
2. Sri Lankan government should identify the SEHs not currently on their 
register with the Ministry of Indigenous Medicine should be enlisted. 
 
3. Despite claims that the preparations produced by the state Siddha 
preparations manufacturers are consistent, the Sri Lankan Ministry of 
Indigenous Medicine should introduce new, stricter regulation for registering the 
names of the preparations as well as, for example, their preparation methods, 
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ingredients and amounts utilised, storage conditions, and shelf-life of 
preparation produced by the SEHs. SEHs who are not willing to reveal such 
essential information should be barred from registering and practising SM. 
Moreover, regulatory procedures should be carried out to identify and exclude 
toxic substances from such preparations. For example, Aristolochia species like 
A. bracteolate clearly cannot be endorsed as a phytomedicine (Michl et al., 
2016). Most notably, many of the inorganic substances are clearly not suitable 
(a topic not covered in detail in this study) because of their level of toxicity, 
many of these ingredients must be withdrawn in the future (toxic plant species 
have been marked in Appendix A and Table 5.2). 
 
4. Tamil quantitative units which have not been standardised should be 
standardised by converting into metric units (4.6. Amounts and dosages used in 
Sri Lankan Siddha Medicine). 
 
5. Currently, a Sri Lankan SM pharmacopeia is not available, thus, it is 
recommended to develop and publish such a legally binding document in the 
near future incorporating SM and Ayurvedic herbal medical substances. 
 
6. Some plant species are rare and those species should be a focus of future 
research and cultivation strategies developed to prevent their disappearance in 
the future (these plant species have been marked in Appendix A and Table 5.2). 
 
Finally, this Ph.D. project focused on the importance of assessing the historical 
TM documents and ethnobotanical survey to identify, document, and compare 
the change and continuity between the historical and contemporary TM 
treatments especially for diabetes. In addition, identifying an α-glucosidase 
inhibitory compound from plant extracts employing metabolomic profiling 
technique. This procedure can be utilised in the future antidiabetic medicinal 
plant researches. 
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Appendix A 
 
Table A.1. List of plant species used in historical antidiabetic Sri Lankan Siddha preparations 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Abelmoschus moschatus Medik. # Malvaceae ேக்பகோலம் (Thakkolam) 
 
 
SE 44, 46, 47 PA 
Abies spectabilis (D.Don) Mirb. * Pinaceae ேோளிச த்திரி (Thaalisapaththiri) 
 
 
LE  9, 44 PA 
Abrus precatorius L. # Fabaceae குன்றிமணி (Kundrimani) RO 10, 43 PA 
      RO 51 SV  
 
    SE 11, 14, 17, 30, 
1, 33 
 
 
PA 
Abutilon indicum (L.) Sweet # Malvaceae துத்தி (Thuththi) RO 45 PA 
      SE 1 
 
 
PA 
Acacia chundra (Rottler) Willd. Fabaceae கருங்கோலி (Karungkaali) BA 25 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      HE 29 PA 
      RE  11, 34 PA 
      RO 27 
 
 
PA 
Acacia leucophloea (Roxb.) Willd. Fabaceae கவள்பவல் (Velvel) BA 13 PA 
      RE  1, 11 
 
 
PA 
Acacia nilotica (L.) Delile Fabaceae கருபவல் (Karuvel) BA 13, 34, 43, 45 PA 
      BA 51, 56 SV  
      RE  1, 11, 13, 17, 
31, 35 
PA 
      TL 18 
 
 
PA 
Achyranthes aspera L. Amaranthaceae நோயுருவி (Naayuruvi) WP 56 SV  
      WP 32 
 
 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Aconitum heterophyllum Wall. ex Royle 
*# 
Ranunculaceae அதிவிையம் (Athividayam) RO 8, 9 PA 
      RO 57, 59, 60 SA 
      RO 55 
 
 
SV  
Acorus calamus L. # Acoraceae வசம்பு (Vasambu) RH 10 
 
 
PA 
Aegle marmelos (L.) Corrêa #$ Rutaceae வில்ரவ (Vilvai) BA  19 PA 
   RO 9, 44, 46, 47 PA 
      RO 60 
 
 
SA 
 
Allium sativum L. #$ Amaryllidaceae கவள்ரை கவங்கோயம் (Vellai 
vengaayam) 
 
 
BU  58 SA 
Aloe vera (L.) Burm.f. #$ Xanthorrhoeaceae கற்ைோரழ (Katraalai) LE 10, 44, 47 PA 
      LE 51 SV  
      RO 53, 55 SV  
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Alpinia calcarata (Haw.) Roscoe # Zingiberaceae சிற்ைைத்ரே (Sitraraththai) RH 47 PA 
      RH 
 
59, 60 
 
 
SA 
Alpinia galanga (L.) Willd. # Zingiberaceae ப ைைத்ரே (Peraraththai) RH 44 PA 
      RH 
 
60 
 
 
SA 
Alternanthera sessilis (L.) R.Br. ex DC. Amaranthaceae க ோன்னோங்கோணி 
(Ponnaangkaani) 
LE 47 PA 
      LE 59 SA 
      WP  
 
44, 46, 47 
 
 
PA 
Alysicarpus vaginalis (L.) DC. Fabaceae குதிரைவோலி (Kuthiraivaali) WP 
 
23 
 
 
PA 
Anacardium occidentale L. #$ Anacardiaceae முந்திரிரக (Munthirihai) FR 9 PA 
      FR 
 
51 
 
 
SV 
176 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Anacyclus pyrethrum (L.) Lag. * Asteraceae அக்கைோகோைம் (Akkaraahaaram) RO 9, 12 PA 
      RO 
 
58, 59, 60 
 
 
SA 
Anethum graveolens L. #$ Apiaceae சேகுப்ர  (Sathahuppai) 
 
SE 
 
58 
 
 
SA 
Aquilaria agallocha Roxb. # Thymelaeaceae அகில் (Ahil) 
 
WO 
 
44 
 
 
PA 
Areca catechu L. # Arecaceae கமுகு (Kamuhu) RE 9 PA 
      SE 1 PA 
      SE 
 
51 
 
 
SV  
Artocarpus heterophyllus Lam. Moraceae  லோ (Palaa) ML 
 
47 
 
 
PA 
Asparagus racemosus Willd. $ Asparagaceae சோத்ேோவோரி (Saaththaavaari) LE 47 PA 
      RH 
 
 
9, 44, 46, 47 
 
 
PA 
177 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Aucklandia lappa DC. [syn. Saussurea 
lappa (Decne.) C.B.Clarke] $ 
 
 
Asteraceae பகோட்ைம் (Kottam) RO 8, 9, 10, 43, 
44, 46, 47 
 
 
PA 
Azadirachta indica A.Juss. #$ Meliaceae பவம்பு (Vembu) RE  
 
1, 11, 34 
 
 
PA 
Bambusa bambos (L.) Voss  Poaceae மூங்கில் (Moongil) LE  
 
29 
 
 
PA 
Boerhavia diffusa L. Nyctaginaceae மூக்கைட்ரை (Mookkarattai) TL 
 
5 
 
 
PA 
Bombax ceiba L. # Malvaceae முள்ளிலவு (Mullilavu) BA 45 PA 
      RE 
  
45 
 
 
PA 
Borassus flabellifer L. Arecaceae  ரன (Panai) FR 
 
12 
 
 
PA 
Cadaba fruticosa (L.) Druce # Capparaceae வீழி (Veeli) LE 
 
44, 47 
 
 
PA 
Caesalpinia bonduc (L.) Roxb. Fabaceae கழற்சி (Kalatchi) TL  
 
21 
 
 
PA 
178 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Cajanus cajan (L.) Millsp. $ Fabaceae துவரை (Thuwarai) RO 
 
 
46 
 
 
PA 
Cannabis sativa L. #$ Cannabaceae கஞ்சோ (Kanjaa) LE 46 
 
PA 
      LE 55 SV  
      LE 58 SA 
      SE 
 
57 
 
 
SA 
Cardiospermum halicacabum L. # Sapindaceae முைக்ககோத்ேோன் 
(Mudakkoththaan) 
 
 
WP 46 PA 
Cassia fistula L. #$ Fabaceae ககோன்ரை (Kondrai) BA 10, 43 PA 
      BA 25, 49 SV  
      LE 11 PA 
      RO 
 
21 
 
 
PA 
Catunaregam spinosa (Thunb.) Tirveng. 
 
Rubiaceae மருக்கோரை (Marukkaarai) RO 
 
27 
 
PA 
179 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Cedrus deodara (Roxb. ex D.Don) G.Don 
$ 
Pinaceae பேவேோரு (Thevathaaru) WO 44, 46, 47 PA 
  
 
  WO 
 
59, 60 
 
 
SA 
Celastrus paniculatus Willd. Celastraceae வோலுளுரவ (Vaaluluvai) SE 
 
 
58 
 
SA 
Centipeda minima (L.) A.Braun & Asch. Asteraceae மருக்ககோழுந்து 
(Marukkolunthu) 
 
 
WP 
 
46 PA 
Cheilocostus speciosus (J.Koenig) 
C.D.Specht [syn. Costus speciosus 
(J.Koenig) Sm.] 
Costaceae கவண்பகோட்ைம் (Venkottam) RH 47 PA 
      RO 57, 58, 60 
 
 
SA 
Chrysopogon zizanioides (L.) Roberty 
[syn. Vetiveria zizanioides (L.) Nash] 
Poaceae இலோமிச்ரச (Ilaamichchai) RO 44 PA 
      RO 9 PA 
      RO 46 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      RO 
 
47 
 
 
PA 
Cinnamomum cappara-coronde Blume Lauraceae கற்பூைம் (Katpooram) RE  8, 9, 44, 47 PA 
      RE  
 
60 
 
 
SA 
Cinnamomum verum J.Presl $ Lauraceae கறுவோ (Karuvaa) BA 46 PA 
      BA 
 
59, 60 
 
 
SA 
Cissampelos pareira L. Menispermaceae மரலேோங்கி (Malaithaangi) TL 4, 6 PA 
      WP 
 
16, 25, 26, 29 
 
 
PA 
Coccinia grandis (L.) Voigt # Cucurbitaceae ககோவ்ரவ (Kovvai) LE 
 
47 
 
 
PA 
Cocculus hirsutus (L.) W.Theob. Menispermaceae கட்டுக்ககோடி (Kattukkodi) LE 
 
34 
 
 
PA 
Cocos nucifera L. $ Arecaceae கேன்ரன (Thennai) FL 10, 11, 48 PA 
      FR 44, 47 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      UF 
 
36, 48 
 
 
PA 
Commiphora mukul (Hook. ex Stocks) 
Engl. $ 
 
 
Burseraceae குக்கில் (Kukkil) RE 35 PA 
Cordia dichotoma G.Forst. Boraginaceae 
 
நறுவிலி (Naruvili) 
 
 
BA 38, 45 PA 
Coscinium fenestratum (Goetgh.) Colebr. 
* 
 
 
Menispermaceae மைமஞ்சள் (Maramanjal) ST 11, 34, 27, 29 
 
PA 
Crocus sativus L. #$ Iridaceae குங்குமம் (Kungkumam) SI  44, 47 PA 
      SI  58, 60 
 
 
SA 
Cuminum cyminum L. #$ Apiaceae சீைகம் (Seeraham) / சிறுஞ்சீைகம் 
(Sirunjcheeraham) 
FR 9, 8, 46 PA 
      FR 55 SV  
      FR 
 
57, 59, 58, 60 SA 
182 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Curculigo orchioides Gaertn. Hypoxidaceae நிலப் ரன (Nilappanai) RH 
 
9, 11, 29, 46 
 
 
PA 
Curcuma aromatica Salisb. # Zingiberaceae கஸ்தூரி மஞ்சள் (Kasththoori 
manjal) 
 
 
RH  11 PA 
Curcuma longa L. #$ Zingiberaceae மஞ்சள் (Manjal) 
 
RH 
 
13, 14, 28, 30 
 
PA 
 
Cyanthillium cinereum (L.) H.Rob. [syn. 
Vernonia cinerea (L.) Less.] 
Asteraceae சீபேவியோர் கசங்கழுநீர் 
(Seetheviyaar sengkaluneer) 
 
 
WP 46 
 
PA 
Cycas circinalis L. *# Cycadaceae மேனகோமம் 
(Mathanakaamam) 
 
 
FL 44 PA 
Cyperus mitis Steud.  Cyperaceae க ருங்பகோரை (Perungkorai) 
 
 
RH 46 
 
PA 
Cyperus rotundus L. $ Cyperaceae பகோரை (Korai) RH  1, 7, 8, 9, 27, 
47 
PA 
183 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
   
RO 26 
 
 
PA 
Datura metel L. # Solanaceae ஊமத்ரே (Oomaththai) SE  12 PA 
      SE  58 SA 
      SE  55 
 
 
SV  
Dichrostachys cinerea (L.) Wight & Arn. 
 
 
Fabaceae விைத்ேல் (Vidaththal) TL  21 
 
 
PA 
Eclipta prostrata (L.) L. Asteraceae கரிசலோங்கண்ணி 
(Karisalaangkanni) 
 
 
WP 1 PA 
Elaeocarpus tuberculatus Roxb. Elaeocarpaceae உருத்திைோட்சம் 
(Uruththiraatcham) 
 
 
SE 60 SA 
Elettaria cardamomum (L.) Maton #$ Zingiberaceae ஏலம் (Elam) FR 8, 9, 44, 46, 47 PA 
      FR 57, 58, 59, 60 SA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      FR 55 SV  
      FR 47 
 
 
PA 
Eleusine coracana (L.) Gaertn. Poaceae குைக்கன் (Kurakkan) SE 2, 3, 6 
 
 
PA 
Embelia ribes Burm.f. Primulaceae வோய்விைங்கம் (Vaaividangam) 
 
SE 27 
 
 
PA 
Erythrina variegata L. Fabaceae முருக்கு (Murukku) LE 47 
 
 
PA 
Erythroxylum monogynum Roxb. Erythroxylaceae கசம்மணத்தி (Semmanaththi) 
 
BA 13 
 
 
PA 
Euphorbia antiquorum L. # Euphorbiaceae கள்ளி (Kalli) LA 54 SV  
      RO 
 
39 
 
 
PA 
Euphorbia hirta L. #$ Euphorbiaceae அம்மோன்  ச்சரிசி (Ammaan 
pachcharisi) 
 
 
WP 37, 45 PA 
185 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Ferula assa-foetida L. #$ Apiaceae க ருங்கோயம் (Perungkaayam) 
 
 
RE  58 
 
 
SA 
Ficus amplissima Sm. Moraceae இத்தி (Iththi) BA 14 
 
 
PA 
 
Ficus benghalensis L. Moraceae ஆல் (Aal) BA 14, 35 PA 
      RO 29 
 
 
PA 
Ficus racemosa L. # Moraceae அத்தி (Aththi) BA 10, 13, 14, 43, 
45, 46,  
PA 
      BA 49, 51 SV  
      LA 45 
 
 
PA 
Ficus religiosa L. Moraceae அைசு (Arasu) BA 14 
 
 
PA 
Foeniculum vulgare Mill. #$ Apiaceae க ருஞ்சீைகம் 
(Perunjcheeraham) 
FR 9 PA 
      FR 55 
 
 
SV  
186 
 
Scientific name Family Tamil name Part 
used 
Preparation Source 
Gardenia crameri Tirveng.  Rubiaceae கம்பி (Kambi) 
 
RE  45 
 
 
PA 
Glycyrrhiza glabra L. #$ Fabaceae அதிமதுைம் (Athimathuram) RO 9, 44, 46, 47 PA 
      RO 51 SV  
      RO 57, 58, 59, 60 
 
 
SA 
Gmelina arborea Roxb. Lamiaceae க ருங்குமிழ் (Perungkumil) RO 27 
 
 
PA 
Gmelina asiatica L. Lamiaceae நிலக்குமிழ் (Nilakkumil) RO 46 
 
 
PA 
Gossypium arboreum L. # Malvaceae  ருத்தி (Paruththi) SE 17, 23, 31 
 
 
PA 
Gymnosporia emarginata (Willd.) 
Thwaites [syn. Maytenus emarginata 
(Willd.) Ding Hou] 
 
 
Celastraceae முட்புல்லோந்தி (Mutpullaanthy) BA 45 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Hemidesmus indicus (L.) R. Br. ex 
Schult. 
Apocynaceae நன்னோரி (Nannaari)  RB 59 SA 
      RO 8, 46, 47 
 
 
PA 
Holarrhena pubescens Wall. ex G.Don * Apocynaceae கவட் ோரல (Vetpaalai) SE 44, 46, 47 PA 
      SE 58 
 
 
SA 
Hybanthus enneaspermus (L.) F.Muell. Violaceae ஓரிேழ்த்ேோமரை 
(Orithalththaamarai) 
 
 
WP 46 PA 
Hygrophila auriculata (Schumach.) Heine 
* 
 
 
Acanthaceae நீர்முள்ளி (Neermulli) WP 1 PA 
Hyoscyamus reticulatus L. # Solanaceae குபைோசோணி ஓமம் (Kurosaani 
omam) 
SE 8, 12, 44, 47 PA 
      SE 57, 58 
 
 
SA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Indigofera tinctoria L. Fabaceae அவுரி (Avuri) LE 18 
 
 
PA 
Ipomoea aquatica Forssk. Convolvulaceae வள்ைல் (Vallal) LE 47 
 
 
PA 
Ipomoea littoralis Blume Convolvulaceae ேோளி (Thaali) LE 47 
 
 
PA 
Justicia adhatoda L. [syn. Adhatoda 
vasica Nees] $ 
 
 
Acanthaceae ஆைோபேோரை (Aadaathodai) RO 50 SA 
Kaempferia galanga L. # 
 
 
Zingiberaceae கச்பசோலம் (Kachcholam) RH 44, 47 
 
PA 
Lannea coromandelica (Houtt.) Merr. 
[syn. Odina wodier Roxb.] # 
 
 
Anacardiaceae ஒதியம் (Othiyam) BA 13, 45 PA 
Limonia acidissima Groff # Rutaceae விைோத்தி (Vilaaththi) FR 9 PA 
      RE  1, 13, 14, 33, 
34, 35, 45 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      RO 30, 31 
 
 
PA 
Madhuca longifolia (J.Koenig ex L.) 
J.F.Macbr. 
Sapotaceae இலுப்ர  (Iluppai) FL 1, 8 PA 
      FL 58 
 
 
SA 
Magnolia champaca (L.) Baill. ex Pierre 
[syn. Michelia champaca L.] * 
Magnoliaceae கசண் கம் (Senpaham)  FL 9, 44, 46 PA 
      FL 60 
 
 
SA 
Mesua ferrea L.  Calophyllaceae சிறுநோகம் (Sirunaaham) FL 44, 46, 47 PA 
      FL 58, 60 
 
 
SA 
Mollugo cerviana (L.) Ser. Molluginaceae  ற் ைோகம் (Patpadaaham) WP 46 
 
 
PA 
Moringa oleifera Lam. $ Moringaceae முருங்ரக (Murungai) BA 20, 22, 28, 29, 
30 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
 
  LE 44 PA 
      RE  1 
 
 
PA 
Mukia maderaspatana (L.) M.Roem. # Cucurbitaceae கமோசுகமோசுக்ரக 
(Mosumosukkai) 
 
 
LE 47 PA 
Murraya koenigii (L.) Spreng. #$ Rutaceae கறிபவம்பு (Karivembu)  LE 45 PA 
      ST 29 PA 
      RO 29 
 
 
PA 
Musa × paradisiaca L. [syn. Musa × 
sapientum L.] 
Musaceae வோரழ (Vaalai) FR 39 PA 
      LE 18 PA 
      RH 9 
 
 
PA 
Myristica fragrans Houtt. # Myristicaceae சோதிக்கோய் (Saathikkaai) LE 1, 9, 44, 46, 47 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      LE 57 SA 
      MA 8, 12, 44, 47 PA 
      MA 57, 58, 60 SA 
      MA 53, 55 SV  
      SE 1, 8, 9, 12, 44, 
46, 47  
PA 
      SE 57, 58, 59, 60 SA 
      SE  55 
 
 
SV  
Myroxylon balsamum (L.) Harms Fabaceae சோம்பிைோணி (Saampiraani) RE  55 
 
 
SV  
Nardostachys jatamansi (D.Don) DC. 
[syn. Nardostachys grandiflora DC] *# 
 
 
Caprifoliaceae சைோமோஞ்சில் (Sadaamaanjil) RO 44, 46, 47 
 
PA 
Nelumbo nucifera Gaertn. $ Nelumbonaceae ேோமரை (Thaamarai) RC 44, 46, 47 PA 
      RH  9 PA 
      RH  51 SV  
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      SE 57 
 
 
SA 
Neopicrorhiza scrophulariiflora (Pennell) 
D.Y.Hong [syn. Picrorhiza 
scrophulariiflora Pennell] $ 
Plantaginaceae கடுகுபைோகிணி (Kaduhurohini) RO 47 PA 
      RO 58, 60 SA 
      SE 44 
 
 
PA 
Nervilia concolor (Blume) Schltr. [syn. 
Nervilia aragoana Gaudich.] 
Orchidaceae ஓரிரலத்ேோமரை 
(Orilaiththaamarai) 
 
 
WP 59 SA 
Nigella sativa L. #$ Ranunculaceae கருஞ்சீைகம் 
(Karunjcheeraham) 
 
 
SE 58, 60 SA 
Nymphaea pubescens Willd. * Nymphaeaceae கசங்கழுநீர் (Sengkaluneer) RH 10,43, 44, 46, 
47 
PA 
      RH  51 
 
 
SV  
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Oroxylum indicum (L.) Kurz Bignoniaceae வோரக (Vaahai) RE  1 
 
 
PA 
Oryza sativa L. $ Poaceae கநல் (Nel) SE 2, 3, 4, 5, 7, 33 PA 
      SE 52 
 
 
SV  
Pandanus odorifer (Forssk.) Kuntze [syn. 
Pandanus odoratissimus L.f.] * 
 
 
Pandanaceae ேோரழ (Thaalai) FL 44, 47 PA 
Panicum antidotale Retz. Poaceae கிருமிசத்துரு (Kirumisaththuru) FR 58 
 
 
SA 
 
Panicum sumatrense Roth * Poaceae சோரம (Saamai) SE 2 
 
 
PA 
Papaver somniferum L. # Papaveraceae அபின் (Abin) LA 12, 37, 39, 40 PA 
      LA 57, 58 SA 
      LA 55 
 
 
SV 
Paspalum scrobiculatum L. * Poaceae வைகு (Varahu) SE 2, 3 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Pavonia odorata Willd. # Malvaceae ப ைோமட்டி (Peraamatti) RO 46 
 
 
PA 
Phoenix dactylifera L. $ Arecaceae ப ரீச்ரச (Pereechchai) FR  8, 9 PA 
      FR 51 
 
 
SV  
Phoenix pusilla Gaertn. Arecaceae ஈச்ரச (Eechchai) FL 10, 46 PA 
      UF 35 
 
 
PA 
Phyllanthus amarus Schumach. & 
Thonn. 
Phyllanthaceae கீழ்கோய்கநல்லி (Keelkaainelli) RO 45 PA 
      WP 46 
 
 
PA 
Phyllanthus emblica L. $ Phyllanthaceae கநல்லி (Nelli)  FR 8, 13, 14, 19, 
26, 28, 29, 30, 
34, 39, 46 
PA 
      FR 51, 55 SV  
      RO 46 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Phyllanthus reticulatus Poir. Phyllanthaceae நீர்ப்பூலோ (Neerppoolaa) BA 14, 45 PA 
      TL 37 
 
 
PA 
Piper chuvya Hunter ex C.DC.  Piperaceae கசவ்வியம் (Sevviyam) RO 58 SA 
      RO 26 
 
 
PA 
Piper cubeba L.f. Piperaceae வோல்மிைகு (Vaalmilahu) FR 58, 59, 60 
 
 
SA 
Piper longum L. $ Piperaceae திப்பிலி (Thippili) FR 44, 45, 46 PA 
      FR 58, 60 SA 
      FR 56 
 
 
SV  
Piper nigrum L. $ Piperaceae மிைகு (Milahu) FR 44, 45 PA 
      FR 60 SA 
      FR 53 
 
 
SV 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Plectranthus hadiensis (Forssk.) 
Schweinf. ex Sprenger [syn. Plectranthus 
zatarhendi var. tomentosus (Benth.) 
Codd] 
 
 
Lamiaceae இருபவலி (Iruveli) RO 44, 46, 47 PA 
Plumbago zeylanica L. Plumbaginaceae ககோடிபவலி (Kodiveli) RB  11 PA 
      RO 26 
 
 
PA 
Pogostemon heyneanus Benth. Lamiaceae  ச்சிரல (Pachchilai) LE 44, 46, 47 
 
 
PA 
Pterocarpus santalinus L.f. * Fabaceae கசஞ்சந்ேனம் 
(Senjchanthanam) 
 
 
WO 44, 46, 47 PA 
Punica granatum L. #$ Lythraceae மோதுரை (Maathulai) FR 9, 45 PA 
      RO 35 
 
 
PA 
Rhus succedanea L. # Anacardiaceae கற்கைகசிங்கி (Katkadahasingi) 
 
GA 9, 11 
 
 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Ricinus communis L. #$ Euphorbiaceae ஆமணக்கு (Aamankku) RO 46 
 
 
PA 
Rivea ornata Choisy Convolvulaceae முசுட்ரை (Musuttai) SE 35 PA 
      TL  21 
 
 
PA 
Rotheca serrata (L.) Steane & Mabb. 
[syn. Clerodendrum serratum (L.) Moon] 
 
 
Lamiaceae சிறுபேக்கு (Siruthekku) RO 58, 60 SA 
Rubia cordifolia L. $ Rubiaceae மஞ்சிட்டி (Manjitti) BU 46 PA 
      RO 44 PA 
      ST 44, 47 
 
 
PA 
Saccharum arundinaceum Retz. Poaceae க ருங்கரும்ர  
(Perungkarumbai) 
 
 
ST 26 PA 
Saccharum officinarum L. Poaceae கரும்பு (Karumbu)  ST  9, 45 PA 
      ST  51 
 
 
SV 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Salacia reticulata Wight Celastraceae கைலிைோஞ்சி (Kadaliraanji) BA 1, 10, 13, 14, 
29, 34, 35, 43, 
45 
PA 
      BA 49, 51 SV  
      RO 46 
 
 
PA 
Santalum album L. * Santalaceae சந்ேனம் (Santhanam) WO 8, 9, 10, 44, 
46, 47 
PA 
      WO 60 SA 
      WO 51 
 
 
SV  
Senna auriculata (L.) Roxb. [syn. Cassia 
auriculata L.] 
Fabaceae ஆவோரை (Aavaarai) BA 1, 8, 10, 13, 
14, 19, 24, 35, 
39, 43 
PA 
      BA 49 SV  
      BA 57 SA 
      FB 23 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      FL 8, 10, 24, 38 PA 
      FL 57 SA 
      LE 8, 11, 23 PA 
      MR 51, 52 SV  
      RB 23 PA 
      RB 53 SV  
      RO 8, 10, 24, 29 PA 
      RO 51 SV  
      RO 57 SA 
      SE 1 PA 
      SE 10, 12, 17, 19, 
29, 30, 31, 34, 
36, 39, 40, 48 
PA 
      SE 57 SA 
      TL 1, 4, 5, 15, 18, 
24 
PA 
      TL 57 SA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      UF 57 SA 
      UF 8, 10, 24, 38 PA 
      WP 20, 21, 34 PA 
      WP 55 
 
 
SV 
Senna sophera (L.) Roxb. [syn. Cassia 
sophera L.] 
 
 
Fabaceae க ோன்னோவரை (Ponnaavarai) MS 3 PA 
Senna tora (L.) Roxb. [syn. Cassia tora 
L.] 
 
 
Fabaceae ஊசித்ேகரை (Oosiththaharai) SE 44, 47 PA 
Sesamum indicum L. $ Pedaliaceae எள்ளு (Ellu) MS 52 SV  
      RO 9 PA 
      SE 1, 5, 7, 18, 35, 
39, 44, 46, 47 
 
 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
Shorea robusta Gaertn * Dipterocarpaceae கவண்குந்திருக்கம் 
(Venkunthirukkam) 
 
 
RE  47 PA 
Sida cordifolia L. # Malvaceae சிற்ைோமட்டி (Sitraamatti) 
 
 
RO 44, 46, 47 
 
PA 
Solanum erianthum D. Don # Solanaceae கறிமுள்ளி (Karimulli) 
 
 
SE 9 
 
PA 
Spermacoce hispida L. Rubiaceae நத்ரேச்சூரி (Naththaichchoori) 
 
 
SE 59 
 
 
SA 
Sterculia foetida L. # Malvaceae பூேவிருக்கம் (Poothavirukkam) 
 
 
BA 46 
 
 
PA 
Stereospermum chelonoides (L.f.) DC. 
[syn. Stereospermum suaveolens 
(Roxb.) DC] 
 
 
Bignoniaceae  ோதிரி (Paathiri) RO 46 PA 
Strychnos potatorum L.f. # Loganiaceae பேற்ைோன் (Thetraan) SE 1, 11, 13, 14, 
21, 23, 28, 29, 
30, 33, 34, 35 
PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
      SE 60 
 
 
SA 
Symplocos racemosa Roxb. Symplocaceae கவள்ளிபலோத்திைம் 
(Velliloththiram) 
 
 
BA 27, 44 PA 
Syzygium aromaticum (L.) Merr. & 
L.M.Perry $ 
Myrtaceae கைோம்பு (Karaambu) FB 8, 9, 12, 15, 
44, 46, 47 
PA 
      FB 58, 59, 60 SA 
      FB 55 
 
 
SV  
Syzygium cumini (L.) Skeels Myrtaceae நோவல் (Naaval) BA  34, 43 PA 
      BA 49, 51 SV  
      MB  50 SV  
      TL  21 
 
 
PA 
Tamarindus indica L. * Fabaceae புளி (Puli) SE 1, 9, 11, 21, 34 PA 
      SE 54 SV  
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Terminalia arjuna (Roxb. ex DC.) Wight 
& Arn. $ 
 
 
Combretaceae மருது (Maruthu) BA 34, 35, 45 
 
 
PA 
Terminalia bellirica (Gaertn.) Roxb. $ Combretaceae ேோன்றி (Thaandri) FR 9, 14, 26, 29, 
30, 34, 46 
 
 
PA 
Terminalia chebula Retz. $ Combretaceae கடுக்கோய் (Kadukkaai) FR 13, 14, 19, 26, 
27, 28, 29, 30, 
31, 46 
PA 
      FR 50 SV  
      SE 9 PA 
      SE 60 SA 
      WP 
 
46 
 
 
PA 
Thespesia populnea (L.) Sol. ex Corrêa 
*# 
Malvaceae பூவைசு (Poovarasu) BA 13 PA 
      RB 23 PA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Tinospora sinensis (Lour.) Merr. [syn. 
Tinospora cordifolia (Willd.) Miers] $ 
Menispermaceae சீந்தில் (Seenthil) ST 27, 44, 46, 47 PA 
      ST 57 SA 
      ST 59 
 
 
SA 
Trachyspermum roxburghianum (DC.) H. 
Wolff [syn. Trachyspermum involucratum 
(Roxb.) H. Wolff] # 
Apiaceae ஓமம் (Omam) / அசமேோகம் 
(Asamathaaham) 
FR 8, 44 PA 
      FR 55 SV  
      FR 57, 58 
 
 
SA 
Tribulus terrestris L. #$ Zygophyllaceae கநருஞ்சில் (Nerunjchil) WP 46 PA 
      RO 26 
 
 
PA 
Trigonella foenum-graecum L. #$ Fabaceae கவந்ேயம் (Venthayam) SE 44, 46, 47 PA 
      SE 59 SA 
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Scientific name Family Tamil name Part 
used 
Preparation Source 
 
 
Vigna mungo (L.) Hepper Fabaceae உழுந்து (Ulunthu) SE 2 
 
 
PA 
Vitex negundo L. Lamiaceae கநோச்சி (Nochchi) LE 47 PA 
      RO 44 
 
 
PA 
Withania somnifera (L.) Dunal #$ Solanaceae அமுக்கிைோய் (Amukkiraai) RH 46 
 
 
PA 
Zingiber officinale Roscoe $ Zingiberaceae இஞ்சி (Inji) RH  35, 39, 40, 44, 
45 
PA 
      RH  58, 59, 60 SA 
      RH  51 
 
 
SV  
Ziziphus jujuba Mill. *# Rhamnaceae இலந்ரே (Ilanthai) LE 11 PA 
      TL 14 
 
 
PA 
Ziziphus rugosa Lam. # Rhamnaceae துைரி (Thudari) TL  21 PA 
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* Rare (threatened) plant species based on IUCN (2018) - Red List of Threatened Species 
# Toxic plant species based on Roth et al. (2012) and Harborne et al (1996) 
$ Very well studied and globally distributed plant species based on American Herbal Pharmacopoeia (2011), Brendler (2010), European 
Medicines Agency (2009), Upton et al. (2016) and World Health Organization Monographs on Selected Medicinal Plants – Volumes 1 to 
4 (1999; 2004; 2007; 2009) 
 
Abbreviations 
Part used 
BA: bark, BU: bulb, FL: flower, FB: flower bud, FR: fruit, HE: heartwood, GA: gall, LA: latex, LE: leaf, MA: mace / aril, MB: mature bark, 
ML: mature leaf, MR: mature root, MS: mature seed, RB: root bark, RC: receptacle, RE: resin, RH: rhizome, RO: root, SE: seed, SI: 
stigma, ST: stem, TL: tender leaf, UF: unripe fruit, WO: wood, WP: whole plant 
 
Preparation 
1: கோந்ேக்குளிரக – Kaanthakkulihai; 2, 3: ேவிடு – Thavidu; 4, 5, 6, 7: பிட்டு – Pittu; 8: ஏலோதிச்சூைணம் – Elaathichchooranam; 9: 
ஏலோதிச்சஞ்சீவிச்சூைணம் – Elaathichchancheevichchooranam; 10: க ரிய குளிரக - Periya kulihai; 11: பமகநோேக்குளிரக – 
Mehanaathakkulihai; 12: க ோை சிந்ேோமணிக்குளிரக - Kapaada Sinthaamanikkulihai; 13: அயக்கோந்ேக்குளிரக – Ayakkaanthakkulihai; 14: 
சுவைப்பிடிப் ோணுண்ரை – Suravappidippaanundai; 15, 16, 17, 18, 19, 20, 21, 22, 23, 24: சலக்கழிச்சல் லவுக்கும் ரகமருந்து - 
Salakkalichchalpalavukkum kaimarunthu; 25, 26, 27, 28, 29, 49, 50, 51: குடிநீர் – Kudineer; 30: கோந்ேோயக்குளிரக – Kaanthaayakkulihai; 31: 
கவள்ரைக்குன்றிமணிக்குளிரக – Vellaikkundrimanikkulihai; 32: கோரீய சிந்தூைம் - Kaareeya sinthooram; 33: மபனோசிரலக்குளிரக – 
Manosilaikkulihai; 34: திரிபலோகவைகம் – Thirilohavadaham; 35, 36, 37, 38, 39, 40, 41, 42: பிைபமகக்குளிரக – Piramehakkulihai; 43: நோவல் 
207 
 
கநய் - Naaval ney; 44: சந்ேனோதிகயண்கணய் – Santhanaathiyennai; 45: வச்சிைசிந்ேோமணி இைசோயனம் - Vachchirasinthaamani irasaayanam; 
46: பிைபமகச்சந்ேனோதிகயண்கணய் – Piramehachchanthanaathiyennai; 47: நீரிழிவுச்சந்ேனோதிகயண்கணய் – Neerilivuchchanthanaathiyennai; 
48: கோந்ேைசக்குளிரக – Kaantharasakkulihai; 52, 53: தூள் – Thool; 54: நீரிழிவுக்கு வங்ககசந்தூைம் - Neerilivukku vangasenthooram; 55: பிைபமக 
நீரிழிவுக்கு கவட்டுமோைன் தூள் - Pirameha neerilivukku Vettumaaran thool; 56: நீரிழிவுக்கு வங்க கசந்தூைம் - Neerilivukku vanga senthooram; 
57: அமுது சர்க்கரைச்சூைணம் - Amuthu Sarkkaraichchooranam; 58: நந்தீசுை சிந்ேோமணி - Nantheesura Sinthaamani; 59: பூைணச்சந்திைோதி 
மோத்திரை - Pooranachchanthiraathi Maaththirai; 60: மிருத்ே சஞ்சீவினி மோத்திரை - Miruththa Sanjeevini Maaththirai  
 
Source 
 PA: Pararasaseharam (Fifth Part) (பரராசபசகரம் (ஐந்ோம் பாகம்) - Pararaasaseharam (Ainthaam Paaham) (Anonymous, 2003), SV: 
Seharaasasehara Treatment (கசகராசபசகர டைத்தியம் - Seharaasasehara Vaiththiyam) (Anonymous, 2000), SA: Siddha Medicinal 
Procedure (சித்ே ஔைே கசய்முடை - Siththa Audatha Seimurai) (Ponniah and Sabapathipillai, 1980).
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Appendix B 
Antidiabetic historical Sri Lankan Siddha Medicine preparations 
1. Pararasaseharam (Fifth Part) (பரராசபசகரம் (ஐந்ோம் பாகம்) - Pararaasaseharam (Ainthaam Paaham))  
This document contains 48 antidiabetic Sri Lankan Siddha preparations and the information of ingredient, amount, method, and dosage 
of each preparation are presented below.  
 
1. காந்தக்குளிகக – Kaanthakkulihai (p. 10) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abutilon indicum (L.) Sweet Seed 5 g 
Acacia leucophloea (Roxb.) Willd. Resin 5 g 
Acacia nilotica (L.) Delile Resin 5 g 
Azadirachta indica A.Juss. Resin 5 g 
Borassus flabellifer L. Fruit juice As required 
Cyperus rotundus L. Rhizome 5 g 
Eclipta prostrata (L.) L. Whole plant juice As required 
Hygrophila auriculata (Schumach.) Heine Whole plant 5 g 
Limonia acidissima Groff Resin 5 g 
209 
 
Scientific / English name Processed botanical drug Amount 
Madhuca longifolia (J.Koenig ex L.) J.F.Macbr. Flower juice As required 
Moringa oleifera Lam. Resin 5 g 
Myristica fragrans Houtt. Seed 5 g 
Myristica fragrans Houtt. Leaf 5 g 
Oroxylum indicum (L.) Kurz Resin  5 g 
Salacia reticulata Wight Bark 5 g 
Senna auriculata (L.) Roxb. Seed 5 g 
Senna auriculata (L.) Roxb. Tender leaf 5 g 
Senna auriculata (L.) Roxb. Bark 5 g 
Sesamum indicum L. Seed 5 g 
Strychnos potatorum L.f.  Seed 5 g 
Tamarindus indica L. Seed 5 g 
Beryl NA 5 g 
Bitumen NA 5 g 
Buffalo curd NA 5 g 
Cinnabar NA 5 g 
Magnetite NA 5 g 
Mercury NA 5 g 
Purified graphite NA 5 g 
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Scientific / English name Processed botanical drug Amount 
Roche alum NA 5 g 
Rose water NA As required 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
 
Mix all the other ingredients except Borassus flabellifer fruit juice, Madhuca longifolia flower juice, rose water, Eclipta prostrata whole 
plant juice, and buffalo curd together.  
 
Grind this mixture while adding Borassus flabellifer followed by Madhuca longifolia flower juice, rose water, Eclipta prostrata whole plant 
juice, and buffalo curd. Then make Strychnos potatorum L.f. (Loganiaceae) seed size tablets and dry them.  
 
Dosage: One tablet morning and night after meals  
 
2. தவிடு – Thavidu (p. 28) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Eleusine coracana (L.) Gaertn. Seed Equal amount 
Oryza sativa L. Seed Equal amount 
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Scientific / English name Processed botanical drug Amount 
Panicum sumatrense Roth Seed Equal amount 
Paspalum scrobiculatum L. Seed Equal amount 
Vigna mungo (L.) Hepper  Seed Equal amount 
 
Method 
Pulverise all the ingredients separately into powder and mix them together. Open dry roast the mixture while stirring.   
 
Dosage: one table spoon three times a day after meals 
 
3. தவிடு – Thavidu (p. 28) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Senna sophera (L.) Roxb. Mature seed Equal amount 
Eleusine coracana (L.) Gaertn. Seed Equal amount 
Oryza sativa L. Seed Equal amount 
Paspalum scrobiculatum L. Seed Equal amount 
 
Method  
Pulverise all the ingredients separately into powder and mix them together. Open dry roast the mixture while stirring. 
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Dosage: one table spoon three times a day after meals 
 
4. பிட்டு - Pittu (p. 29) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cissampelos pareira L. Tender leaf Equal amount 
Oryza sativa L. Open dry roasted seed flour Equal amount 
Senna auriculata (L.) Roxb. Tender leaf Equal amount 
 
Method 
Mix tender leaves of Cissampelos pareira and Senna auriculata together and add to open dry roasted rice flour. Then add hot water to 
the mixture and stir it to make small chunks. Open steam the mixture until observing the steam passing through it. 
 
Dosage: Consume as food as required once a day either morning or night 
 
5. பிட்டு - Pittu (p. 29) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Boerhavia diffusa L. Tender leaf Equal amount 
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Scientific / English name Processed botanical drug Amount 
Oryza sativa L. Open dry roasted seed flour Equal amount 
Sesamum indicum L.  Seed oil cake Equal amount 
 
Method 
Mix Boerhavia diffusa tender leaf and sesame oil cake together and add to open roasted rice flour. Then add hot water to the mixture and 
stir it to make small chunks. Open steam the mixture until observing the steam passing through it.   
 
Dosage: Consume as food as required once a day either morning or night 
 
6. பிட்டு - Pittu (p. 29) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cissampelos pareira L. Tender leaf Equal amount 
Eleusine coracana (L.) Gaertn. Open dry roasted seed flour Equal amount 
Oryza sativa L. Open dry roasted seed flour Equal amount 
Senna auriculata (L.) Roxb. Tender leaf Equal amount 
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Method 
Mix open roasted rice flour and Eleusine coracana seed flour together and add tender leaves of Senna auriculata and Cissampelos 
pareira to it. Then add hot water to the mixture and stir it to make small chunks. Open steam the mixture until observing the steam 
passing through it.   
 
Dosage: Consume as food as required once a day either morning or night 
 
7. பிட்டு - Pittu (p. 29) 
Ingredients  
Scientific / English name Processed botanical drug Amount 
Cyperus rotundus L. Rhizome flour  Equal amount  
Oryza sativa L. Open dry roasted seed flour Equal amount  
Sesamum indicum L. Puffed seed Equal amount  
 
Method 
Mix Cyperus rotundus rhizome flour and Sesamum indicum seed puff together and add to open roasted rice flour. Then add hot water to 
the mixture and stir it to make small chunks. Open steam the mixture until observing the steam passing through it.   
 
Dosage: Consume as food as required once a day either morning or night 
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8. ஏலாதிச்சூரணம் – Elaathichchooranam (p. 33) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Aconitum heterophyllum Wall. ex Royle Root Equal amount  
Aucklandia lappa DC. Root Equal amount  
Cinnamomum cappara-coronde Blume Resin Equal amount  
Cuminum cyminum L. Dried fruit Equal amount  
Cyperus rotundus L. Rhizome Equal amount  
Elettaria cardamomum (L.) Maton Dried fruit Equal amount  
Hemidesmus indicus (L.) R. Br. ex Schult. Root Equal amount  
Hyoscyamus reticulatus L. Seed Equal amount  
Madhuca longifolia (J. Koenig ex L.) J. F. Macbr. Flower Equal amount  
Myristica fragrans Houtt. Mace Equal amount  
Myristica fragrans Houtt. Seed Equal amount  
Phoenix dactylifera L. Fruit Equal amount  
Phyllanthus emblica L. Fruit Equal amount  
Santalum album L. Wood Equal amount  
Senna auriculata (L.) Roxb. Leaf Equal amount  
Senna auriculata (L.) Roxb. Flower Equal amount  
Senna auriculata (L.) Roxb. Unripe fruit Equal amount  
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Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Root Equal amount  
Senna auriculata (L.) Roxb. Bark Equal amount  
Syzygium aromaticum (L.) Merr. & L.M. Perry Flower bud Equal amount  
Trachyspermum roxburghianum (DC.) H. Wolff Dried fruit Equal amount  
Dried cow gallstone NA Equal amount  
Male deer musk NA Equal amount  
 
Method 
Sundry all the ingredients and pulverise or scrape or press or crush all the ingredients separately where applicable. Mix all the 
ingredients together and sift the mixture.  
 
Dosage: 265 mg three times a day after meals 
 
9. ஏலாதிச்சஞ்சீவிச்சூரணம் - Elaathichchancheevichchooranam (p. 34) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abies spectabilis (D. Don) Mirb. Leaf 5 g 
Aconitum heterophyllum Wall. ex Royle Root 5 g 
Aegle marmelos (L.) Corrêa Root 5 g 
217 
 
Scientific / English name Processed botanical drug Amount 
Anacardium occidentale L. Fruit 5 g 
Anacyclus pyrethrum (L.) Lag. Root 5 g 
Areca catechu L.  Resin 5 g 
Areca catechu L.  Seed 5 g 
Asparagus racemosus Willd. Tuber 5 g 
Aucklandia lappa DC.  Root 5 g 
Chrysopogon zizanioides (L.) Roberty Root 5 g 
Cinnamomum cappara-coronde Blume Resin 5 g 
Cuminum cyminum L. Dried fruit 5 g 
Curculigo orchioides Gaertn. Tuber 5 g 
Cyperus rotundus L. Rhizome 5 g 
Elettaria cardamomum (L.) Maton Dried fruit 5 g 
Foeniculum vulgare Mill. Dried fruit 5 g 
Glycyrrhiza glabra L. Root 5 g 
Limonia acidissima Groff  Fruit 5 g 
Magnolia champaca (L.) Baill. ex Pierre Flower 5 g 
Musa × paradisiaca L. Rhizome 5 g 
Myristica fragrans Houtt. Seed 5 g 
Myristica fragrans Houtt. Leaf 5 g 
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Scientific / English name Processed botanical drug Amount 
Nelumbo nucifera Gaertn. Rhizome 5 g 
Phoenix dactylifera L. Fruit 5 g 
Punica granatum L. Fruit 5 g 
Rhus succedanea L. Gall 5 g 
Saccharum officinarum L. jaggery NA 65 g 
Santalum album L. Wood 5 g 
Sesamum indicum L. Root 5 g 
Solanum erianthum D. Don Seed 5 g 
Syzygium aromaticum (L.) Merr. & L.M. Perry Flower bud 5 g 
Tamarindus indica L. Seed 5 g 
Terminalia bellirica (Gaertn.) Roxb. Fruit pulp 5 g 
Terminalia chebula Retz. Seed 5 g 
Asbestos NA 5 g 
Dried cow gallstone NA 5 g 
Male deer musk NA 5 g 
Roche alum NA 5 g 
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Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Mix all the ingredients together and add Saccharum 
officinarum jaggery (one third of the amount of powder) to the mixture. Preserve it.  
 
Dosage: 265 mg three times a day after meals 
 
10. பெரிய குளிகக - Periya kulihai (p. 40) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Root 30 g 
Acorus calamus L. Rhizome 30 g 
Aloe vera (L.) Burm.f. Dried pulp of leaf 30 g 
Aucklandia lappa DC.  Root 30 g 
Cassia fistula L.  Bark 30 g 
Cocos nucifera L. Flower 30 g 
Ficus racemosa L. Bark 30 g 
Nymphaea pubescens Willd. Rhizome 30 g 
Phoenix pusilla Gaertn. Flower 30 g 
Salacia reticulata Wight Bark 30 g 
Santalum album L. Wood 30 g 
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Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Bark 30 g 
Senna auriculata (L.) Roxb. Flower 30 g 
Senna auriculata (L.) Roxb. Root 30 g 
Senna auriculata (L.) Roxb. Seed 30 g 
Senna auriculata (L.) Roxb. Unripe fruit 30 g 
Dried cow gallstone NA 30 g 
Gold NA 30 g 
Mica NA 30 g 
Pearl NA 30 g 
Red coral  NA 30 g 
Reservior water NA As required 
Roche alum NA 30 g 
 
Method 
Pulverise or press or scrape or crush all the ingredients separately where applicable.  Mix mica, roche alum, dried cow gallstone, pearl, 
red coral, gold, Nymphaea pubescens rhizome, roots of Aucklandia lappa, Abrus precatorius and Senna auriculata, Aloe vera dried pulp 
of leaf, Santalum album wood, flowers of Phoenix pusilla, Cocos nucifera, and Senna auriculata, seed and unripen fruit of Senna 
auriculata, barks of Senna auriculata and Salacia reticulata together.  
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Then mix Ficus racemosa bark and Acorus calamus rhizome together and pour reservoir water. Boil and filter it.  
 
Grind previously prepared mixture while adding the decoction for three days. Finally make Ficus racemosa L. (Moraceae) fruit size 
tablets and shade dry.  
 
Dosage: One tablet twice a day after meals 
 
11. மேகநாதக்குளிகக – Mehanaathakkulihai (p. 41) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed 5 g 
Acacia chundra (Rottler) Willd. Resin 10 g 
Acacia leucophloea (Roxb.) Willd. Resin 10 g 
Acacia nilotica (L.) Delile Resin 10 g 
Azadirachta indica A. Juss. Resin 10 g 
Cassia fistula L.  Leaf juice As required 
Cocos nucifera L. Flower 10 g 
Coscinium fenestratum (Goetgh.) Colebr.  Stem 10 g 
Curculigo orchioides Gaertn. Rhizome 10 g 
Curcuma aromatica Salisb. Rhizome 10 g 
222 
 
Scientific / English name Processed botanical drug Amount 
Plumbago zeylanica L. Root bark 10 g 
Rhus succedanea L. Gall 5 g 
Senna auriculata (L.) Roxb. Leaf juice As required 
Strychnos potatorum L.f.  Seed 5 g 
Tamarindus indica L. Seed outer skin 5 g 
Ziziphus jujuba Mill.   Leaf juice As required 
Black tin powder  NA 30 g 
Gypsum NA 10 g 
Mercury calx NA 10 g 
Mica NA 20 g 
Purified sulphur and arsenic NA 50 g 
 
Method  
Pulverise or press or scrape or crush all the ingredients separately where applicable.  
 
Mix mica, mercury calx, gypsum, black tin red powder, purified sulphur and arsenic, resins of Acacia chundra, A. leucophloea, A. nilotica, 
and Azadirachta indica, Coscinium fenestratum stem, Plumbago zeylanica root bark, rhizomes of Curcuma aromatica and Curculigo 
orchioides, Cocos nucifera flower, Tamarindus indica seed outer skin, seeds of Abrus precatorius and Strychnos potatorum, and 
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Rhus succedanea gall together and grind the mixture with Senna auriculata leaf juice for 3 days. Then grind with leaf juices of Ziziphus 
jujuba and Cassia fistula each per 3 days and make Strychnos potatorum seed size tablets. Shade dry them.  
 
Dosage: One tablet twice a day after meals 
 
12. கொட சிந்தாேணிக்குளிகக - Kapaada Sinthaamanikkulihai (p. 42) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Anacyclus pyrethrum (L.) Lag. Root 5 g 
Areca catechu L.  Resin  5 g 
Datura metel L. Seed 2.5 g 
Hyoscyamus reticulatus L. Seed 5 g 
Myristica fragrans Houtt. Seed 5 g 
Myristica fragrans Houtt. Mace 5 g 
Papaver somniferum L. Latex 2.5 g 
Senna auriculata (L.) Roxb. Seed 55 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 g 
Asbestos NA 5 g 
Beryl NA 5 g 
Buffalo buttermilk  NA 10 ml 
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Scientific / English name Processed botanical drug Amount 
Cinnabar NA 5 g 
Magnetite NA 5 g 
Roche alum NA 5 g 
 
Method 
Pulverise or press or scrape or crush all the ingredients separately where applicable.  
Mix all the other ingredients together except Senna auriculata seed and buffalo whey together. Lightly open dry roast Senna auriculata 
seed while stirring and add to the mixture. Grind the mixture while adding buffalo curd and make Solanum torvum Sw. (Solanaceae) fruit 
size tablets. Then shade dry them.  
 
Dosage: One tablet twice a day after meals for 40 days 
 
13. அயக்காந்தக்குளிகக - Ayakkaanthakkulihai (pp. 42, 43) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia leucophloea (Roxb.) Willd. Bark 400 g 
Acacia nilotica (L.) Delile Bark 400 g 
Acacia nilotica (L.) Delile Resin Equal amount 
Curcuma longa L. Rhizome Equal amount 
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Scientific / English name Processed botanical drug Amount 
Erythroxylum monogynum Roxb. Bark 400 g 
Ficus racemosa L. Bark 400 g 
Lannea coromandelica (Houtt.) Merr. Bark 400 g 
Limonia acidissima Groff  Resin Equal amount 
Phyllanthus emblica L. Fruit Equal amount 
Salacia reticulata Wight Bark 400 g 
Senna auriculata (L.) Roxb. Bark 400 g 
Strychnos potatorum L.f.  Seed Equal amount 
Terminalia chebula Retz. Fruit pulp Equal amount 
Thespesia populnea (L.) Sol. ex Corrêa Bark 400 g 
Graphite  NA Equal amount 
Iron NA Equal amount 
Magnetite NA Equal amount 
Mercury NA Equal amount 
Mica NA Equal amount 
Water NA 4800 ml 
 
Method  
Mix graphite and mercury together and melt the mixture. Then crush it.  
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Pulverise or press or scrape or crush all the other ingredients separately where applicable.  
 
Mix crushed molten graphite and mercury mixture, iron, magnetite, mica, Terminalia chebula fruit pulp, Phyllanthus emblica fruit, 
Strychnos potatorum seed, Curcuma longa rhizome, resins of Acacia nilotica and Limonia acidissima together.  
 
Mix barks of Ficus racemose, Senna auriculata, Salacia reticulata, Acacia nilotica, A. leucophloea, Lannea coromandelica, Thespesia 
populnea and Erythroxylum monogynum together. Pour water and boil it for 8 days.  
 
Grind previously prepared mixture while adding the decoction and make Areca catechu L. (Arecaceae) seed size (5 g) tablets. Shade dry 
and crush them into powder.  
 
Dosage: One tablet twice a day after meals 
 
14. சுவறப்பிடிப்ொணுண்கட – Suravappidippaanundai (p. 12) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed 50 g 
Curcuma longa L. Rhizome 50 g 
Ficus amplissima Sm. Bark 3200 g 
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Scientific / English name Processed botanical drug Amount 
Ficus benghalensis L. Bark 3200 g 
Ficus racemosa L. Bark 3200 g 
Ficus religiosa L. Bark 3200 g 
Limonia acidissima Groff  Resin 200 g 
Phyllanthus emblica L. Fruit 400 g 
Phyllanthus reticulatus Poir. Bark 160 g 
Salacia reticulata Wight Bark 800 g 
Senna auriculata (L.) Roxb. Bark 1600 g 
Strychnos potatorum L.f.  Outer skin removed seed 50 g 
Terminalia bellirica (Gaertn.) Roxb. Fruit 400 g 
Terminalia chebula Retz. Fruit 400 g 
Ziziphus jujuba Mill. Tender leaf 80 g 
Cow urine NA 50 g 
Graphite NA 50 g 
Human colostrum / foremilk NA 50 g 
Water NA 9600 ml 
Water NA 4800 ml 
Magnetite NA 50 g 
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Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Mix barks of Ficus racemosa L., Ficus amplissima, 
Ficus benghalensis, and Ficus religiosa, Senna auriculata, Salacia reticulata, and Phyllanthus reticulatus and Ziziphus jujuba tender leaf 
and pour 9600 ml water into the mixture. Then boil until reaching one eight of the initial volume.  
 
Mix Terminalia chebula, fruits of Phyllanthus emblica, and Terminalia bellirica together and pour 4800 ml water into the mixture and boil 
until reaching one fourth of the initial volume.  Add this decoction to previously prepared decoction and stir it. Then boil the decoction 
mixture and filter it.  
 
Grind graphite with human colostrum. Pour cow urine to magnetite and boil it thoroughly. Mix ground graphite, boiled magnetite, 
Curcuma longa rhizome and seeds of Abrus precatorius, and Strychnos potatorum together and grind with previously prepared decoction 
mix. Then boil and add Limonia acidissima resin. Boil it again and make 5 g tablets. Finally, shade dry them.  
 
Dosage: One tablet twice a day after meals 
 
15. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Tender leaf Half handful 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 
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Scientific / English name Processed botanical drug Amount 
Buffalo buttermilk NA 1200 ml 
Dried cow gallstone NA 244 g 
 
Method 
Pulverise all the ingredients separately and mix them together. Pour buffalo buttermilk into a clay pot and cover the pot mouth with a 
piece of cotton cloth. Place the ground mixture on the cloth and cover by placing another clay pot upside down on top of the pot with 
buttermilk. Then boil it. Finally grind the mixture with boiled buffalo buttermilk.  
 
Dosage: 10 ml twice a day after meals for 21 days 
 
16. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific name Processed botanical drug Amount 
Cissampelos pareira L. Whole plant As required  
 
Method 
Shade dry and pulverise Cissampelos pareira whole plant.  
 
Dosage: As required three times a day after meals 
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17. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed 5 g 
Acacia nilotica (L.) Delile Resin 20 g 
Gossypium arboreum L. Seed 15 g 
Senna auriculata (L.) Roxb. Seed 10 g 
Buffalo buttermilk NA As required  
 
Method 
Pulverise all the ingredients separately and mix them together. Then grind the mixture with buffalo buttermilk. 
 
Dosage: As required twice a day after meals 
 
18. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia nilotica (L.) Delile Tender leaf Equal amount 
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Scientific / English name Processed botanical drug Amount 
Indigofera tinctoria L. Leaf Equal amount 
Musa × paradisiaca L.  Leaf Equal amount 
Senna auriculata (L.) Roxb. Tender leaf Equal amount 
Sesamum indicum L. oil  NA Equal amount 
Magnetite NA As required 
 
Method 
Pulverise or press or crush all the other ingredients separately where applicable except Musa × paradisiaca leaf. Then mix them 
together. Wrap the mixture in a Musa × paradisiaca leaf and burn it in dried Oryza sativa L. (Poaceae) husk. Then grind it with sesame 
oil.  
 
Dosage: As required twice a day after meals 
 
19. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Aegle marmelos (L.) Corrêa Bark Equal amount 
Phyllanthus emblica L. Fruit  Equal amount 
Senna auriculata (L.) Roxb. Seed Equal amount 
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Senna auriculata (L.) Roxb. Bark Equal amount 
Terminalia chebula Retz. Dried fruit  Equal amount 
Buffalo buttermilk NA As required 
 
Method 
Pulverise all the other ingredients separately except Phyllanthus emblica fruit and mix them together. Pour buffalo buttermilk into 
Phyllanthus emblica fruit and macerate overnight. Then press all Phyllanthus emblica fruits and pour the solution into previously prepared 
powder. Dissolve it.  
 
Dosage: As required twice a day before meals 
 
20. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Moringa oleifera Lam. Bark Equal amount 
Senna auriculata (L.) Roxb. Whole plant Equal amount 
Honey NA Equal amount 
 
Method 
Grind both ingredients separately and mix them together. Grind the mixture with honey.  
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Dosage: As required twice a day after meals 
 
21. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Caesalpinia bonduc (L.) Roxb. Tender leaf Equal amount 
Cassia fistula L.  Root Equal amount 
Dichrostachys cinerea (L.) Wight & Arn. Tender leaf Equal amount 
Rivea ornata Choisy Tender leaf Equal amount 
Senna auriculata (L.) Roxb. Whole plant Equal amount 
Strychnos potatorum L.f.  Seed Equal amount 
Syzygium cumini (L.) Skeels Tender leaf Equal amount 
Tamarindus indica L. Seed juice Equal amount 
Ziziphus rugosa Lam. Tender leaf Equal amount 
Roche alum NA Equal amount 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Then mix them together and grind the mixture.  
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Dosage: As required three times a day after meals 
 
22. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 27) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Moringa oleifera Lam. Bark As required 
Honey NA As required 
 
Method 
Pulverise Moringa oleifera bark and grind with honey.  
 
Dosage: As required twice a day after meals 
 
23. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (pp. 27, 28) 
Ingredients 
Scientific name Processed botanical drug Amount 
Alysicarpus vaginalis (L.) DC. Whole plant  Half handful  
Gossypium arboreum L. Seed  One quatar handful 
Senna auriculata (L.) Roxb. Flower bud  Half handful 
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Scientific name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Leaf  Half handful 
Senna auriculata (L.) Roxb. Root bark  Half handful 
Strychnos potatorum L.f.  Seed  One quater handful 
Thespesia populnea (L.) Sol. ex Corrêa Mature root bark  Half handful 
 
Method 
Pulverise or press all the ingredients separately where applicable. Then mix them together and grind the mixture.  
 
Dosage: Lemon size three times a day after meals 
 
24. சலக்கழிச்சல்ெலவுக்கும் ககேருந்து - Salakkalichchalpalavukkum kaimarunthu (p. 28) 
Ingredients 
Scientific name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Bark Equal amount 
Senna auriculata (L.) Roxb. Flower Equal amount 
Senna auriculata (L.) Roxb. Root Equal amount 
Senna auriculata (L.) Roxb. Tender leaf Equal amount 
Senna auriculata (L.) Roxb. Unripe fruit Equal amount 
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Method 
Pulverise all the ingredients separately and mix them together.  
 
Dosage: As required three times a day after meals 
 
25. குடிநீர் – Kudineer (p. 30) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia chundra (Rottler) Willd. Bark Equal amount 
Cassia fistula L.  Bark Equal amount 
Cissampelos pareira L. Whole plant  Equal amount 
Water NA As required 
 
Method 
Mix all the ingredients and pour water into the mixture. Boil it until reaching one eighth of the initial volume.  
 
Dosage: As required twice a day before meals 
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26. குடிநீர் – Kudineer (p. 30) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cissampelos pareira L. Whole plant Equal amount 
Cyperus rotundus L. Root Equal amount 
Phyllanthus emblica L. Fruit Equal amount 
Piper chuvya Hunter ex C. DC.  Root Equal amount 
Plumbago zeylanica L. Root Equal amount 
Saccharum arundinaceum Retz. Stem Equal amount 
Terminalia bellirica (Gaertn.) Roxb. Fruit Equal amount 
Terminalia chebula Retz. Fruit Equal amount 
Tribulus terrestris L. Root Equal amount 
Water NA As required 
 
Method 
Mix all the ingredients and pour water into the mixture. Boil the mixture.  
 
Dosage: As required twice a day before meals 
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27. குடிநீர் – Kudineer (p. 30) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia chundra (Rottler) Willd. Root Equal amount 
Catunaregam spinosa (Thunb.) Tirveng. Root Equal amount 
Coscinium fenestratum (Goetgh.) Colebr.  Stem Equal amount 
Cyperus rotundus L. Rhizome Equal amount 
Embelia ribes Burm.f. Seed Equal amount 
Gmelina arborea Roxb. Root Equal amount 
Symplocos racemosa Roxb. Bark Equal amount 
Terminalia chebula Retz. Fruit Equal amount 
Tinospora sinensis (Lour.) Merr.  Stem Equal amount 
Water NA As required 
 
Method 
Mix all the ingredients and pour water into the mixture. Boil the mixture.  
 
Dosage: As required twice a day before meals 
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28. குடிநீர் – Kudineer (p. 30) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Curcuma longa L. Rhizome 120 g 
Moringa oleifera Lam. Bark 160 g 
Phyllanthus emblica L. Fruit 80 g 
Strychnos potatorum L.f.  Seed 40 g 
Terminalia chebula Retz. Fruit 200 g 
Water NA As required 
 
Method 
Mix all the ingredients and pour water into the mixture. Boil it until reaching one eighth of the initial volume.  
 
Dosage: As required twice a day before meals 
 
29. குடிநீர் – Kudineer (p. 30) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia chundra (Rottler) Willd. Heartwood Equal amount 
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Scientific / English name Processed botanical drug Amount 
Bambusa bambos (L.) Voss  Leaf Equal amount 
Cissampelos pareira L. Whole plant Equal amount 
Coscinium fenestratum (Goetgh.) Colebr.  Stem Equal amount 
Curculigo orchioides Gaertn. Rhizome Equal amount 
Ficus benghalensis L. Root Equal amount 
Moringa oleifera Lam. Bark Total amount of all the other ingredients 
Murraya koenigii (L.) Spreng. Stem Equal amount 
Murraya koenigii (L.) Spreng. Root Equal amount 
Phyllanthus emblica L. Fruit Equal amount 
Salacia reticulata Wight Bark Equal amount 
Senna auriculata (L.) Roxb. Seed Equal amount 
Senna auriculata (L.) Roxb. Root Equal amount 
Strychnos potatorum L.f.  Seed Equal amount 
Terminalia bellirica (Gaertn.) Roxb. Fruit Equal amount 
Terminalia chebula Retz. Fruit Equal amount 
Water NA As required 
 
Method 
Mix all the ingredients and pour water into the mixture. Boil the mixture.  
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Dosage: As required twice a day before meals for seven days  
 
30. காந்தாயக்குளிகக – Kaanthaayakkulihai 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed  25 g 
Curcuma longa L. Rhizome  25 g 
Limonia acidissima Groff  Root  25 g 
Moringa oleifera Lam. Bark  50 g 
Phyllanthus emblica L. Fruit  25 g 
Senna auriculata (L.) Roxb. Seed  75 g 
Strychnos potatorum L.f.  Seed  25 g 
Terminalia bellirica (Gaertn.) Roxb. Fruit  25 g 
Terminalia chebula Retz. Fruit  25 g 
Graphite NA  80 g 
Magnetite NA  25 g 
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Method 
Mix fruits of Terminalia chebula, Phyllanthus emblica, and Terminalia bellirica and pour water into the mixture. Then boil it. Pulverise or 
crush all the other ingredients separately where applicable. Then mix them and grind with previously prepared decoction. Finally make 
244 g size tablets.  
 
Dosage: One tablet twice a day after meals 
 
31. பவள்கைக்குன்றிேணிக்குளிகக – Vellaikkundrimanikkulihai (p. 37) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed Equal amount  
Acacia nilotica (L.) Delile Resin  Equal amount 
Gossypium arboreum L. Seed  Equal amount 
Limonia acidissima Groff  Root  Equal amount 
Senna auriculata (L.) Roxb. Seed  Equal amount 
Terminalia chebula Retz. Fruit  Equal amount  
Magnetite NA  Equal amount 
Water NA  As required 
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Method 
Pulverise Terminalia chebula fruit and pour water into it. Then boil it.  
 
Open dry roast all the other ingredients separately while stirring. Pulverise or crush all the ingredients separately where applicable. Then 
mix and grind with previously prepared decoction. Make 244 g size tablets.  
 
Dosage: One tablet twice a day after meals 
 
32. காரீய சிந்தூரம் - Kaareeya sinthooram (p. 38) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Achyranthes aspera L. Whole plant  160 g 
Purified graphite NA 160 g 
 
Method 
Pulverise both ingredients separately and mix. Then open dry roast the mixture while stirring until turning into red.  
 
Dosage: As required twice a day after meals 
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33. ேம ாசிகலக்குளிகக – Manosilaikkulihai (p. 37) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Seed 30 g 
Limonia acidissima Groff  Resin 50 g 
Oryza sativa L. Seed macerated water As required 
Oryza sativa L. Seed As required 
Strychnos potatorum L.f.  Seed 30 g 
Graphite NA 80 g 
Magnetite NA 90 g 
Mercury NA 10 g 
Red arsenic NA 45 g 
 
Method 
Pulverise or crush all the ingredients except mercury separately where applicable. Then mix. Place the mixture as a heap on a cotton 
cloth and dig a hole on the middle of the heap (from the peak of the heap). Then pour mercury into the hole and wrap the mixture with the 
cloth. Tie it and macerate in Oryza sativa (rice) washed water for 4 days. On the fourth day grind the macerated mixture with Oryza sativa 
seed macerated water and make Abrus precatorius L. (Fabaceae) seed size (125 mg) tablets. Finally, shade dry them.  
 
Dosage: One tablet twice a day after meals 
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34. திரிமலாகவடகம் – Thirilohavadaham (p. 39) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia chundra (Rottler) Willd. Resin 40 g 
Acacia nilotica (L.) Delile Bark 4000 g 
Azadirachta indica A. Juss. Resin 40 g 
Cocculus hirsutus (L.) W. Theob. Leaf 4000 g 
Coscinium fenestratum (Goetgh.) Colebr.  Stem outer skin 40 g 
Limonia acidissima Groff  Resin 40 g 
Phyllanthus emblica L. Fruit 40 g 
Salacia reticulata Wight Bark 4000 g 
Senna auriculata (L.) Roxb. Whole plant 4000 g 
Senna auriculata (L.) Roxb. Seed 600 g 
Strychnos potatorum L.f.  Seed 40 g 
Syzygium cumini (L.) Skeels Bark 4000 g 
Tamarindus indica L. Seed juice 40 g 
Terminalia arjuna (Roxb. ex DC.) Wight & Arn. Bark 4000 g 
Terminalia bellirica (Gaertn.) Roxb. Fruit 40 g 
Iron NA 40 g 
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Scientific / English name Processed botanical drug Amount 
Magnetite NA 40 g 
Mercury NA 40 g 
Water  NA 115.2 l 
 
Method 
Mix Senna auriculata whole plant, barks of Salacia reticulata, Syzygium cumini, Acacia nilotica, and Terminalia arjuna, and Cocculus 
hirsutus leaf and pour water into the mixture. Then boil it until reaching to one eighth of initial volume and filter.  
 
Pulverise or press or crush iron, magnetite, mercury, Coscinium fenestratum stem outer skin, Tamarindus indica seed juice, resins of 
Limonia acidissima, Azadirachta indica, and Acacia chundra, seeds of Strychnos potatorum and Senna auriculata, Terminalia bellirica 
and Phyllanthus emblica separately where applicable. Then mix them and grind the mixture with previously prepared decoction. Then boil 
the mixture and after cooled make Areca catechu L. (Arecaceae) seed size tablets. Finally, shade dry them.  
 
Dosage: One tablet twice a day after meals 
 
35. பிரமேகக்குளிகக – Piramehakkulihai (pp. 37, 38) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia nilotica (L.) Delile Resin As required 
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Scientific / English name Processed botanical drug Amount 
Commiphora mukul (Hook. ex Stocks) Engl. Resin As required 
Ficus benghalensis L. Bark 80 g 
Limonia acidissima Groff  Resin As required 
Phoenix pusilla Gaertn. Unripe fruit 80 g 
Punica granatum L. Root 80 g 
Rivea ornata Choisy Seed As required 
Salacia reticulata Wight Bark 80 g 
Senna auriculata (L.) Roxb. Bark 80 g 
Sesamum indicum L. Seed As required 
Strychnos potatorum L.f.  Seed As required 
Terminalia arjuna (Roxb. ex DC.) Wight & Arn. Bark 80 g 
Zingiber officinale Roscoe Rhizome 80 g 
Graphite NA As required 
Iron powder NA As required 
Magnetite  NA As required 
Mercury NA As required 
Red ochre NA As required 
Stibnite NA As required 
Sulphur NA As required 
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Scientific / English name Processed botanical drug Amount 
Zinc  NA As required 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Mix barks of Ficus benghalensis, Salacia reticulata, 
Senna auriculata, and Terminalia arjuna, Punica granatum root, Phoenix pusilla unripe fruit, and Zingiber officinale and pour water into 
the mixture. Then boil until reaching to one eighth of initial volume and filter.  
 
Mix all the other ingredients together and grind the mixture with previously prepared decoction. Make Punica granatum L. (Lythraceae) 
seed size tablets and shade dry them.  
 
Dosage: One tablet twice a day after meals 
 
36. பிரமேகக்குளிகக – Piramehakkulihai (p. 38) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cocos nucifera L. Unripe fruit 10 
Senna auriculata (L.) Roxb. Seed 40 g 
Buffalo buttermilk NA As required 
Graphite NA 8 g 
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Scientific / English name Processed botanical drug Amount 
Magnetite  NA 8 g 
Mercury NA 8 g 
Sulfur NA 8 g 
 
Method 
Pulverise or scrape or press or crush all the other ingredients except buffalo buttermilk separately where applicable. Then mix them 
together and grind it with buffalo buttermilk. Make tablets and macerate them in buffalo buttermilk.  
 
Dosage: As required twice a day after meals 
 
37. பிரமேகக்குளிகக – Piramehakkulihai (p. 38) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Euphorbia hirta L.  Whole plant 1 Handful 
Papaver somniferum L. Latex 1952 g 
Phyllanthus reticulatus Poir. Tender leaf Size of a small coconut 
Buffalo buttermilk NA 2400 ml 
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Method 
Mix Phyllanthus reticulatus tender leaf and Euphorbia hirta whole plant mix together and close steam using buffalo buttermilk instead of 
water. Then add Papaver somniferum to it and grind the mixture. Then make Caesalpinia bonduc (L.) Roxb. (Fabaceae) seed size tablets 
and shade dry.  
 
Dosage: One tablet twice a day after meals 
 
38. பிரமேகக்குளிகக – Piramehakkulihai (p. 38) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cordia dichotoma G.Forst. Bark Equal amount 
Senna auriculata (L.) Roxb. Flower Equal amount 
Senna auriculata (L.) Roxb. Unripe fruit Equal amount 
Buffalo buttermilk NA As required 
Buttermilk NA As required 
Cow milk NA As required 
Graphite NA 20 g 
Mercury NA 80 g 
Mercury NA 20 g 
Sulphur NA 80 g 
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Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Mix mercury (80 g), sulphur and Cordia dichotoma 
bark and pour cow milk into the mixture. Then boil the mixture. Melt graphite and mix with mercury (20 g). Mix Senna auriculata flower 
and unripe fruit together and close steam using buttermilk instead of water. Mix all three mixtures and grind with buffalo buttermilk. Make 
Caesalpinia bonduc (L.) Roxb. (Fabaceae) seed size tablets. Finally shade dry.  
 
Dosage: One tablet twice a day after meals 
 
39. பிரமேகக்குளிகக – Piramehakkulihai (p. 39) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Euphorbia antiquorum L. Root 25 g 
Musa × paradisiaca L.  Fruit Equal amount 
Papaver somniferum L. Latex Equal amount 
Phyllanthus emblica L. Fruit 25 g 
Senna auriculata (L.) Roxb. Seed 120 g 
Senna auriculata (L.) Roxb. Firewood As required 
Senna auriculata (L.) Roxb. Seed Equal amount 
Sesamum indicum L. oil Seed Equal amount 
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Scientific / English name Processed botanical drug Amount 
Zingiber officinale Roscoe Rhizome Equal amount 
Graphite NA Equal amount 
Honey NA Equal amount 
Lead NA Equal amount 
Magnetite NA 25 g 
Mercury NA Equal amount 
Water NA Equal amount 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Mix magnetite, Phyllanthus emblica fruit, Euphorbia 
antiquorum root, and Senna auriculata seed in a rusted (reddish-yellow hydrated ferric oxides) bowl and pour Sesamum indicum oil while 
stirring. Then pour water (twice the amount of previously prepared mixture) into a clay pot and cover and tie a piece of cotton cloth on the 
mouth of the pot.  Then place the mixture on the cloth and cover and tie the mixture with another piece of cotton cloth. Cover the covered 
mixture with another clay pot placing upside down and use Senna auriculata bark as firewood to boil the mixture until the whole water 
evaporates. Preserve the mixture in an oily container.   
 
Dosage: 5 g twice a day after meals 
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40. பிரமேகக்குளிகக – Piramehakkulihai (p. 39) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Papaver somniferum L. Latex  Equal amount 
Senna auriculata (L.) Roxb. Seed As required  
Zingiber officinale Roscoe Rhizome Equal amount 
Graphite NA Equal amount 
Honey NA As required   
Lead NA Equal amount  
Mercury NA Equal amount 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable. Melt lead and mix with all the other ingredients 
together. Then grind the mixture while adding honey and make Solanum trilobatum L. (Solanaceae) fruit size tablets.  
 
Dosage: One tablet twice a day after meals 
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41. பிரமேகக்குளிகக – Piramehakkulihai (p. 39) 
Ingredients 
English name Processed botanical drug Amount 
Ant egg  NA  As required 
Buffalo milk  NA  As required 
Milk  NA  As required 
 
Method 
Press ant egg and dry thoroughly. Then grind it with buffalo milk and leave it for a day. Grind it with milk and shade dry the mixture. Then 
grind and sift it.  
 
Dosage: Oryza sativa L. (Poaceae) seed size three times a day  
 
42. பிரமேகக்குளிகக – Piramehakkulihai (p. 39) 
Ingredients 
English name Processed botanical drug Amount 
Ant egg  NA  As required 
Orpiment  NA  As required 
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Method 
Open dry roast ant egg and grind it. Then mix with purified arsenic trisulfide and grind the mixture.  
 
Dosage: As required three times a day after meals 
 
43. நாவல் பநய் - Naaval ney (pp. 44, 45) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Root 15 g 
Acacia nilotica (L.) Delile Bark 30 g 
Aucklandia lappa DC.  Root 10 g 
Cassia fistula L.  Bark 30 g 
Ficus racemosa L. Bark 30 g 
Nymphaea pubescens Willd. Rhizome 5 g 
Salacia reticulata Wight Bark 30 g 
Senna auriculata (L.) Roxb. Bark 30 g 
Syzygium cumini (L.) Skeels Bark 30 g 
Ghee NA 600 ml 
Roche alum NA 20 g 
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Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
  
Mix barks of Syzygium cumini, Ficus racemosa, Cassia fistula, Senna auriculata, Salacia reticulata, and Acacia nilotica. Pour water to the 
mixture. Boil and add ghee. Then boil it again.  
 
Mix Nymphaea pubescens rhizome, roots of Aucklandia lappa and Abrus precatorius and roche alum and grind with previously prepared 
mixture.  
 
Dosage: Consume 5 g twice a day after meals 
 
44. சந்த ாதிபயண்பணய் – Santhanaathiyennai (pp. 50, 51) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abelmoschus moschatus Medik. Seed 30 g 
Abies spectabilis (D. Don) Mirb. Leaf 30 g 
Aegle marmelos (L.) Corrêa Root 240 g 
Aloe vera (L.) Burm.f. Leaf 3600 ml 
Alpinia galanga (L.) Willd. Rhizome 30 g 
Alternanthera sessilis (L.) R.Br. ex DC. Whole plant 3600 ml 
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Scientific / English name Processed botanical drug Amount 
Aquilaria agallocha Roxb. Wood 240 g 
Asparagus racemosus Willd. Rhizome juice 3600 ml 
Aucklandia lappa DC. Root 30 g 
Cadaba fruticosa (L.) Druce Leaf 3600 ml 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 30 g 
Chrysopogon zizanioides (L.) Roberty Root 240 g 
Cinnamomum cappara-coronde Blume Resin As required 
Cocos nucifera L. Fruit water 3600 ml 
Crocus sativus L. Stigma As required 
Cycas circinalis L. Flower 30 g 
Elettaria cardamomum (L.) Maton Dried fruit 30 g 
Glycyrrhiza glabra L. Root 30 g 
Holarrhena pubescens Wall. ex G. Don Seed 30 g 
Hyoscyamus reticulatus L. Seed 30 g 
Kaempferia galanga L. Rhizome 30 g 
Magnolia champaca (L.) Baill. ex Pierre Flower 30 g 
Mesua ferrea L.  Flower 30 g 
Moringa oleifera Lam. Leaf juice 3600 ml 
Myristica fragrans Houtt. Leaf 30 g 
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Scientific / English name Processed botanical drug Amount 
Myristica fragrans Houtt. Mace 30 g 
Myristica fragrans Houtt. Seed 30 g 
Nardostachys jatamansi (D. Don) DC.  Root 30 g 
Nelumbo nucifera Gaertn. Receptacle 240 g 
Neopicrorhiza scrophulariiflora (Pennell) D. Y. Hong  Seed 30 g 
Nymphaea pubescens Willd. Rhizome 30 g 
Pandanus odorifer (Forssk.) Kuntze Flower As required 
Piper longum L. Dried fruit 30 g 
Piper nigrum L. Dried fruit 30 g 
Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger Root 30 g 
Pogostemon heyneanus Benth. Leaf 30 g 
Pterocarpus santalinus L.f. Wood 30 g 
Rubia cordifolia L. Root 30 g 
Rubia cordifolia L. Stem 30 g 
Santalum album L. Wood 480 g 
Senna tora (L.) Roxb. Seed 30 g 
Sesamum indicum L. oil NA 7200 ml 
Sida cordifolia L. Root 240 g 
Symplocos racemosa Roxb. Bark 30 g 
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Scientific / English name Processed botanical drug Amount 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 30 g 
Tinospora sinensis (Lour.) Merr. Stem 240 g 
Trachyspermum roxburghianum (DC.) H. Wolff Dried fruit 30 g 
Trigonella foenum-graecum L. Seed 30 g 
Vitex negundo L. Root juice 3600 ml 
Zingiber officinale Roscoe Dried rhizome 30 g 
Bitumen NA 30 g 
Dried cow gallstone NA As required 
Male deer musk NA As required 
Stibnite NA 30 g 
Water NA 4200 ml 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
 
Mix woods of Aquilaria agallocha and Santalum album, Aegle marmelos root, Nelumbo nucifera receptacle, Tinospora sinensis stem 
juice, roots of Sida cordifolia and Chrysopogon zizanioides together and pour water to the mixture. Boil and filter it.  
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Mix Myristica fragrans mace, rhizomes of Kaempferia galanga, Alpinia galanga, and Nymphaea pubescens, roots of Nardostachys 
jatamansi , Plectranthus hadiensis, Rubia cordifolia, Glycyrrhiza glabra, and Aucklandia lappa, flowers of Cycas circinalis, Mesua ferrea, 
and Magnolia champaca, dried fruits of Elettaria cardamomum, Trachyspermum roxburghianum, Piper nigrum, and Piper longum, leaves 
of Pogostemon heyneanus, Myristica fragrans, and Abies spectabilis, seeds of Abelmoschus moschatus, Holarrhena pubescens, 
Hyoscyamus reticulatus, Trigonella foenum-graecum, Senna tora, Neopicrorhiza scrophulariiflora, and Myristica fragrans, Rubia cordifolia 
stem, Symplocos racemosa bark, woods of Cedrus deodara and Pterocarpus santalinus, Zingiber officinale dried rhizome, Syzygium 
aromaticum flower bud, bitumen, and stibnite together and mix this mixture with previously prepared decoction. Macerate it.  
 
Then mix Alternanthera sessilis whole plant juice, Vitex negundo root juice, Asparagus racemosus rhizome juice, leaf juices of Aloe vera, 
Moringa oleifera, and Cadaba fruticose and Cocos nucifera fruit water together and add this mixture and sesame oil to macerated 
mixture.  
 
After that boil until reaching wax state and mix Pandanus odorifer flower, Crocus sativus stigma, Cinnamomum cappara-coronde resin, 
dried cow gallstone and male deer musk together. Then add to the boiled mixture before it cooled.  
 
Dosage: Apply as required all over the body including head once a day and have a shower.  
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45. வச்சிரசிந்தாேணி இரசாய ம் - Vachchirasinthaamani irasaayanam (pp. 45, 46) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abutilon indicum (L.) Sweet Root 400 g 
Acacia nilotica (L.) Delile Bark 400 g 
Bombax ceiba L.  Bark 400 g 
Bombax ceiba L.  Resin 400 g 
Cordia dichotoma G. Forst. Bark 400 g 
Euphorbia hirta L. Whole plant 400 g 
Ficus racemosa L. Bark 400 g 
Ficus racemosa L. Latex 400 g 
Gardenia crameri Tirveng.  Resin 400 g 
Gymnosporia emarginata (Willd.) Thwaites  Bark 400 g 
Lannea coromandelica (Houtt.) Merr. Bark 400 g 
Limonia acidissima Groff  Resin 400 g 
Murraya koenigii (L.) Spreng. Leaf 4000 g 
Murraya koenigii (L.) Spreng. Leaf juice 2400 ml 
Phyllanthus amarus Schumach. & Thonn. Root 400 g 
Phyllanthus reticulatus Poir. Bark 400 g 
Piper longum L. Dried fruit 400 g 
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Scientific / English name Processed botanical drug Amount 
Piper nigrum L. Dried fruit powder 400 g 
Punica granatum L. Fruit juice 600 ml 
Saccharum officinarum L. jaggery  NA 200 g 
Salacia reticulata Wight Bark 400 g 
Terminalia arjuna (Roxb. ex DC.) Wight & Arn. Bark 400 g 
Zingiber officinale Roscoe Dried rhizome 200 g 
Bitumen NA 20 g 
Honey NA 600 ml 
Kerria lacca  NA 400 g 
Mercury NA 400 g 
Mica  NA 200 g 
Water NA 230.4 l 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
 
Mix mercury, barks of Ficus racemosa, Cordia dichotoma, Acacia nilotica, Salacia reticulata, Bombax ceiba, Terminalia arjuna, 
Gymnosporia emarginata, Phyllanthus reticulatus, and Lannea coromandelica, roots of Phyllanthus amarus, Abutilon indicum, and 
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Euphorbia hirta, resins of Bombax ceiba, Limonia acidissima, Bauhinia variegata, and Gardenia crameri and Kerria lacca, Zingiber 
officinale dried rhizome, Piper longum dried fruit, and Murraya koenigii leaf. Pour water into the mixture and boil.  
 
Then pour Murraya koenigii leaf juice and Punica granatum fruit juice into the mixture. Add Piper nigrum dried fruit powder, bitumen, 
mica, and Saccharum officinarum crushed jaggery. Pour honey and boil until reaching wax state.  
 
Dosage: 1250 mg twice a day after meals for 40 days 
 
46. பிரமேகச்சந்த ாதிபயண்பணய் – Piramehachchanthanaathiyennai (pp. 51, 52) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abelmoschus moschatus Medik. Seed 15 g 
Aegle marmelos (L.) Corrêa Root 1 Handful 
Alternanthera sessilis (L.) R.Br. ex DC. Whole plant 1 Handful 
Asparagus racemosus Willd. Rhizome juice 600 ml 
Aucklandia lappa DC. Root 15 g 
Cajanus cajan (L.) Millsp. Root macerated water 600 ml 
Cannabis sativa L. Purified leaf 1 Handful 
Cardiospermum halicacabum L. Whole plant 1 Handful 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 15 g 
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Scientific / English name Processed botanical drug Amount 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 160 g 
Centipeda minima (L.) A. Braun & Asch. Whole plant 15 g 
Chrysopogon zizanioides (L.) Roberty  Root 40 g 
Cinnamomum verum J. Presl Bark 15 g 
Cuminum cyminum L. Dried fruit 15 g 
Curculigo orchioides Gaertn. Rhizome 1 Handful 
Cyanthillium cinereum (L.) H. Rob. Whole plant 1 Handful 
Cyperus mitis Steud.  Rhizome 1 Handful 
Eclipta prostrata (L.) L. Whole plant 1 Handful 
Elettaria cardamomum (L.) Maton  Dried fruit 15 g 
Ficus racemosa L. Bark 15 g 
Glycyrrhiza glabra L. Root 15 g 
Gmelina asiatica L. Root 1 Handful 
Hemidesmus indicus (L.) R. Br. ex Schult. Root 1 Handful 
Holarrhena pubescens Wall. ex G. Don Seed 15 g 
Hybanthus enneaspermus (L.) F. Muell. Whole plant 1 Handful 
Magnolia champaca (L.) Baill. ex Pierre  Flower 15 g 
Mesua ferrea L.  Flower 15 g 
Mollugo cerviana (L.) Ser. Whole plant 1 Handful 
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Scientific / English name Processed botanical drug Amount 
Myristica fragrans Houtt. Leaf 15 g 
Myristica fragrans Houtt. Seed 15 g 
Nardostachys jatamansi (D. Don) DC. Root 15 g 
Nelumbo nucifera Gaertn. Receptacle juice 600 ml 
Nymphaea pubescens Willd. Rhizome 15 g 
Pavonia odorata Willd. Root 1 Handful 
Phoenix pusilla Gaertn. Flower 15 g 
Phyllanthus amarus Schumach. & Thonn. Whole plant 1 Handful 
Phyllanthus emblica L. Fruit 15 g 
Phyllanthus emblica L. Fruit juice 600 ml 
Phyllanthus emblica L. macerated water Root 600 ml 
Piper longum L. Dried fruit 15 g 
Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger  Root 40 g 
Pogostemon heyneanus Benth. Leaf 15 g 
Pterocarpus santalinus L.f. Wood 40 g 
Ricinus communis L.  Root 1 Handful 
Rubia cordifolia L. Bulb 15 g 
Salacia reticulata Wight macerated water Root 600 ml 
Santalum album L. Wood 160 g 
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Scientific / English name Processed botanical drug Amount 
Sesamum indicum L. oil  Seed As required 
Sida cordifolia L. Root 1 Handful 
Sterculia foetida L.  Bark 15 g 
Stereospermum chelonoides (L.f.) DC.  Root 1 Handful 
Syzygium aromaticum (L.) Merr. & L. M. Perry Dried flower bud 15 g 
Terminalia bellirica (Gaertn.) Roxb. Fruit 15 g 
Terminalia chebula Retz. Fruit 15 g 
Tinospora sinensis (Lour.) Merr.  Stem 1 Handful 
Tribulus terrestris L. Whole plant 1 Handful 
Trigonella foenum-graecum L. Seed 15 g 
Withania somnifera (L.) Dunal Rhizome 1 Handful 
Butter NA 15 g 
Civet musk NA 30 g 
Cow milk NA 600 ml 
Dried cow gallstone NA 15 g 
Kerria lacca macerated water NA 600 ml 
Water NA 600 ml 
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Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
 
Mix woods of Santalum album, Cedrus deodara (160 g), and Pterocarpus santalinus and pour water into the mixture. Then boil the 
mixture. 
 
Mix Phyllanthus emblica fruit juice, Cannabis sativa  purified leaf, macerated water of Salacia reticulata, Phyllanthus emblica, (600 ml) 
and Cajanus cajan, rhizomes of Cyperus mitis, Asparagus racemosus, Curculigo orchioides, and Withania somnifera, roots of Gmelina 
asiatica, Ricinus communis, Sida cordifolia, Pavonia odorata, Hemidesmus indicus, Aegle marmelos, Stereospermum chelonoides, 
Plectranthus hadiensis, and Chrysopogon zizanioides, Tinospora sinensis  stem, whole plants of Phyllanthus amarus, Tribulus terrestris, 
Cardiospermum halicacabum, Mollugo cerviana, Alternanthera sessilis, Cyanthillium cinereum, Hybanthus enneaspermus, and Eclipta 
prostrata, Nelumbo nucifera receptacle juice, Phoenix pusilla fruit juice, Kerria lacca macerated water, and cow milk and pour water into 
the mixture. Then boil the mixture. Then mix this decoction with previously prepared decoction and pour sesame oil.  
 
After that mix barks of Sterculia foetida, Ficus racemosa, and Cinnamomum verum, Syzygium aromaticum bud, Rubia cordifolia bulb, 
dried fruits of Cuminum cyminum, Elettaria cardamomum and Piper longum, flowers of Mesua ferrea and Magnolia champaca, fruits of 
Phyllanthus emblica (15 g), Terminalia chebula, and  Terminalia bellirica leaves of Pogostemon heyneanus and Myristica fragrans, 
Nymphaea pubescens rhizome, roots of Glycyrrhiza glabra, Nardostachys jatamansi , and Aucklandia lappa, seeds of Trigonella foenum-
graecum, Holarrhena pubescens, Myristica fragrans, Abelmoschus moschatus, Centipeda minima whole plant, Cedrus deodara wood (15 
g), and butter and add to the decoction mixture. Grind and filter it. Finally sprinkle dried cow gallstone and civet musk and preserve.  
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Dosage: Apply as required all over the body (from head to toe) once a day and have a shower 
 
47. நீரிழிவுச்சந்த ாதிபயண்பணய் – Neerilivuchchanthanaathiyennai (pp. 54, 55, 56) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abelmoschus moschatus Medik. Seed 30 g 
Aegle marmelos (L.) Corrêa Root 240 g 
Aloe vera (L.) Burm.f. Leaf juice 3600 ml 
Alpinia calcarata (Haw.) Roscoe Rhizome 30 g 
Alternanthera sessilis (L.) R.Br. ex DC. Whole plant 240 g 
Alternanthera sessilis (L.) R.Br. ex DC. Leaf juice 3600 ml 
Artocarpus heterophyllus Lam. Mature leaf 30 g  
Asparagus racemosus Willd. Rhizome 240 g 
Asparagus racemosus Willd. Leaf juice 3600 ml 
Aucklandia lappa DC. Root 240 g 
Cadaba fruticosa (L.) Druce Leaf juice 3600 ml 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 30 g 
Cheilocostus speciosus (J. Koenig) C. D. Specht Root 30 g 
Chrysopogon zizanioides (L.) Roberty Root 240 g 
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Scientific / English name Processed botanical drug Amount 
Chrysopogon zizanioides (L.) Roberty Root 30 g 
Cinnamomum cappara-coronde Blume Resin As required 
Coccinia grandis (L.) Voigt Leaf juice 3600 ml 
Cocos nucifera L. Tender fruit water 7200 ml 
Crocus sativus L. Stigma 30 g 
Crocus sativus L. Stigma As required 
Cyperus rotundus L. Rhizome 240 g 
Cyperus rotundus L. Rhizome 30 g 
Elettaria cardamomum (L.) Maton Dried fruit 30 g 
Erythrina variegata L. Leaf juice 3600 ml 
Glycyrrhiza glabra L. Root 30 g 
Hemidesmus indicus (L.) R. Br. ex Schult. Root 240 g 
Holarrhena pubescens Wall. ex G. Don Seed 30 g 
Hyoscyamus reticulatus L. Seed 30 g 
Ipomoea aquatica Forssk. Leaf 30 g 
Ipomoea littoralis Blume Leaf juice 3600 ml 
Kaempferia galanga L. Rhizome 30 g 
Mesua ferrea L. Flower 30 g 
Mukia maderaspatana (L.) M. Roem. Leaf 30 g 
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Scientific / English name Processed botanical drug Amount 
Myristica fragrans Houtt. Leaf 30 g 
Myristica fragrans Houtt. Mace 30 g 
Myristica fragrans Houtt. Seed 30 g 
Nardostachys jatamansi (D. Don) DC. Root 30 g 
Nelumbo nucifera Gaertn. Receptacle 240 g 
Neopicrorhiza scrophulariiflora (Pennell) D. Y. Hong Root 30 g 
Nymphaea pubescens Willd. Rhizome 30 g 
Pandanus odorifer (Forssk.) Kuntze Flower petal As required 
Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger Root 30 g 
Pogostemon heyneanus Benth. Leaf 30 g 
Pterocarpus santalinus L.f. Wood 30 g 
Rubia cordifolia L. Stem 30 g 
Santalum album L. Wood 240 g 
Santalum album L. Wood 30 g 
Senna tora (L.) Roxb. Seed 30 g 
Sesamum indicum L. oil Seed 7200 ml 
Shorea robusta Gaertn Resin 30 g 
Sida cordifolia L. Root 240 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Dried flower bud 30 g 
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Scientific / English name Processed botanical drug Amount 
Tinospora sinensis (Lour.) Merr. Stem 240 g 
Trigonella foenum-graecum L. Seed 30 g 
Vitex negundo L. Leaf juice 3600 ml 
Bitumen NA 30 g 
Civet musk NA 30 g 
Cow milk NA 30 g 
Dried cow gallstone NA 30 g 
Male deer musk NA 30 g 
Water NA As required 
 
Method 
Pulverise or scrape or press or crush all the ingredients separately where applicable.  
Mix roots of Sida cordifolia, Aucklandia lappa, Chrysopogon zizanioides (240 g), Aegle marmelos, and Hemidesmus indicus, rhizomes of 
Asparagus racemosus and Cyperus rotundus (240 g), Santalum album wood (240 g), Alternanthera sessilis whole plant, Tinospora 
sinensis stem, Nelumbo nucifera receptacle and pour water into the mixture. Boil until reaching one eighth of the initial volume.  
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Mix Cocos nucifera tender fruit water, Sesamum indicum oil, and leaf juices of Coccinia grandis, Ipomoea littoralis, Alternanthera sessilis, 
Asparagus racemosus, Aloe vera, Cadaba fruticosa, Erythrina variegata, and Vitex negundo and pour into the previously prepared 
decoction.  
 
Mix bitumen, Syzygium aromaticum dried flower bud, Elettaria cardamomum dried fruit, Mesua ferrea  flower, leaves of Ipomoea 
aquatica, Mukia maderaspatana, Myristica fragrans and Pogostemon heyneanus, Artocarpus heterophyllus mature leaf, Myristica 
fragrans mace, Shorea robusta resin, rhizomes of Kaempferia galanga, Nymphaea pubescens, Alpinia calcarata, and Cyperus rotundus 
(30 g), roots of Chrysopogon zizanioides (30 g), Nardostachys jatamansi, Cheilocostus speciosus, Plectranthus hadiensis, Neopicrorhiza 
scrophulariiflora, and Glycyrrhiza glabra, seeds of Myristica fragrans, Abelmoschus moschatus, Hyoscyamus reticulatus, Trigonella 
foenum-graecum, Holarrhena pubescens, and Senna tora, Rubia cordifolia stem, Crocus sativus stigma (30 g), and woods of Santalum 
album (30 g), Cedrus deodara, and Pterocarpus santalinus and mix with previously prepared decoction.  
 
Blend with cow milk until reaching mustard seed particle size and spread Pandanus odorifer flower petals over it. Then filter it.  
 
Mix male deer musk, dried cow gallstone, and civet musk, Cinnamomum cappara-coronde resin, and Crocus sativus stigma and add to 
the filtered mixture. Mix while stirring.  
 
Dosage: Apply as required all over the body (from head to toe) once a day and have a shower 
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48. காந்தரசக்குளிகக – Kaantharasakkulihai (p. 36) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Cocos nucifera L. Flower 40 g  
Cocos nucifera L. Unripe fruit 4 
Senna auriculata (L.) Roxb. Seed 40 g 
Buffalo buttermilk NA As required  
Magnetite NA 40 g 
Mercury NA 80 g 
 
Method 
Mix all the other ingreadients except buffalo buttermilk. Then grind the mixture with buffalo buttermilk and make 244 g size tablets. Finally 
shade dry.  
 
Dosage: One tablet twice a day after meals 
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2. Seharaasasehara Treatment (கசகராசபசகர டைத்தியம் - Seharaasasehara Vaiththiyam)  
Seharaasasehara Treatment has 8 preparations used to treat diabetes in Sri Lankan Siddha Medicine. Details information of these 
preparations are described further.  
49. குடிநீர் - Kudineer (vs 25; p. 205) 
Ingredients 
Scientific / English name Processed botanical drug Amount  
Cassia fistula L.  Bark 30 g 
Ficus racemosa L. Bark 30 g 
Salacia reticulata Wight Bark 30 g 
Senna auriculata (L.) Roxb. Bark 30 g 
Syzygium cumini (L.) Skeels Bark 30 g 
Water NA As required 
  
Method 
Macerate all the ingredients in water overnight and filter. Then boil it.  
 
Dosage: As required twice a day before meals 
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50. குடிநீர் – Kudineer (vss 30, 31; p. 205) 
Ingredients 
Scientific / English name Processed botanical drug Amount  
Syzygium cumini (L.) Skeels Mature bark 100 g 
Magnetite NA 50 g 
Reservoir water  NA 1200 ml 
 
Method 
Pulverise Syzygium cumini mature bark and crush magnetite. Mix both of them together and pour reservoir water. Finally boil thoroghly 
until the whole water evaporates.   
 
Dosage: As required twice a day after meals 
 
51. குடிநீர் – Kudineer (vss 32, 33; p. 205) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Abrus precatorius L. Root Equal amount 
Acacia nilotica (L.) Delile Bark Equal amount 
Aloe vera (L.) Burm.f. Dried leaf pulp Equal amount 
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Scientific / English name Processed botanical drug Amount 
Anacardium occidentale L. Fruit Equal amount 
Areca catechu L.  Seed Equal amount 
Ficus racemosa L. Bark Equal amount 
Glycyrrhiza glabra L. Root Equal amount 
Nelumbo nucifera Gaertn. Rhizome Equal amount 
Nymphaea pubescens Willd. Rhizome Equal amount 
Phoenix dactylifera L. Fruit Equal amount 
Phyllanthus emblica L. Dried fruit Equal amount 
Saccharum officinarum L. jaggery NA As required 
Salacia reticulata Wight Bark Equal amount 
Santalum album L. Wood Equal amount 
Senna auriculata (L.) Roxb. Root Equal amount 
Syzygium cumini (L.) Skeels Bark Equal amount 
Terminalia chebula Retz. Dried fruit Equal amount 
Zingiber officinale Roscoe Dried rhizome Equal amount 
Water NA As required 
 
Method 
Mix all the ingredients together and pour water to the mixture. Then boil it. 
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Dosage: As required twice a day before meals 
 
52. தூள் – Thool (vs 40; p. 205) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Mature root Equal amount 
Sesamum indicum L. Mature seed Equal amount 
Oryza sativa L. Seed  Equal amount 
 
Method 
Pulverise all the ingredients separately and mix them together.  
 
Dosage: 625 mg three times a day after meals 
 
53. தூள் – Thool (vs 41; p. 207) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Root bark 5 g 
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Method 
Pulverise Senna auriculata root. 
 
Dosage: 625 mg three times a day after meals 
 
54. நீரிழிவுக்கு வங்கபசந்தூரம் - Neerilivukku vangasenthooram (vss 43, 44; pp. 207, 208) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Euphorbia antiquorum L. Latex 5 g 
Tamarindus indica L. Seed skin 5 g 
 Tin NA 5 g 
 
Method 
Mix tin with Euphorbia antiquorum latex and melt it by heating. Grind Tamarindus indica seed skin and mix it with previously prepared 
mixture. Place into a clay pot and place another clay pot (as a lid to cover the pot) on top the clay pot with mixtures. Place this set up in a 
furnace and burn it. Once cooled the powder would appear as red.  
 
Dosage: 1.25 mg twice a day after meals 
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55. பிரமேக நீரிழிவுக்கு பவட்டுோறன் தூள் - Pirameha neerilivukku Vettumaaran thool (vs 45; p. 208) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Aconitum heterophyllum Wall. ex Royle Root 5 g 
Cannabis sativa L. Purified leaf 5 g 
Cuminum cyminum L. Dried fruit 5 g 
Datura metel L. Seed 5 g 
Elettaria cardamomum (L.) Maton Dried fruit 5 g 
Foeniculum vulgare Mill. Dried fruit 5 g 
Myristica fragrans Houtt. Mace 5 g 
Myristica fragrans Houtt. Seed 5 g 
Myroxylon balsamum (L.) Harms Resin 5 g 
Papaver somniferum L. Latex 5 g 
Phyllanthus emblica L. Dried fruit 5 g 
Piper longum L. Dried fruit 5 g 
Senna auriculata (L.) Roxb. Whole plant 5 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 g 
Trachyspermum roxburghianum (DC.) H. Wolff Dried fruit 5 g 
Bitumen NA 5 g 
Magnetite  NA 5 g 
280 
 
 
Method 
Pulverise and sift all the ingredients separately. Then mix them together.  
 
Dosage: 5 g three times a day after meals 
 
56. நீரிழிவுக்கு வங்க பசந்தூரம் - Neerilivukku vanga (vs 42; p. 207) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Acacia nilotica (L.) Delile Bark  Equal amount  
Achyranthes aspera L. Whole plant   Equal amount  
Aloe vera (L.) Burm.f. Root  Equal amount  
Piper nigrum L. Dried fruit  Equal amount  
Tin  NA  Equal amount  
 
Method 
Mix tin and Aloe vera (L.) Burm.f. root together and burn the mixture. Then pulverise all the other ingredients separately and mix them 
together. Finally add previously burnt ash into this mixture and open dry roast while stirring.  
 
Dosage: As required twice a day after meals 
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3. சித்த ஔடத பசய்முகற - Siththa Audatha Seimurai – Siddha Medicinal Procedure 
This source contains 4 antidiabetic preparations of Sri Lankan SM.  
 
57. அமுது சர்க்ககரச்சூரணம் (ஏட்டுப்பிரதி) - Amuthu Sarkkaraichchooranam (Ettuppirathi) (p. 14) 
Ingredients 
Scientific / English name Processed botanical drug Amount 
Aconitum heterophyllum Wall. ex Royle Root 25 g 
Cannabis sativa L. Seed 6.25 g 
Cheilocostus speciosus (J. Koenig) C. D. Specht Root 25 g 
Cuminum cyminum L. Dried fruit 25 g 
Elettaria cardamomum (L.) Maton Dried fruit 25 g 
Glycyrrhiza glabra L. Root 25 g 
Hyoscyamus reticulatus L. Seed 25 g 
Myristica fragrans Houtt. Leaf 25 g 
Myristica fragrans Houtt. Mace 25 g 
Myristica fragrans Houtt. Seed 25 g 
Nelumbo nucifera Gaertn. Seed 100 
Papaver somniferum L. Latex 6.25 g 
Senna auriculata (L.) Roxb. Bark 25 g 
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Scientific / English name Processed botanical drug Amount 
Senna auriculata (L.) Roxb. Flower 25 g 
Senna auriculata (L.) Roxb. Root 25 g 
Senna auriculata (L.) Roxb. Seed 25 g 
Senna auriculata (L.) Roxb. Tender leaf 25 g 
Senna auriculata (L.) Roxb. Unripe fruit 25 g 
Syzygium aromaticum (L.) Merr. & L.M. Perry Flower bud 25 g 
Tinospora sinensis (Lour.) Merr. Stem 1500 g 
Trachyspermum roxburghianum (DC.) H. Wolff Dried fruit 25 g 
Civet musk NA 6.25 g 
Male deer musk NA 6.25 g 
 
Method 
Pulverise Senna auriculata bark, Syzygium aromaticum flower bud, dried fruits of Cuminum cyminum, Trachyspermum roxburghianum 
and Elettaria cardamomum, Senna auriculata flower, Myristica fragrans leaf, Myristica fragrans mace, roots of Cheilocostus speciosus, 
Glycyrrhiza glabra, Senna auriculata, and Aconitum heterophyllum, seeds of Senna auriculata, Myristica fragrans, Nelumbo nucifera, and 
Hyoscyamus reticulatus, and tender leaf and unripen fruit of Senna auriculata separately and mix them together.  
 
Then pulverise male deer musk, civet musk, Papaver somniferum resin, Cannabis sativa seed, and Tinospora sinensis stem together 
and mix with previously prepared mixture. Finally grind the mixture.  
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Dosage: 125 – 250 g twice a day after meals  
 
58. நந்தீசுர சிந்தாேணி (சுமதச கவத்திய ஔடதத்திரட்டு) - Nantheesura Sinthaamani (Suthesa Vaithiya Audathaththirattu) (p. 20) 
Ingredients 
Scientific / English name Processed botanical drug Amount  
Allium sativum L. Bulb 5 g 
Anacyclus pyrethrum (L.) Lag. Root 5 g 
Anethum graveolens L.  Seed 5 g 
Cannabis sativa L. Purified leaf 5 g 
Celastrus paniculatus Willd. Seed 5 g 
Cheilocostus speciosus (J. Koenig) C.D.Specht  Root 5 g 
Crocus sativus L. Stigma 5 g 
Cuminum cyminum L. Dried fruit 5 g 
Datura metel L. Seed 5 g 
Elettaria cardamomum (L.) Maton Dried fruit 5 g 
Ferula assa-foetida L. Resin 5 g 
Glycyrrhiza glabra L. Root 5 g 
Holarrhena pubescens Wall. ex G. Don Seed 5 g 
Hyoscyamus reticulatus L. Seed 10 g 
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Scientific / English name Processed botanical drug Amount  
Madhuca longifolia (J. Koenig ex L.) J. F. Macbr. Flower 5 g 
Mesua ferrea L.  Flower 5 g 
Myristica fragrans Houtt. Mace 5 g 
Myristica fragrans Houtt. Seed 5 g 
Neopicrorhiza scrophulariiflora (Pennell) D. Y. Hong Root 5 g 
Nigella sativa L. Seed 5 g 
Panicum antidotale Retz. Dried fruit 5 g 
Papaver somniferum L. Purified latex  5 g 
Piper chuvya Hunter ex C. DC.  Root 5 g 
Piper cubeba L.f. Fruit 5 g 
Piper longum L. Dried fruit 5 g 
Rotheca serrata (L.) Steane & Mabb. Root 5 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 g 
Trachyspermum roxburghianum (DC.) H. Wolff  Dried fruit 5 g 
Zingiber officinale Roscoe Rhizome 5 g 
Purified Arsenic NA 5 g 
Purified borax NA 5 g 
Purified cinnabar NA 5 g 
Purified magnetite NA 5 g 
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Scientific / English name Processed botanical drug Amount  
Rock salt NA 5 g 
 
Method 
Pulverise or scrape or press or crack all the ingredients separately where applicable and mix them together. Finally, open dry roast the 
mixture seven times, while stirring.  
 
Dosage: One tablet twice a day after meals 
 
59. பூரணச்சந்திராதி ோத்திகர (இருொகலச்பசட்டியார் கவத்திய விைக்கம்) Pooranachchanthiraathi Maaththirai (Irupaalaichchettiyar 
Vaiththiya Vilakkam) (p. 41) 
Ingredients 
Scientific / English name / English name Processed botanical drug Amount 
Aconitum heterophyllum Wall. ex Royle Root 5 g 
Alpinia calcarata (Haw.) Roscoe Rhizome 5 g 
Alternanthera sessilis (L.) R.Br. ex DC. Leaf juice 500 ml 
Anacyclus pyrethrum (L.) Lag. Root 5 g 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 5 g 
Cinnamomum verum J. Presl Bark 5 g 
Cuminum cyminum L. Dried fruit 5 g 
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Scientific / English name / English name Processed botanical drug Amount 
Elettaria cardamomum (L.) Maton Dried fruit 5 g 
Glycyrrhiza glabra L. Root 5 g 
Hemidesmus indicus (L.) R. Br. ex Schult. Root bark 5 g 
Myristica fragrans Houtt. Seed 5 g 
Nervilia concolor (Blume) Schltr. Whole plant 5 g 
Piper cubeba L.f. Dried fruit 5 g 
Spermacoce hispida L. Seed 5 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 g 
Tinospora sinensis (Lour.) Merr. Stem juice 500 ml 
Trigonella foenum-graecum L. Seed 5 g 
Zingiber officinale Roscoe Dried rhizome 5 g 
Beryl NA 80 g 
Rhinoceros horn  NA 160 g 
 
Method 
Pulverise or scrape or press or crack all the ingredients separately where applicable and mix them together except Tinospora sinensis 
stem, Alternanthera sessilis leaf, and Hybanthus enneaspermus whole plant.  
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Grind the mixture with Tinospora sinensis stem juice for a day followed by Alternanthera sessilis leaf juice, and Hybanthus 
enneaspermus whole plant juice each per day. Finally make Solanum trilobatum L. (Solanaceae) fruit size tablets and dry them.  
 
Dosage: One tablet twice a day after meals   
 
60. மிருத்த சஞ்சீவினி ோத்திகர (இருொகலச்பசட்டியார் கவத்திய விைக்கம்) - Miruththa Sanjeevini Maaththirai (Irupaalaichchettiyaar 
Vaiththiya Vilakkam) (pp. 47, 48) 
Ingredients 
 
Scientific / English name Processed botanical drug Amount  
Aconitum heterophyllum Wall. ex Royle Root 5 g 
Aegle marmelos (L.) Corrêa Root 5 g 
Alpinia calcarata (Haw.) Roscoe Rhizome 5 g 
Alpinia galanga (L.) Willd. Rhizome 5 g 
Anacyclus pyrethrum (L.) Lag. Root 5 g 
Cedrus deodara (Roxb. ex D. Don) G. Don Wood 5 g 
Cheilocostus speciosus (J. Koenig) C. D. Specht  Root 5 g 
Cinnamomum cappara-coronde Blume Resin 5 g 
Cinnamomum verum J. Presl Bark  5 g 
Cinnamomum verum J. Presl Bark  5 g 
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Scientific / English name Processed botanical drug Amount  
Crocus sativus L. Stigma 5 g 
Cuminum cyminum L. Seed 5 g 
Elaeocarpus tuberculatus Roxb. Seed 5 g 
Elettaria cardamomum (L.) Maton Dried fruit 5 g 
Glycyrrhiza glabra L. Root 5 g 
Justicia adhatoda L. Root 60 g 
Magnolia champaca (L.) Baill. ex Pierre Flower 5 g 
Mesua ferrea L.  Flower 5 g 
Myristica fragrans Houtt. Mace 5 g 
Myristica fragrans Houtt. Seed 5 g 
Neopicrorhiza scrophulariiflora (Pennell) D. Y. Hong Root 5 g 
Nigella sativa L. Seed 5 g 
Piper cubeba L.f. Dried fruit  5 g 
Piper longum L. Dried fruit 5 g 
Piper nigrum L. Dried fruit 5 g 
Rotheca serrata (L.) Steane & Mabb. Root 5 g 
Santalum album L. Wood 5 g 
Strychnos potatorum L.f.  Seed 5 g 
Syzygium aromaticum (L.) Merr. & L. M. Perry Flower bud 5 g 
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Scientific / English name Processed botanical drug Amount  
Terminalia chebula Retz. Seed 5 g 
Zingiber officinale Roscoe Dried rhizome 5 g 
Deer horn calx  NA 5 g 
Dried cow gallstone NA 5 g 
Gold calx NA 5 g 
Purified NA 5 g 
Purified cinnabar NA 50 g 
Purified pearl NA 5 g 
Red coral NA 5 g 
Rhinoceros horn  NA 5 g 
Rock salt  NA 5 g 
Silver calx NA 5 g 
Water NA   
 
Method 
Pulverise or scrape or press or crack all the other ingredients separately where applicable and mix the ingredients together except roots 
of Aegle marmelos and Justicia adhatoda, Piper longum dried fruit, Magnolia champaca flower, barks of Cinnamomum verum and 
Santalum album, and purified cinnabar.  
 
290 
 
Pour water to Justicia adhatoda root and boil it until reaching one eighth of the initial volume. Grind previously prepared mixture with this 
decoction for a day followed by decoctions of Piper longum dried fruit, Aegle marmelos root, Magnolia champaca flower, and Santalum 
album bark per day.  
 
Then add purified cinnabar to the ground mixture and grind it with Cinnamomum verum bark decoction for 12 hours. Finally make Vigna 
radiata (L.) R. Wilczek (Fabaceae) seed size tablets and shade dry them.  
 
Dosage: One tablet twice a day after meals 
 
Note: If this preparation taken with appropriate adjuvant, dead could be alive.  
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Appendix C 
 
Pharmacology studies of reviewed plants   
 
Table C.1. Detailed information of pharmacological and clinical studies of reviewed plants 
Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
Abelmoschus 
moschatus Medik. 
 
 
Malvaceae In vivo AE Myricetin SID 1 mg/kg 30 min Liu I.M. et al. (2005) 
Abrus precatorius L. Fabaceae In vitro LE Lupenone AAI    31 µM NA Yonemoto et al. (2014) 
    In vitro LE 24-
methylenecycloartenone 
AAI    0.6 mM NA Yonemoto et al. (2014) 
    In vitro LE Luteolin  AAI    3.1 mM NA Yonemoto et al. (2014) 
    In vitro LE 50% Methanol AAI    NS NA Yonemoto et al. (2014) 
    In vitro SE Methanol AAI    1 mg/ml NA Vadivel et al. (2011a) 
    In vitro SE Methanol AAI    1 mg/ml NA Vadivel et al. (2011a) 
    In vitro SE Methanol AGI  1 mg/ml NA Vadivel et al. (2011a) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vitro SE Methanol AAI  NS NA Vadivel et al. (2011b) 
    In vitro 
 
SE Methanol 
 
 
AGI 1 mg/ml NA Vadivel et al. (2011b) 
 
Abutilon indicum (L.) 
Sweet 
Malvaceae In vivo LE 99.5% Methanol NOR, SID 500 mg/kg 2 h Adisakwattana et al. 
(2009) 
    In vivo LE Aqueous NOR 400 mg/kg 4 h Seetharam et al. (2002) 
    In vivo LE, 
TW, 
RO 
Ethanol NOR 400 mg/kg 4 h Krisanapun et al. (2011) 
    In vivo LE, 
TW, 
RO 
Aqueous SID NS 2 week Krisanapun et al. (2010) 
    In vivo LE, 
TW, 
RO 
Aqueous NOR, SID 0.5 g/kg 30 min Krisanapun et al. (2009) 
    In vitro  LE 99.5% Methanol 
 
AGI 2.45 mg/ml NA Adisakwattana et al. 
(2009) 
 
 
Acacia leucophloea 
(Roxb.) Willd. 
Fabaceae In vivo FL 70% Methanol AID 25 mg/kg 21 d El-Toumy et al. (2009) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vivo NS NS AID 1.5 mg/100 g 
bw 
16 d Eskander and Jun (1995) 
    In vitro SE Phenol AAI    148.7 µg/mg NA Gautam et al. (2012) 
    In vitro SE Phytic acid AAI    8.8 µg/mg NA Gautam et al. (2012) 
    In vitro SE L-Dopa AAI    239.7 µg/mg NA Gautam et al. (2012) 
    In vitro SE Methanol AAI  NS NA Vadivel et al. (2011b) 
    In vitro SE Methanol 
 
 
AGI 
 
1 mg/ml NA Vadivel et al. (2011b) 
Acacia nilotica (L.) 
Delile 
Fabaceae In vivo BA NS db/db 100 mg/kg 7 d Babish et al. (2010) 
    In vivo BA Aqueous AID 2 ml /200 g 
bw 
NS Ahmad M.M. and Shaikh 
(1989) 
    In vivo BA Aqueous GLD 2 ml /200 g 
bw 
NS Ahmad M.M. and Shaikh 
(1989) 
    In vivo FR Methanol NOR 200 mg/kg  3 week Abuelgassim (2013) 
    In vivo LE 80% Methanol AID 400 mg/kg 2, 3 
week 
Asad et al. (2015) 
    In vivo LE 80% Methanol SID 300 mg/kg  3 week Asad et al. (2011) 
    In vivo PO 30% Methanol SID 150 mg/kg 60 d Omara et al. (2012) 
    In vivo PO 75% Methanol AID 400 mg/kg 1 month Ahmad M. et al. (2008) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vitro HE NS 
 
3T3-L1 
adipocytes 
 
 
50 µg/ml 2 d Babish et al. (2010) 
Achyranthes aspera 
L. 
Amaranthaceae In vivo  LE, 
ST 
80% Ethanol  AID 200 mg/kg 2 week Talukder et al. (2012) 
    In vivo  WP Aqueous  AID 4 g/kg 4 h Akhtar and Iqbal (1991) 
    In vivo  WP Methanol  AID 4 g/kg 4 h Akhtar and Iqbal (1991) 
    In vivo  WP NA 
 
 
NOR 2 g/kg 4 h Akhtar and Iqbal (1991) 
 
Acorus calamus L.  Acoraceae In vivo  RA Ethanol db/db  100 mg/kg 3 week Wu H. et al. (2007) 
    In vivo RA Ethanol NOR 200 mg/kg 1 h Si et al. (2010) 
    In vivo RA Ethanol GLD 400 mg/kg 1 h Si et al. (2010) 
    In vivo RA Ethanol AMY 100 mg/kg 30 min Si et al. (2010) 
    In vivo RA 70% Ethanol db/db 100 mg/kg 5 week Liu Y.X. et al. (2015) 
    In vivo RA 70% Ethanol SID 100 mg/kg 4 week Liu Y.X. et al. (2015) 
    In vivo RA 70% Ethanol DIO 100 mg/kg 2 week Liu Y.X. et al. (2015) 
    In vivo RH Methanol SID 200 mg/kg 21 d Prisilla et al. (2012) 
    In vitro RA Ethanol AGI 0.41 µg/ml NA Si et al. (2010) 
    In vitro RA Ethanol L6 rat 
skeletal 
muscle cell 
12.5 µg/ml  NA Wu H.S. et al. (2009) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vitro RH 1β,5α-guiane-4β,10α-
diol-6one 
 
 
HepG2 cell 1 µg/ml NA Zhou C.X. et al. (2012) 
Aerva lanata (L.) 
Juss. 
Amaranthaceae In vivo AE 50% Ethanol AID 500 mg/kg 2 week Vetrichelvan and 
Jegadeesan (2002) 
    In vivo AE Methanol, Aqueous SID 200 mg/kg 2 week Rajesh R. et al. (2012) 
    In vivo LE Ethanol AID 400 mg/kg 28 d Deshmukh et al. (2008) 
    In vivo RO Methanol SNI 10 mg/kg 2 week Agrawal et al. (2013) 
    In vivo WP 70% Ethanol SID 500 mg/kg 300 min Riya et al. (2015) 
    In vitro WP 70% Ethanol AGR 108.7 μg/ml NA Riya et al. (2015) 
    In vitro WP Ethyl acetate AGR 208.04 μg/ml NA Riya et al. (2015) 
    In vitro WP 70% Ethanol AGI 81.76 μg/ml NA Riya et al. (2015) 
    In vitro WP Ethyl acetate 
 
 
AGI 108.23 μg/ ml NA Riya et al. (2015) 
Alpinia calcarata 
(Haw.) Roscoe 
Zingiberaceae In vivo  RH Ethanol SID 200 mg/kg 30 d Rajasekar et al. (2014) 
    In vivo  RH Ethanol AID 100 mg/kg/d 21 d Raj et al. (2011) 
    In vitro  RH Ethanol RHE NS NA Rajasekar et al. (2014) 
    In vitro  RH Ethanol 
 
 
AGI 50 μl/ml NA Rajasekar et al. (2014) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
Alpinia galanga (L.) 
Willd. 
Zingiberaceae In vitro  AE Methanol SID 200 mg/kg 21 d Verma et al. (2015) 
    In vivo  RH  Ethanol SID 200 mg/kg 40 d Kaushik et al. (2013) 
    In vivo  RH  Ethanol AID 200 mg/kg 2 week Chudiwal et al. (2008) 
    In vivo  RH  Ethanol GID 200 mg/kg 2 week Chudiwal et al. (2008) 
    In vivo  RH  Methanol AID 3, 4 g/kg 6 h Akhtar M.S. et al. (2002) 
    In vivo  RH  Aqueous 
 
 
AID 4 g/kg 6 h Akhtar M.S. et al. (2002) 
Alternanthera sessilis 
(L.) R.Br. ex DC. 
Amaranthaceae In vivo  AE 95% Ethanol FID 250 mg/kg 2 week Tan and Kim (2013) 
    In vivo  AE 95% Ethanol 
 
 
SID 250 mg/kg 2 week Tan and Kim (2013) 
Anacyclus pyrethrum 
(L.) Lag. 
 
 
Asteraceae In vitro RO Ethanol AAI 29.25 µg/ml NA Kumar V.K. and Lalitha 
(2014) 
Areca catechu L.  Arecaceae In vivo HW Ethanol SID 250 mg/kg  24 h Parveen and Ahmad 
(1994) 
    In vivo HW Ethanol NGL 250 mg/kg  24 h Parveen and Ahmad 
(1994) 
    In vivo HW Aqueous NGL 250 mg/kg  24 h Parveen and Ahmad 
(1994) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vivo HW Aqueous SID 250 mg/kg  24 h Parveen and Ahmad 
(1994) 
    In vivo NS Ethyl acetate NOR 500 mg/kg  2 h Boucher et al. (1994)  
    In vivo NS Ethyl acetate AID 250 mg/kg 7 d Boucher et al. (1994)  
    In vivo  SE Procyanidin 
 
 
SID 1 mg/ml 5 week Huang et al. (2013)  
Aristolochia 
bracteolata Lam. 
 
 
Aristolochiaceae In vivo WP Methanol SID 200 mg/kg 28 d Raju and Reddy (2017) 
Artocarpus 
heterophyllus Lam. 
Moraceae Clinical  ML Aqueous NOR, DIA 20 g/kg 
(starting 
material) 
1 h Fernando et al. (1991) 
    In vivo LE Ethanol AID 100 mg/kg 7 d Okonkwo et al. (2015) 
    In vivo  LE 70% Ethanol, n-butanol SID 200 mg/kg 10 d Omar et al. (2011) 
    In vitro  LE Aqueous AAI  1000 μl/ml NA Kotowaroo et al. (2006) 
    In vivo  ML Dichloromethane SID 20 mg/kg 5 week Chackrewarthy et al. 
(2010) 
    In vitro  SE Aqueous 
 
 
AGL NS 
 
NA Shakthi Deve et al. (2014) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
Averrhoa carambola 
L. 
Oxalidaceae In vivo FR NA SID 25 mg/kg 21 d Pham et al. (2017) 
    In vivo LE Methanol GLD 400 mg/kg 1 h Shahreen et al. (2012) 
    In vivo LE Apigenin-6-C-(2''-O-α-
rhamnopyranosyl)-β-
fucopyranoside 
NOR 20 mg/kg  180 min Cazarolli et al. (2012) 
    In vivo LE Apigenin-6-C-β-
fucopyranoside  
NOR 20 mg/kg  180 min Cazarolli et al. (2012) 
    In vivo RO 2-dodecyl-6-
methoxycycyclohexa-2,5-
1,4-dione 
 
 
HFD 12.5 mg/kg 16 week Li et al. (2016) 
Bambusa bambos (L.) 
Voss  
 
 
Poaceae In vitro NS NS 3T3-L1 
adipocytes 
 
50 µg/ml NA Babish et al. (2010) 
Boerhavia diffusa L. Nyctaginaceae 
 
In vivo  LE Aqueous  
 
 
AID 200 mg/kg 4 week Pari and Satheesh (2004) 
 
Bombax ceiba L.  Malvaceae 
 
In vivo BA Ethyl acetate  SID 600 mg/kg 21 d Bhavsar and Talele 
(2013)  
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
Borassus flabellifer L. Arecaceae In vivo RO Ethanol AID NS 1 week Debnath et al. (2013) 
    In vivo RO Ethanol 
 
 
NOR 100 mg/kg 
 
7 d Debnath et al. (2013) 
 
Caesalpinia bonduc 
(L.) Roxb. 
 
 
Fabaceae In vivo SE 60% Methanol SID 250 mg/kg 21 d Jana et al. (2012) 
Calotropis procera 
(Aiton) Dryand. 
Asclepiadaceae In vivo LA NA AID 100 mg/kg 31 d Roy et al. (2005) 
    In vivo LE Aqueous SID 200 mg/kg 15 d Alrheam and Saad-Al 
Shehri (2015) 
    In vivo LE Chloroform SID 200 mg/kg 15 d Alrheam and Saad-Al 
Shehri (2015) 
    In vivo LE Ethanol SID 200 mg/kg 15 d Alrheam and Saad-Al 
Shehri (2015) 
    In vivo LA NA SID 200 mg/kg 15 d Alrheam and Saad-Al 
Shehri (2015) 
    In vivo LA Aqueous AID 100 mg/kg 90 d Kumar V. and Padhy 
(2011) 
    In vivo LE Ethanol SID 300 mg/kg 4 week Neto et al. (2013) 
    In vivo RO Methanol SID 100 mg/kg 42 d Yadav et al. (2014) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vitro LE Aqueous AGI 3.25 mg/ml NA Kazeem et al. (2016) 
    In vitro 
 
LE Ethanol 
 
 
AAI 7.80 mg/ml NA Kazeem et al. (2016) 
Cardiospermum 
halicacabum L. 
 
 
Sapindaceae In vivo LE Ethanol SID 200 mg/kg 45 d Veeramani et al. (2008, 
2012) 
 
Cheilocostus 
speciosus (J.Koenig) 
C.D.Specht  
Costaceae In vivo  RH Costunolide, eremanthin SID 20 mg/kg  NS Eliza et al. (2011) 
    In vivo  RH Hexane SID 250 mg/kg 60 d Daisy et al. (2008); Eliza 
et al. (2011) 
    In vivo  RH Aqueous SID 200 mg/kg  240 min Rajesh M. et al. (2009) 
    In vivo  RH Eremanthin SID 20 mg/kg  60 d Eliza et al. (2009a) 
    In vivo RH Ethyl acetate, methanol SID 400 mg/kg 60 d Daisy et al. (2008)  
    In vivo RH NA NOR NS 30 min Mosihuzzaman et al. 
(1994) 
    In vivo  RO 95% Ethanol SID 400 mg/kg 4 week Ali et al. (2014) 
    In vivo  RO Costunolide SID 5 mg/kg  30 d Eliza et al. (2009b) 
    In vivo  RO 95% Ethanol AID 300 mg/kg 4 week Bavarva and 
Narasimhacharya (2008) 
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Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vitro LE Methanol AAI 67.5 µg/ml NA Perera, H.K.I., et al. 
(2016) 
    In vitro LE Methanol AGI 5.88 mg/ml NA Perera, H.K.I., et al. 
(2016) 
 
 
Chrysopogon 
zizanioides (L.) 
Roberty  
 
 
 
Poaceae In vivo  RO Ethanol AID 100 mg/kg 28 d Karan et al. (2013) 
Coccinia grandis (L.) 
Voigt 
Cucurbitaceae In vivo LE Aqueous SID 0.75 g/kg 30 d Attanayake et al. (2015) 
    In vivo  LE Aqueous 
 
 
AID 0.75 g/kg 
 
4 h 
 
Attanayake et al. (2013) 
Cocculus hirsutus (L.) 
W.Theob. 
Menispermaceae In vivo  AE Methanol SID 400 mg/kg 15 d Sangameswaran and 
Jayakar (2007) 
    In vivo AE Methanol AID NS NS Ganapaty et al. (2006) 
    In vivo  LE Aqueous AID 250 mg/kg 6 h Badole et al. (2006) 
    In vivo  LE Aqueous NOR 1000 mg/kg 30 min Badole et al. (2006) 
    In vivo 
 
RO Methanol AID NS NS Satyanarayana et al. 
(2001) 
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Scientific name Family Level of 
scientific 
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Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
 
 
Coscinium 
fenestratum (Goetgh.) 
Colebr.  
Menispermaceae In vivo  ST Ethanol  SNI 500 mg/kg 12 d Punitha et al. (2005) 
    In vivo  ST Ethanol  SNI NS 12 d Shirwaikar et al. (2005a) 
    In vivo 
 
ST 99% Chloroform 
 
NOR, SID 250 mg/kg 5 d Shirwaikar et al. (2005b) 
Curculigo orchioides 
Gaertn. 
Hypoxidaceae In vivo  RH Aqueous SID 100 mg/kg 28 d Thakur et al. (2012) 
    In vivo  RT 90% Ethanol AID 500 mg/kg 7 d Madhavan et al. (2007)  
    In vivo  RT Aqueous AID 500 mg/kg  7 d Madhavan et al. (2007)  
    In vitro RH Ethanol 3T3-L1 cell 214.73 µg/ml NA Gulati et al. (2015) 
    In vitro WO Ethanol 
 
3T3-L1 cell 171.45 µg/ml NA Gulati et al. (2015) 
Curcuma aromatica 
Salisb. 
 
 
Zingiberaceae In vitro RH Dichloromethane AAI 8.97 μl/ml NA Nampoothiri et al. (2015) 
Cyanthillium cinereum 
(L.) H.Rob. 
Asteraceae Clinical  RO NA T2D 6 g/d 
(preparation 
contains 
unknown 
amount) 
 
6 month Bin Sayeed et al. (2013) 
Datura metel L. Solanaceae In vivo  SE NA NOR, AID 25 mg/kg  8 h Murthy et al. (2004) 
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Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
 
 
Dichrostachys cinerea 
(L.) Wight & Arn. 
 
 
Fabaceae In vitro ST (−)-mesquitol AGI    32 μM NA Raghavan (2004) 
Dregea volubilis (L.f.) 
Benth. ex Hook.f. 
 
 
Asclepiadaceae In vivo LE Ethanol SID 200 mg/kg 210 min Natarajan and Arul Gnana 
Dhas (2013) 
Eclipta prostrata (L.) 
L. 
Asteraceae In vivo WP Eclalbasaponin II AID 10 mg/kg 7 d Rahman et al. (2011) 
    In vivo WP Methanol 
 
 
AID 300 mg/kg 7 d Rahman et al. (2011) 
Eleusine coracana 
(L.) Gaertn. 
Poaceae Clinical  NS NA T1D, NOR NS 30 min Urooj et al. (2006) 
    In vitro  SE NA AGI NS NA Kunyanga et al. (2012) 
    In vitro  SE Methanol AGI NS NA Kunyanga et al. (2012) 
    In vitro  SE 50% Ethanol AGI NS NA Kunyanga et al. (2011) 
    In vitro  SE NS 
 
 
AGI NS NA Kunyanga et al. (2011) 
Embelia ribes Burm.f. Primulaceae In vivo FR 70% Ethanol FDI and 
SID 
100 mg/kg 21 d Bhandari et al. (2013); 
Chaudhari et al. (2013) 
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scientific 
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Active compound / 
extract 
Bioassay / 
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Dosage / 
concentration 
Duration  Reference 
    In vivo FR Ethanol SID 200 mg/kg 40 d Bhandari and Ansari 
(2009) 
    In vivo  FR Ethanol SID 100 mg/kg 6 week Bhandari et al. (2008a) 
    In vivo FR Aqueous SID 100 mg/kg 40 d Bhandari and Ansari 
(2008b) 
    In vivo FR 90% Ethanol SID 100 mg/kg 40 d Bhandari et al. (2007) 
    In vivo FR 90% Ethanol 
 
 
SID 200 mg/kg 20 d Bhandari et al. (2002) 
Erythrina variegata L. Fabaceae In vivo 
 
LE 95% Methanol 
 
 
SID 900 mg/kg 21 d Kumar A. et al. (2011) 
Euphorbia antiquorum 
L. 
Euphorbiaceae In vivo  RO 95% Ethanol FRF 200 mg/kg 21 d Madhavan et al. (2015)  
    In vivo  RO Aqueous 
 
 
FRF 200 mg/kg 21 d Madhavan et al. (2015)  
Ficus amplissima Sm. Moraceae In vivo BA Methanol GLD 50 mg/kg 1 h Arunachalam and 
Parimelazhagan (2013) 
    In vivo BA Methanol NOR 50 mg/kg 3 h Arunachalam and 
Parimelazhagan (2013) 
    In vivo BA Methanol 
 
SID 50 mg/kg 21 d Arunachalam and 
Parimelazhagan (2013) 
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Active compound / 
extract 
Bioassay / 
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Dosage / 
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Duration  Reference 
Ficus benghalensis L. Moraceae In vivo  SB 95% Ethanol AID 250 mg/kg 
twice a d 
 
 
1 week Kar et al. (2003) 
Ficus racemosa L. Moraceae Clinical  BA Aqueous T2D 1.2 g/d 1 month Ahmed et al. (2011) 
    In vivo  BA Aqueous AID, NOR 200 mg/kg  1 month Bhaskara Rao et al. 
(2002) 
    In vivo  FR 80% Ethanol SID 1.25 g/kg bw 
per 10 ml 
water 
60 min Jahan et al. (2009) 
    In vivo  FR 80% Ethanol NOR 1.25 g/kg bw 
per 10 ml 
water 
60 min Jahan et al. (2009) 
    In vivo LE β-sitosterol, stigmasterol, 
lanosterol 
SID 100 mg/kg 7 d Kushwaha et al., (2015) 
    In vivo  LE 80% Ethanol NOR, AID 100, 200, 300 
mg/kg bw 
6 h Patil V.V. et al. (2010) 
    In vivo  SB 95% Ethanol FDI, SID 200, 400 
mg/kg 
2 week Veerapur et al. (2012) 
    In vitro  BA NA AAI  NS NA Ahmed and Urooj (2010a) 
    In vitro  BA NA AGI 280 μg/ml NA Ahmed and Urooj (2010a) 
    In vitro  BA NA BGI 212 μg/ml NA Ahmed and Urooj (2010a) 
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    In vitro  BA NS AAI  NS NA Ahmed and Urooj (2010a) 
    In vitro  BA NS AGI 259 μg/ml NA Ahmed and Urooj (2010a) 
    In vitro  BA NS BGI 223 μg/ml NA Ahmed and Urooj (2010a) 
    In vitro SB 95% Ethanol RHE 100 μg/ml  NA Veerapur et al. (2012) 
    In vitro  SB Aqueous 
 
 
GD A 5 mmol/l NA Ahmed and Urooj (2010b) 
Ficus religiosa L. Moraceae In vivo BA Aqueous SID 200 mg/kg 4 week Kirana et al. (2011) 
    In vivo BA Aqueous SID, GLD 50 mg/kg 21 d Pandit et al. (2010) 
    In vivo BA Aqueous SID 100 mg/kg 4 week Kirana et al. (2009) 
    In vivo LE Aqueous 
 
 
SID 300 mg/kg 2 h Shukla et al. (2012) 
Gmelina arborea 
Roxb. 
Lamiaceae In vivo  BA Aqueous AID 1 g/kg 4 h Attanayake et al. (2013) 
    In vivo BA Aqueous SID 250 mg/kg 28 d Kulkarni Y.A. and 
Veeranjaneyulu (2013)  
 
 
Gmelina asiatica L. Lamiaceae In vivo RO 95% Ethanol NOR, AID 100 mg/kg 6 h Kasiviswanath et al. 
(2005) 
 
 
Gossypium arboreum 
L. 
Malvaceae In vitro  LE Aqueous AAI    10.10 mg/ml NA Kazeem et al. (2013) 
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    In vitro  
 
LE Acetone 
 
AGI    2.75 mg/ml NA Kazeem et al. (2013) 
Hemidesmus indicus 
(L.) R. Br. ex Schult. 
Apocynaceae In vivo RO β-amyrin palmitate AID 50 µg/kg 15 d Nair et al. (2014) 
    In vivo RO β-amyrin palmitate GLD 50 µg/kg 15 d Nair et al. (2014) 
    In vivo RO β-amyrin palmitate SID 50 µg/kg 20 d Nair et al. (2014) 
    In vivo RO 2-hydroxy-4-methoxy 
benzoic acid 
SID 500 µg/kg 7 week Gayathri and Kannabiran 
(2009) 
    In vivo RO Aqueous SID 500 mg/kg 12 week Gayathri and Kannabiran  
(2008) 
    In vivo RO Aqueous GLD 500 mg/kg 12 week Gayathri and Kannabiran  
(2008) 
    In vivo RO Ethanol NOR NS NS Rokeya et al. (1997) 
    In vivo RO Ethanol T1D NS NS Rokeya et al. (1997) 
    In vivo 
 
RO Ethanol 
 
T2D NS NS Rokeya et al. (1997) 
Hybanthus 
enneaspermus (L.) 
F.Muell. 
 
 
Violaceae In vivo  WP Ethanol SID 250 mg/kg 21 d Patel et al. (2011) 
Hygrophila auriculata 
(Schumach.) Heine 
Acanthaceae In vivo AE 50% Ethanol SID 100 mg/kg 3 week Vijayakumar et al. (2006) 
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Ipomoea aquatica 
Forssk. 
Convolvulaceae In vivo EP  Aqueous GLU 
challenged 
3.4 g/kg 2 h Malalavidhane et al. 
(2000) 
    In vivo EP  Aqueous GLU 
challenged 
3.3 g/kg 2 h Malalavidhane et al. 
(2001) 
    In vivo LE, 
ST 
NA SID 3.4 g/kg 1 week Malalavidhane et al. 
(2003) 
 
 
Madhuca longifolia 
(J.Koenig ex L.) 
J.F.Macbr. 
Sapotaceae In vivo BA Methanol NOR 100 mg/kg 30 min Dahake et al. (2010) 
    In vivo BA Methanol GLD 100 mg/kg 12 d Dahake et al. (2010) 
    In vivo 
 
BA Methanol 
 
SID 100 mg/kg NS Dahake et al. (2010) 
Magnolia champaca 
(L.) Baill. ex Pierre  
Magnoliaceae In vivo FB Aqueous GLD 400 mg/kg 1 h Jarald et al. (2008) 
    In vivo FB Ethanol GLD 400 mg/kg 1 h Jarald et al. (2008) 
    In vivo FB Ethanol AID 200 mg/kg 7 d Jarald et al. (2008) 
    In vivo 
 
FB Petroleum ether GLD 400 mg/kg 1 h Jarald et al. (2008) 
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Merremia emarginata 
(Burm. f.) Hallier f. 
 
 
Convolvulaceae In vivo NS Methanol SID 100 mg/kg 28 d Gandhi and Sasikumar 
(2012) 
Mukia 
maderaspatana (L.) 
M.Roem. 
 
 
Cucurbitaceae In vitro WP Methanol Rat liver 
slice 
0.25 mg/ml  NS Srilatha and Ananda 
(2014) 
Musa × paradisiaca L. Musaceae Clinical  FR NA T2D 5 g 1 week Edo et al. (2011) 
    In vivo FL Ethanol AID 200 mg/kg  8 d Dhanabal et al. (2005) 
    In vivo FL Chloroform AID 0.25 g/kg bw 30 d Pari and Umamaheswari 
(2000) 
    In vivo FL Chloroform AID 0.25 g/kg 30 d Pari and Maheswari 
(1999) 
    In vivo FR NA NGL 500 mg/kg bw 4 h Rai et al. (2009) 
    In vivo IN Methanol SID 200 mg/kg 
bw/d 
60 d Nisha and Mini (2013) 
    In vivo IS Aqueous SID 50, 75 g/l 7 d Jaber et al. (2013) 
    In vivo RO 60% Methanol SID 80 mg/100 g 
bw/d 
14 d Mallick et al. (2007) 
    In vivo ST Lyophilized juice SID 50 mg/kg 4 week Dikshit et al. (2012) 
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    In vivo SU 70% Methanol AID 5, 10 mg/kg 21 d Akinlolu et al. (2015) 
    In vivo UF NA SID 65 mg/kg bw 12 d Eleazu and Okafor (2015) 
    In vivo UF NA SID NS 1 d Shodehinde et al. (2015) 
    In vivo UF NA SID NS 21 d Eleazu et al. (2013) 
    In vivo 
 
UF Ethanol 
 
 
SID 100 mg/kg/d 10 d Kumar M. et al. (2013) 
Myristica fragrans 
Houtt. 
Myristicaceae In vivo  FR 50% Ethanol CID 150 mg/kg 7 d Arulmozhi et al. (2007) 
    In vivo  SK Macelingan db/db 10 mg/kg 14 d Han et al. (2008) 
    In vitro  MA Methanol AGI 0.85 mg/ml NA Patil S.B. et al. (2011) 
    In vitro  LE Methanol Insulin 
secreting 
BRIN-
BD11 cell 
 
 
1.731 μg/l NS Chee et al. (2007) 
Nardostachys 
jatamansi (D.Don) 
DC. 
 
 
Caprifoliaceae In vivo HR Aqueous SID 125 mg/kg 3 d Song et al. (2010)  
Oroxylum indicum (L.) 
Kurz 
Bignoniaceae In vivo SB 50% Ethanol SNI 250 mg/kg 28 d Singh J. and Kakkar 
(2013)  
311 
 
Scientific name Family Level of 
scientific 
evidence 
Part 
used 
Active compound / 
extract 
Bioassay / 
model 
Dosage / 
concentration 
Duration  Reference 
    In vivo SB Oroxylin A AGI 25.90 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB Chrysin AGI 57.59 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB Methoxy chrysin  AGI 95 µl/ml NA Rao J.M. et al. (2007)  
    In vivo SB Oroxyloside methyl ester AGI 97.31 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB Baiclain  AGI 38.71 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB Acetone AGI 84 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB Acetone AGI 124 µg/ml NA Rao J.M. et al. (2007)  
    In vivo SB 50% Ethanol BSA 2.10 µg/ml NA Singh J. and Kakkar 
(2013)  
 
 
Pandanus odorifer 
(Forssk.) Kuntze  
 
Pandanaceae In vivo RO 80% Ethanol AID 150 mg/kg 10 d Venkatesh et al. (2012) 
Papaver somniferum 
L. 
 
Papaveraceae In vivo  SE Aqueous AID, GLD 2 ml /200 g NS Ahmad M.M. and Shaik 
(1989) 
 
Paspalum 
scrobiculatum L. 
 
 
Poaceae In vivo  SE Ethanol AID 500 mg/kg 15 d Jain et al. (2010) 
Phyllanthus amarus 
Schumach. & Thonn. 
Phyllanthaceae In vivo AE 98% Methanol AID 100 mg/kg 25 d Okoli et al. (2011) 
    In vivo AE Methanol NGL 200 mg/kg 1 h Okoli et al. (2010) 
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    In vivo AE Methanol AID 200 mg/kg 28 d Okoli et al. (2010) 
    In vivo NS Aqueous AID 200 mg/kg  45 d Lemus et al. (2013) 
    In vivo TL 95% Ethanol AID 300 mg/kg  4 week Bavarva and 
Narasimhacharya (2007) 
    In vitro AE 98% Methanol AAI  2.15 mg/ml NA Okoli et al. (2011) 
    In vitro AE 99% Methanol 
 
 
AGI  0.2 mg/ml NA Okoli et al. (2011) 
Phyllanthus 
reticulatus Poir. 
 
 
Phyllanthaceae In vivo  LE Petroleum ether, Ethanol AID 1000 mg/kg 21 d Kumar S. et al. (2008) 
Plumbago zeylanica 
L. 
Plumbaginaceae In vivo  RO Plumbagin SID 15 mg/kg 28 d Sunil et al. (2012) 
    In vivo  RO 70% Ethanol SID 100 mg/kg 42 d Zarmouh et al. (2010) 
    In vivo  RO Ethanol 
 
 
NOR 400 mg/kg 30 d Olagunju et al. (2000) 
Pterocarpus 
santalinus L.f. 
Fabaceae In vivo BA 95% Ethanol SID 150 mg/kg 45 d Kondeti et al. (2010) 
    In vivo BA 95% Ethanol AID 0.25 g/kg  7 h Rao B.K. et al. (2001) 
    In vivo 
 
HE Aqueous 
 
 
SID 250 mg/kg 16 week Halim and Misra (2011) 
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Salacia reticulata 
Wight 
Celastraceae Clinical  BA NA T2D 2 g/d 90 d Radha and Amrithaveni 
(2009) 
    In vivo  LE Aqueous SID 1 mg NS Yoshino et al. (2009) 
    In vivo  LE Aqueous MAL 
loaded 
1 mg  30 min Yoshino et al. (2009) 
    In vivo  LE Aqueous SUC 
loaded 
1 mg 30 min Yoshino et al. (2009) 
    In vivo ST Aqueous KK-Ayd 4.5 mg dry 
matter/10 ml 
water 
4 week Im et al. (2009) 
    In vitro LE Aqueous AGI 31 µg/ml NA Yoshino et al. (2009) 
    In vitro LE Aqueous 
 
 
AGI 13 µg/ml 
 
NA Yoshino et al. (2009) 
Santalum album L. Santalaceae In vivo  NS Petroleum ether SID 10 μl/kg twice 
a d 
 
 
60 d Kulkarni C.R. et al. (2012) 
Scoparia dulcis L. Plantaginaceae In vivo LE Aqueous AID 0.45 g/kg 45 d Pari and Venkateswaran 
(2002) 
    In vivo NS Methanol SID 200 mg/kg 21 d Mishra et al. (2013) 
    In vivo NS Aqueous SID 50 mg/kg 3 week Pari and Latha (2004) 
    In vivo WP Scoparic acid D SID 20 mg/kg 15 d Latha et al. (2009) 
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    In vivo WP Aqueous SID 200 mg/kg 15 d Latha et al. (2004) 
    In vivo WP Aqueous SID 200 mg/kg 3 week Pari and Latha (2005) 
    In vivo WP Aqueous SID 200 mg/kg 6 week Latha and Pari, (2003); 
Pari and Latha, (2006) 
    In vitro NS Methanol 
 
 
AGI 80.35 μg/ml NA Mishra et al. (2013) 
Senna auriculata (L.) 
Roxb. 
Fabaceae In vivo  FL 2-(3-acetoxy-4,4,14- 
trimethylandrost-8-en-17-
yl) 
AID 5 mg/kg 15 d Venkatachalam et al. 
(2013) 
    In vivo  FL Chloroform GLD 400 mg/kg  2 h Jarald et al. (2010) 
    In vivo  FL Ethanol AID 200 mg/kg 7 d Jarald et al. (2010) 
    In vivo  FL Ethanol AID 200 mg/kg 7 d Jarald et al. (2010) 
    In vivo  FL Chloroform Fasted 
NOR  
400 mg/kg 30 min Jarald et al. (2010) 
    In vivo  FL 50% Methanol AID 0.20 g/kg 8 d Surana et al. (2008) 
    In vivo  FL 90% Ethanol AID 250 mg/kg 1 h Hatapakki et al. (2005) 
    In vivo  FL Methanol NOR 4.9 mg/kg 30 min Abesundara et al. (2004) 
    In vivo  FL Methanol NOR 5 mg/kg 60 min Abesundara et al. (2004) 
    In vivo  FL Aqueous SID 0.45 g/kg 30 d Latha and Pari (2003) 
    In vivo  LE Aqueous SID 400 mg/kg  5 h Gupta et al. (2009a) 
    In vivo  LE Aqueous SID 100 mg/kg 21 d Gupta et al. (2009b) 
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    In vivo  LE Aqueous AID 400 mg/kg 3 d Gupta et al. (2009c) 
    In vivo  LE 50% Ethanol NOR 200 mg/kg 4 h Sabu and Subburaju 
(2002) 
    In vivo  LE 50% Ethanol AID 200 mg/kg 3 d Sabu and Subburaju 
(2002) 
    In vivo  WP 95% Ethanol SID 400 mg/kg 28 d Juvekar and Halade 
(2006) 
    In vivo  WP Aqueous SID 250 mg/kg 28 d Juvekar and Halade 
(2006) 
    In vitro  FL Methanol AGI 0.196 mg/ml NA Venkatachalam et al. 
(2013) 
    In vitro FL Methanol AGI 0.023 mg/ml NA Abesundara et al. (2004) 
    In vitro LE 50% Ethanol RHE 25 mg/ml NA Sabu and Subburaju 
(2002) 
    In vitro NS Kaempferol-3-O-
rutinoside 
AGI NS NA Habtemariam (2012) 
    In vitro NS Kaempferol-3-O-
rutinoside 
 
 
PLI NS NA Habtemariam (2012) 
Senna sophera (L.) 
Roxb. 
Fabaceae In vivo SE Aqueous DIA 2 g 2 week Feng (2003) 
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Senna tora (L.) Roxb. Fabaceae In vivo SE 85% Methanol NOR 20 mg/100 g 
bw 
 
 
30 min Nam and Choi (2008) 
Sesbania grandiflora 
(L.) Pers. 
 
 
Fabaceae In vivo LE Methanol HFD and 
SID 
200 mg/kg 28 d Panigrahi et al. (2016) 
Setaria italica (L.) 
P.Beauv. 
 
 
Poaceae In vitro SE 70% Ethanol AGI 1.1 µg/ml NA Kim et al. (2011) 
Sida cordifolia L. 
 
Malvaceae In vivo AE Ethanol 
 
SID 400 mg/kg 28 d Ahmad M. et al. (2014) 
Stereospermum 
chelonoides (L.f.) DC. 
 
Bignoniaceae In vivo BA 95% Ethanol SID 200 mg/kg 14 d Balasubramanian et al. 
(2009) 
Strychnos potatorum 
L.f.  
 
 
Loganiaceae In vivo  SE NA SID 100 mg/kg 12 week Biswas et al. (2012) 
Syzygium cumini (L.) 
Skeels 
Myrtaceae In vivo BA NS SID 500 mg/kg 21 d Tripathi and Kohli (2014) 
    In vivo BA Methanol GLD 5 mg/20 mg 
bw 
30 min Rafiullah et al. (2006) 
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    In vivo BA Methanol GID 5 mg/20 g 30 min Villaseñor and Lamadrid 
(2006) 
    In vivo LE Chloroform AAI 25 mg/ml NA Bhat et al. (2011) 
    In vivo  LE Ethanol AID 125 mg/kg 1 h Schoenfelder et al. (2010) 
    In vivo  LE Ethanol NOR 200 mg/kg 
twice a d 
7 d Oliveira et al. (2005) 
    In vivo  MS Mycaminose SID 50 mg/kg 15 d Kumar A. et al. (2013) 
    In vivo  MS Ethyl acetate, Methanol SID 200 mg/kg 15 d Kumar A. et al. (2013) 
    In vivo  SE Aqueous AID 200 mg/g NS Peixoto and Freitas 
(2013) 
    In vivo  SE 80% Ethanol SID 1.25 g/kg 21 d Bhuyan et al. (2010) 
    In vivo  SE Chloroform SID 2 g/ml 21 d Bopp et al. (2009) 
    In vivo SE Cuminoside SID 50 mg/kg 21 d Farswan et al. (2009) 
    In vivo SE Petroleum ether, 
Chloroform, Acetone, 
Methanol, Aqueous 
SID 100 mg/kg 21 d Farswan et al. (2009) 
    In vivo SE Ethanol SID NS NS Mandal et al. (2008) 
    In vivo SE Aqueous SID 200 mg/kg 4 h Randriamampionona et 
al. (2008) 
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    In vivo SE Ethanol AID 75 mg/100 g 
bw 
30 d Singh N. and Gupta 
(2007) 
    In vivo SE 15% Unextracted (intact) 
diet 
AID, NOR 3 g 21 d Pandey and Khan (2002) 
    In vivo SE 15% defatted seed diet AID, NOR 3 g 21 d Pandey and Khan (2002) 
    In vivo SE 6% Gummy fibre diet AID, NOR 3 g 21 d Pandey and Khan (2002) 
    In vitro LE Aqueous ADI 60 µg/ml NA Teixeira et al. (2004) 
    In vitro SE Belulinic acid, 3,5,7,4'-
tetrahydroxy flavanone 
AAI NS NA Karthic et al. (2008) 
    In vitro SE Aqueous AAI   NS NA Singh N. et al. (1990) 
    In vitro SK 70% Ethanol AGI (SUC), 
AGI (MAL) 
299.2 µg/ml NA Shinde et al. (2008) 
    In vitro SK Acetone AGI (SUC), 
AGI (MAL) 
 
 
120.9 µg/ml NA Shinde et al. (2008) 
Tamarindus indica L. Fabaceae In vivo  SB 90% Methanol AID 250 mg/kg 16 h Yerima et al. (2014) 
    In vivo  SB 90% Methanol AID 1000 mg/kg 4 h Yerima et al. (2014) 
    In vivo  SB 90% Methanol GID 250 mg/kg 5 h Yerima et al. (2014) 
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    In vivo  SB 90% Methanol GID 500 mg/kg 1 h Yerima et al. (2014) 
    In vivo  SB 90% Methanol GID 1000 mg/kg 3 h Yerima et al. (2014) 
    In vivo  SB 90% Methanol DIA 100 mg/kg 24 h Yerima et al. (2014) 
    In vivo  SE Methanol AID 200 mg/kg 2 week Nahar et al. (2014) 
    In vivo  SE Aqueous SID 120 mg/kg 4 week Sole and Srinivasan 
(2012) 
    In vivo SE Aqueous FRF 20 mg/0.5 ml 
water/100 g 
bw 
8 week Shahraki et al., (2011) 
    In vivo  SE Aqueous SID 50 mg/kg 1 week Hamidreza et al. (2010) 
    In vivo  SE Aqueous SID 80 mg/0.5 ml 
water/ 100 g 
bw 
14 d Maiti et al. (2005) 
    In vivo  SE Aqueous SID 80 mg/0.5 ml 
water/ 100 g 
bw 
7 d Maiti et al. (2004) 
    In vivo  TL Petroleum ether Fluoride 
exposed 
NS 4 week Vasant and 
Narasimhacharya (2012) 
    In vitro SE Phenol AAI  1 mg/ml NA Gautam et al. (2012) 
    In vitro SE L-Dopa AAI  1 mg/ml NA Gautam et al. (2012) 
    In vitro SE Phytic acid AAI  1 mg/ml NA Gautam et al. (2012) 
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    In vitro SE Methanol AAI  NS NA Vadivel et al. (2011b) 
    In vitro SE Methanol AGI 1 mg/ml NA Vadivel et al. (2011b) 
    In vitro LE NA 
 
AAI  23.2 µM NA Funke and Melzig (2006) 
 
Thespesia populnea 
(L.) Sol. ex Corrêa 
Malvaceae In vivo  FP Aqueous, 5% Chloroform AID 200 mg/kg 28 d Belhekar et al. (2013) 
    In vivo  FP Ethanol AID 200 mg/kg 28 d Belhekar et al. (2013) 
    In vitro  LE  Methanol AAI   20 μg/ml NA Sangeetha and Vedasree 
(2012) 
    In vitro  LE  Ethyl acetate  AAI   50 μg/ml NA Sangeetha and Vedasree 
(2012) 
 
 
Vitex negundo L. Lamiaceae In vivo  LE Iridoid glucoside SID 50 mg/kg  30 d Sundaram et al. (2012)  
    In vivo LE Methanol GID 5 mg/20 g bw 60 min Villaseñor and Lamadrid 
(2006)  
 
Ziziphus jujuba Mill. Rhamnaceae In vivo  NS Aqueous SID 25 mg/kg 21 d Hemmati et al., (2015) 
    In vivo  NS Hydroalcoholic SID 25 mg/kg 21 d Hemmati et al., (2015) 
 
Abbreviation 
NA: not applicable, NS: not stated 
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Part used 
AE: aerial, BA: bark, EP: edible part, FB: flower bud, FE: fruit peel, FL: flower, FP: fruit pulp, FR: fruit, HE: heartwood, HR: herb, HW: 
hard wood, IN: inflorescence, IS: infructescence stalk, LA: latex, LE: leaf, MA: mace / aril, ML: mature leaf, MS: mature seed, PO: pod, 
RA: radix, RH: rhizome, RO: root, RT: root tuber, SB: stem bark, SE: seed, SK: seed kernel, ST: stem, SU: sucker, TL: tender leaf, TW: 
twig, UF: unripe fruit, WO: wood, WP: whole plant 
 
Model 
ADI: Adenosine deaminase inhibition, AID: Alloxan induced diabetic, AMY: Amylum loaded, AGL: Antiglycation assay, BSA: Bovine 
serum albumin glycosylation inhibition assay, CID: Chlorpromazine induced diabetic, DIO: diet induced obese, FDI: fat diet induced, FRF: 
Fructose fed, GD: Glucose diffusion, GID: Glucose induced diabetic, GLD: Glucose loaded, GLU: Glucose, MAL: Maltase, NGL: 
normoglycemic, NOR: normal, PLI: Pancreatic lipase inhibition assay, RHE: rat hemidiaphragm, SID: Streptozotocin induced diabetic , 
SNI:, Streptozotocin Nicotinamide induced diabetic, SUC: Sucrase, T1D: Type 1 diabetic, T2D: Type 2 diabetic, AAI: α-amylase inhibition 
assay, AGI: α-glucosidase inhibition assay, BGI: β-glucosidase inhibition assay. 
 
Duration 
d: day, h: hour, min: minute
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Appendix D 
Ethnobotanical survey questionnaire 
Section A  
1. Have any diabetic patients consulted you? 
(i) Yes (ii) No 
 
2. How many diabetic patients consult you in a week? 
 
3. How do you diagnose diabetes?  
 
4. Name the preparations you use to treat diabetic patients who consult you?  
 
5. Describe the procedures used to prepare the antidiabetic preparations? 
 
6. What are the plant species and parts that you use in the antidiabetic 
preparations? 
 
7. What animal parts do you use in the antidiabetic preparations? 
 
8. What are the inorganic substances you use in the antidiabetic preparations 
(e.g. borax and mercury)?  
 
Section B 
To compare the responses, we need some general demographic data about 
you.  
10. Age:  
 
11. Gender: Male / Female  
 
12. Number of years practicing Siddha Medicine: 
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Glossary 
 
Alloxan-induced diabetic model 
Alloxan (2,4,5,6-tetraoxypyrimidine; 5,6-dioxyuracil) is toxic to β-cells in the 
pancreas and destroy them to produce T1D conditions.  
 
Biomedicine 
“A system in which medical doctors and other healthcare professionals (such as 
nurses, pharmacists, and therapists) treat symptoms and diseases using drugs, 
radiation, or surgery. It is also called allopathic medicine, conventional 
medicine, mainstream medicine, and Western medicine”. 
 
db/db (diabetic dyslipidaemia) mouse 
The db/db mouse is a T2D model with dyslipidemia (harmful levels of one or 
more types of lipid in the blood) and obesity metabolic conditions.  
 
fa/fa (Zucker fatty) rat 
Fa/fa rat is a genetic obesity animal model and shows hyperlipidemia (high level 
of lipids in the blood), hyperphagia (excessive eating), and hyperinsulinemia 
(excess levels of insulin in the blood than glucose level).   
 
KKAy (Kyoji Kondo Ay/a) mouse 
Prof. Kyoji Kondo developed a diabetic mouse strain called KK (Kyoji Kondo) 
mouse. Then Prof. Kyoji Kondo and Prof. Masahiko Nishimura introduced an 
obesity gene Ay into KK mouse to create a developed T2D model.  
 
OLETF (Otsuka Long-Evans Tokushima Fatty) rat 
This is an obesity model originated from an outbred colony of Long Evans rat 
and distinguished by hyperphagia-induced obesity. It is used as a late onset 
T2D model.  
Streptozotocin-induced diabetic model 
Streptozotocin [2-deoxy-2-(3-(methyl-3-nitrosoureido)–D-glucopyranose] is also 
toxic to β-cells in the pancreas and destroy them to create T1D conditions.   
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